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                                 Abstract                  
The essential family of aminoacyl-tRNA synthetase (AARS) enzymes catalyzes the 
attachment of an amino acid to its cognate tRNA during ribosome-based translation of 
mRNA.  Leucyl-tRNA synthetase (LeuRS) ensures fidelity in protein synthesis via 
proofreading or editing mechanisms.  The editing that hydrolyzes noncognate amino acids 
mischarged onto tRNA
Leu
 is called post-transfer editing.  The hydrolytic post-transfer editing 
active site is located in a discretely folded polypeptide insertion called connective 
polypeptide 1 (CP1) that is linked to the enzyme‟s main body by two flexible β-strand 
linkers.  Disruption of the CP1 domain-based editing function in LeuRS results in amino acid 
toxicities that compromise cell viability.  A fluorescence-based in vivo assay was designed to 
quantify the effects of editing defects and hence assess the limits of mistranslation that can be 
borne by the cell.  Sequence enabled reassembly of N and C-terminal fragments of the green 
fluorescence protein (GFP) were studied in vivo in the presence of editing defective LeuRS 
and noncognate amino acids.   
In the yeast cytoplasmic LeuRS (ycLeuRS), the conserved post-transfer editing 
pocket is the target binding site for a novel class of benzoxaborole-based antimicrobials that 
trap tRNA
Leu
 and halt protein synthesis.  Resistance mutations (D487G and D487N) to the 
antimicrobial compound AN2690 lie outside the drug binding pocket and provided a unique 
opportunity to study editing mechanisms in the ycLeuRS.  The Asp487 residue is located in a 
CP1 domain-based eukaryote-specific flexible insert called I4 that forms a „cap‟ over the 
benzoxaborole-AMP adduct bound in the CP1 domain editing active site.  Mutational and 
biochemical analysis at Asp487 identified a salt bridge between Asp487 and Arg316 in the 
hinge region of the I4 cap that is critical to tRNA deacylation.  Thus, this electrostatic 
interaction stabilizes the cap during binding of the editing substrate for hydrolysis in the 
ycLeuRS. 
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An alternative pre-transfer editing pathway has also been identified in LeuRS and 
cleaves the noncognate amino acid before it is transferred to tRNA
Leu
, at the stage of 
aminoacyl-AMP production.  Co-existence of both pre- and post-transfer editing pathways 
was highlighted in the ycLeuRS, as has also been shown earlier for E. coli LeuRS.  Detailed 
biochemical investigations on the editing activity of this enzyme revealed that ycLeuRS shifts 
between the two editing pathways and this shift is dictated by the chemical identity of the 
noncognate amino acid misactivated by the enzyme.  While isoleucine is mainly cleared via 
the post-transfer editing route that targets Ile-tRNA
Leu
, methionine is edited via the pre-
transfer pathway by hydrolysis of methionyl-adenylate in ycLeuRS.  
The yeast mitochondrial LeuRS (ymLeuRS) was recruited to perform an alternate 
cellular role of mRNA splicing.  Splicing-sensitive sites have been located within and in 
close proximity to the CP1 domain.  Remarkably, E. coli LeuRS supports splicing in vivo, 
although its CP1 domain appears to lack the finer adaptations for efficient splicing compared 
to its counterpart from the ymLeuRS.    In vitro and in vivo analysis dissected functional 
divergences of the ymLeuRS CP1 domain that accommodate an alternate cellular role for 
RNA splicing at the expense of its housekeeping aminoacylation and editing function.  A 
close look at the connecting β-strands between the CP1 domain and main body highlighted 
that these β-strands, as well short extensions into the enzyme main body, are indispensable to 
not only LeuRS‟s editing function, but also to its splicing activity. 
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Chapter I:  Introduction 
 
I.1.  Overview of Aminoacyl-tRNA Synthetases 
 
The process of translating the genetic code into the amino acid sequence of proteins is 
mediated by adapter molecules called transfer RNA (tRNA) and an ancient family of 
enzymes called aminoacyl-tRNA synthetases (AARSs) (Nawaz, 2008).  Each of the twenty 
naturally occurring amino acids is typically recognized by a corresponding AARS (except for 
lysine which can have two AARSs in some species (Lévque F., 1990)).  Since the genetic 
code is degenerate, in most cases, there is more than one tRNA for each amino acid.  The 
tRNAs which accept the same amino acid are called isoacceptor tRNAs (Bjӧrk, 1996).  Each 
is recognized by a single AARS.   
During the process of mRNA codon-directed protein synthesis, the AARSs catalyze 
the covalent attachment of the cognate amino acid to one or more of the tRNA isoacceptors.  
The tRNAs contain identity elements that act as molecular determinants or antideterminants 
for accurate recognition by the respective synthetase (Giegé, et al., 1998; Soma, et al., 1996).  
Studies have shown that all AARSs catalyze essentially the same reaction: ATP-dependent 
activation of the cognate amino acid to form an aminoacyl-adenylate intermediate, followed 
by transfer of the activated amino acid to the 2ʹ- or 3ʹ-OH of the terminal adenosine at the 3ʹ-
end of the tRNA, resulting in formation of the aminoacylated tRNA (Ibba and Sӧll, 2000).   
Despite their common catalytic mechanism, the AARSs are divided into two classes, I 
and II, based on active site architectural differences and sequence and structural homologies 
(Table I.1, Table I.2) (Arnez and Moras, 1997; Cusack, et al., 1990; Eriani, et al., 1990; Ribas 
de Pouplana and Schimmel, 2001).  The active site core of class I AARSs are characterized 
by the presence of a structural motif consisting of six-stranded parallel β sheet.  The β-strands 
are intervened by four α helices (Figure I.1).  This motif has been classified as Rossmann 
dinucleotide binding fold (Buehner, et al., 1974; Rossmann, et al., 1974).  In addition, two 
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class-defining  signature peptide sequences (Schimmel, 1987) „KMSKS‟ (Lys-Met-Ser-Lys-
Ser) (Hountondji, et al., 1986) and „HIGH‟ (His-Ile-Gly-His)  (Webster, et al., 1984) are also 
part of the active site core of class I AARSs.  When present, the „KMSKS‟ motif is always 
accompanied by the „HIGH‟ motif.  Although these two signature sequences are in distal 
                  
 
                     Table I.1.  Classification of AARSs based on active site architectural  
                                       differences and sequence and structural homology*  
    
                     *The AARSs highlighted in blue possess proofreading activities to clear  
                     misactivated and/or mischarged amino acids. 
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Figure I.1.  Active site topologies of class I and II AARSs.  (Left) Class I synthetase parallel 
β sheet Rossmann fold.  Catalytically important conserved motifs (HIGH and KMSKS) are 
marked.  The dashed lines represent CP1 and CP2 insertion domains.  (Right)  Class II 
synthetase antiparallel β sheet.  The three characteristic motifs are highlighted.  The arrows 
and cylinders represent β strands and α helices, respectively.   
 
regions of the primary sequence of the Rossmann nucleotide binding fold, they fold together 
to comprise the active site.  The HIGH and KMSKS sequences interact with ATP (Figure I.2) 
(Arnez and Moras, 1997; Fersht, et al., 1988; Perona, et al., 1993).  Recent structural studies 
on TyrRS have captured snapshots of the extensive induced-fit local conformational changes 
within the KMSKS loop that drive the ATP-dependent activation of amino acid at the 
substrate binding site (Kobayashi, et al., 2005).  More recent complementary structural and 
thermodynamic data from Charles W. Carter Jr.‟s lab show that energetically favorable 
conformational changes within the flexible KMSKS loop lead to significantly tighter 
interactions between the enzyme and nucleotide uniformly in the pyrophosphate (PPi) and 
adenosine binding subsites (Retailleau, et al., 2007).  
On the other hand, the active site of class II AARSs present a completely different and 
largely unique topology consisting of eight-stranded antiparallel β sheet flanked by α helices 
(Figure I.1).  Interestingly, the E. coli biotin synthetase/repressor protein (BirA) is an AARS- 
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Figure I.2.  Active site conserved sequences in class I and II AARSs.  (Left)  Crystal structure 
of class I GlnRS from E. coli in complex with ATP and tRNA
Gln
 (not shown here) (PDB: 
1GTR) (Perona, et al., 1993).  The ATP is bound in an extended conformation and interacts 
with the conserved sequences HIGH and (K)MSK(S).  (Right)  Crystal structure of class II 
AspRS from yeast in complex with ATP and tRNA
Asp
 (not shown here) (PDB: 1ASZ) 
(Cavarelli, et al., 1994).  The ATP is bound in a bent conformation.  The three conserved 
motifs 1, 2 and 3 are highlighted in yellow, green and blue, respectively. 
 
like protein which has a domain that structurally resembles the class II seryl-tRNA synthetase 
(SerRS) catalytic domain (Ibba, 2005).  Based on sequence homology, three motifs have been 
defined, in order of their occurrence (Cusack, et al., 1990; Eriani, et al., 1990).  These three 
conserved motifs form a helix-loop-strand (motif 1), strand-loop-strand (motif 2) and strand-
helix (motif 3) (Figure I.1).  In the class II synthetases, the ATP is cradled at the active site by 
motifs 2 and 3 (Figure I.2) (Arnez and Moras, 1997; Perona, et al., 1993).  Although the 
motifs have a conserved core, they vary in length and are conserved by as little as a single 
invariant residue.  The sequences defining the motifs are:  motif 1, gΦxxΦxxPΦΦ; motif 2, 
(F/Y/H)Rx(E/D)(4-12x)(R/H)xxxFxxx(D/E) and motif 3, λxΦgΦgΦeRΦΦΦΦΦ (The 
abbreviations are:  x, variant; Φ, hydrophobic, λ, small amino acids.  Lower case letters 
indicate that the amino acid is partially conserved). 
Because class I and II AARSs each use their conserved characteristic active site 
sequences to bind ATP, there is little or no variation within the members of a class.  
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However, the ATP-binding conformation is distinct for the two classes of enzymes (Arnez 
and Moras, 1997).  While class I synthetases bind ATP in a fully extended conformation 
(Perona, et al., 1993), class II synthetases bind ATP is a more compact conformation where 
the γ-phosphate is folded back or bent over the adenine base (Figure I.2) (Cavarelli, et al., 
1994).   
Distinctions in tRNA binding between the two classes of AARSs dictate different 
regiochemistries of the aminoacylation reaction (Arnez and Moras, 1997).  Class I 
synthetases attach the amino acid to the 2ʹ-OH of the ribose of the terminal adenosine, while 
the class II synthetases attach the amino acid at the 3ʹ-OH of the ribose.  In addition, the 3ʹ-
CCA end of the tRNA is bent in a hairpin manner into the active site in the class I GlnRS-
tRNA
Gln
 crystal structure (Perona, et al., 1993), while it is extended straight in the class II 
AspRS-tRNA
Asp
 structure (Cavarelli, et al., 1994).  This is because the two classes of AARSs 
bind tRNA distinctly.  The class I enzymes approach the tRNA acceptor stem from the minor 
groove (Arnez and Steitz, 1996), whereas the class II enzymes approach tRNA from the 
major groove (Sankaranarayanan, et al., 1999).  However, a generalization of the tRNA-
binding pattern for all the synthetases is inappropriate since the tRNA-binding geometries are 
suggested mainly by AARS:tRNA crystal structures and not all synthetase crystal structures 
have been solved with tRNA.   
It is noteworthy that unlike a class-defining amino acid-binding pocket sequence, a 
common tRNA-binding motif has not been identified for all the synthetases.  A case in point 
is the eubacterial and eukaryotic LysRS which are known to be class II enzymes.  However, 
LysRS from the archaea Methanococcus maripaludis is unrelated to class II AARSs (Ibba, et 
al., 1997).  Instead, the presence of amino acid sequences similar to the Rossmann 
dinucleotide-binding domain classifies this LysRS as a class I synthetase (Ibba, et al., 1997).   
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           Table I.2.  Principle differences between class I and II AARSs 
 
 
 
Natural non-standard amino acids have been incorporated co-translationally to expand 
the genetic code in several organisms (Liu and Schultz, 2010; Sethi, et al., 2005).  The 
strategy used in these cases is to reprogram a termination codon on the mRNA (particularly 
the amber codon) to encode the non-standard amino acid.  An orthogonal pair of (suppressor 
tRNA:AARS) is one of the main requirements to design new systems.  The most prominent 
natural example is the presence of selenocysteine (Sec) in proteins from all three domains of 
life.  Directed by specific mRNA structural features, the amber codon-encoded 
selenocysteine is co-translationally incorporated with the help of amber suppressor tRNA
Sec
, 
SerRS, selenocysteine synthase and a special elongation factor (SelB) (Leibundgut, et al., 
2005).  Similarly, the natural amino acid pyrrolysine (pyl) can be cotranstaionally 
incorporated, directed by special mRNA features and using an analogous system to 
selenocysteine incorporation, that is, an amber suppressor tRNA
Pyl
 and an AARS-like protein 
PylS (Srinivasan, et al., 2002) or LysRS (Polycarpo, et al., 2003).   
Genes encoding cysteinyl-tRNA synthetase (CysRS) have been detected in organisms 
across the three kingdoms of life, except in certain methanogenic archaea.  In these 
  
7 
 
organisms, the cysteine codons are translated indirectly (Sauerwald, et al., 2005).  The first 
step in this indirect mechanism is the formation of Sep-tRNA
Cys
 by a unique AARS called O-
phosphoseryl tRNA synthetase (SepRS) that attaches O-phosphoserine (Sep) to tRNA
Cys
.  A 
second enzyme called SepCysS then converts Sep-tRNA
Cys
 to Cys-tRNA
Cys 
in the presence 
 
 
Figure I.3.  Strategy for co-translational incorporation of non-standard amino acids.  (Top)  
Indirect mechanism of cysteine codon translation in methanogenic archaea.  (Bottom)  Co-
translational incorporation of O-phosphoserine (Sep) in E. coli proteins.  Solid blue and green 
lines represent mRNA and polypeptide chain, respectively. 
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of a natural sulfate donor (Figure I.3, top).  More recently, this indirect mechanism in archaea 
has been used to cotranslationally incorporate O-phsophoserine (Sep) in E. coli proteins 
(Park, et al., 2011).  In this strategy, mutations in the archaeal tRNA
Cys
 generated the archaeal 
amber suppressor tRNA
Sep
.  The archaeal (SepRS/amber suppressor tRNA
Sep
), which then 
served as an orthogonal pair in E. coli cells was used along with a special elongation factor 
(EF-Sep) to co-translationally add O-phosphoserine (Sep) to the E. coli proteome (Figure I.3, 
bottom).   
As the ancient family of AARSs evolved, several of the synthetases have acquired 
insertion domains or short peptides in addition to their aminoacylation catalytic domains.  
These insertion domains are dedicated to a variety of diverse functions.  The most prominent 
among them is proofreading/editing during the aminoacylation reaction.  In class I AARSs 
the hydrolytic editing domain is the conserved connective polypeptide 1 (CP1 (Starzyk, et al., 
1987)) (Hou, et al., 1991; Starzyk, et al., 1987) domain) that is inserted into the Rossmann 
dinucleotide-binding fold of the aminoacylation active site (Lin, et al., 1996; Mursinna, et al., 
2001; Schmidt and Schimmel, 1994; Starzyk, et al., 1987).   
In class II synthetases, the editing domain that is responsible for hydrolytic editing is 
relatively more diverse in their location and structure (Beebe, et al., 2003; Wong, et al., 
2002).  The hydrolytic editing domain of E. coli threonyl-tRNA synthetase (ThrRS) exists as 
an additional appendage at the N-terminus (Dock-Bregeon, et al., 2000).  On the other hand, 
based on primary structures, the ProRS family can be divided into „prokaryotic-like‟ and 
„eukaryotic-like‟ groups.  The „prokaryotic-like‟ group, which includes bacterial and 
eukaryotic mitochondrial enzymes, carries out hydrolytic editing of mischarged tRNA via a 
large insertion domain (INS) located between motifs 2 and 3 that constitute the 
aminoacylation active site (Wong, et al., 2002; Wong, et al., 2003).  Surprisingly, the 
„eukaryotic-like‟ ProRS group that includes the eukaryotic and archaeal enzymes lacks the 
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INS domain, but instead has a C-terminal extension that is missing from the „prokaryotic-
like‟ group.  Some lower eukaryotes possess an N-terminal extension domain that bears weak 
homology to the INS domain (Ahel, et al., 2003).  
Another example of an insertion domain is the anticodon binding domain (ABD).  
The ABD is essential to recognize the tRNA anticodon loop for most AARSs except LeuRS, 
SerRS, and alanyl-tRNA synthetase (AlaRS) (Asahara, et al., 1993; Giegé, et al., 1998).  
Significantly, the ABDs possess markedly variable structures.  For example, the ABDs from 
glutamyl-tRNA synthetase (GluRS) (Nureki, et al., 1995) and glutaminyl-tRNA synthetase 
(GlnRS) (Rould, et al., 1989) are mainly comprised of α helices and β strands respectively.   
 
I.2.  Mechanism of the aminoacylation reaction 
 
The AARSs catalyze the covalent attachment of an amino acid to the 3ʹ-end of the 
cognate tRNA (Ibba and Sӧll, 2000).  The aminoacylation reaction occurs in two steps.  In 
the first step, the enzyme-bound amino acid is activated in an ATP-dependent fashion to form 
the enzyme-bound aminoacyl adenylate (AA-AMP) intermediate.  In the second step, the 
activated amino acid is transferred to the 3ʹ-end of the tRNA forming the charged or aminoa- 
 
 
 
Figure I.4.  Cartoon representation of the two-step aminoacylation reaction catalyzed by 
AARSs.  Step 1 involves ATP-dependent activation of the amino acid (AA), forming the 
enzyme-bound aminoacyl adenylate (AA-AMP) intermediate at the synthetic active site.  
Step 2 entails the transfer of the activated amino acid to the 3ʹ-end of the tRNA. 
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cylated tRNA (AA-tRNA
AA
) (Figure I.4).  Although the first step of amino acid activation is 
independent of tRNA, GluRS, GlnRS, ArgRS and LysRS-I require tRNA as a cofactor (Ibba, 
et al., 1996). 
The first step of amino acid activation occurs by in-line nucleophilic displacement 
where the α-carboxylate oxygen of the amino acid attacks the α-phosphate of ATP, forming 
the AA-AMP intermediate.  Cleavage of the phosphoanhydride linkage between the α- and 
the β-phosphate of ATP releases PPi (Figure I.5).  In the second step, the 2ʹ-hydroxyl (for 
class I AARSs) or the 3ʹ-hydroxyl (for class II AARSs) of the ribose of the terminal 
adenosine (A76) at the 3ʹ-end of the tRNA makes a nucleophilic attack on the carboxyl 
carbon of the AA-AMP intermediate (Figure I.5).  This cleaves the mixed anhydride bond in 
the adenylate, resulting in transfer of the amino acid to the 3ʹ-end of the tRNA. 
For both classes, the amino acid and ATP-binding pockets are well defined templates 
in which the substrates are optimally positioned for formation and stabilization of the 
transition state.  Within this active site, specificity of a particular AARS for its cognate amino 
acid is determined by idiosyncratic contacts between the amino acid side chain and active site 
residues.  The specificity of substrate recognition is further enhanced by an induced fit 
mechanism in which ATP-binding triggers mostly local conformational changes within the 
aminoacylation active site, particularly the conserved KMSKS sequence of class I synthetases 
(Retailleau, et al., 2007).  Thus, although all AARSs catalyze the same overall two-step 
aminoacylation reaction, substrate binding, and stabilization of the transition state are 
dependent on distinct features of the active site which are class-specific.   
In class I AARSs, biochemical and structural studies have shown extensive 
conformational rearrangements of the KMSKS and in some cases, the HIGH motif, following 
ATP binding, to stabilize the transition state using ATP-binding energy (First and Fersht, 
1995; Kobayashi, et al., 2005).  Thermodynamic data obtained from isothermal titration  
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Figure I.5.  Mechanism of the two-step aminoacylation reaction in class I AARSs.  (Top)  
The first step involves a nucleophilic attack by the α-carboxyl oxygen of the amino acid at 
the α-phosphate of ATP, forming the aminoacyl adenylate intermediate.  (Bottom)  In the 
second step the 2ʹ-OH of the ribose ring of terminal adenosine at the 3ʹ-end of tRNA makes a 
second nucleophilic attack (for class I AARSs) at the carboxyl carbon of the aminoacyl 
adenylate intermediate, forming the aminoacylated tRNA. 
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Figure I.6.  Amino acid-binding pocket of LeuRS.  Co-crystal structure of T. thermophilus 
LeuRS with the analog of leucyl-adenylate (5ʹ-O-[N-(leucyl)-sulfamoyl] adenosine) 
(LeuAMS) bound at the aminoacylation active site (PDB: 1H3N) (Cusack, et al., 2000).  
Residues which H-bond with LeuAMS are shown in different colors.  A largely hydrophobic 
pocket (Met40, Phe41, Tyr43, Phe501, Tyr507, His541 and His545) that binds the leucine 
side chain is highlighted in green. 
 
calorimetry reveal that tight ATP-binding is largely driven by favorable entropy changes 
associated with the induced-fit assembly at the active site (Retailleau, et al., 2007).  These 
studies also reveal a transition state in which the KMSKS signature sequence forms 
increasingly tighter bonds with PPi, the leaving group, weakening linkage to the α-phosphate 
of ATP.  The complexed structure of T. thermophilus LeuRS with the analog of leucyl-
adenylate (5ʹ-O-[N-(leucyl)-sulfamoyl] adenosine) (LeuAMS) at the aminoacylation active 
site have provided molecular details of the amino acid and ATP-binding pockets.  Both the 
ribose and the adenine of ATP interact with the active site via multiple hydrogen bonds.  The 
ribose is stacked on top of Met576 and is hydrogen bonded to Glu540 and Gln574, whereas 
the adenine base is hydrogen bonded to Gln574, Val577 and Met638 (Figure I.6) (Cusack, et 
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al., 2000).  The α-amino group of leucine forms a hydrogen bond with the Asp80 side chain 
and the carbonyl oxygen of leucine interacts with His541.  The leucine side chain binds in a 
largely hydrophobic pocket at the active site, comprised of Met40, Phe41, Tyr43, Phe501, 
Tyr507, His541 and His545 (Figure I.6) (Cusack, et al., 2000).   
In class II AARSs, numerous structural (Cavarelli, et al., 1994) and mutational studies 
(Stehlin, et al., 1997) show the importance of motifs 2 and 3 in ATP and amino acid 
recognition and activation.  The active site of these enzymes promotes amino acid activation 
by binding ATP and amino acid in an orientation that facilitates the reaction mechanism and 
stabilizes the transition state, particularly by motif 2 (Cusack, 1997).  Significantly, not only 
is the recognition of the specific amino acid idiosyncratic to the specific synthetase, but there 
is also considerable variation in the magnitude of the induced-fit associated with amino acid 
binding. While the active sites of seryl-tRNA synthetase (SerRS) (Belrhali, et al., 1995) and 
aspartyl-tRNA synthetase (AspRS) (Cavarelli, et al., 1994) form a relatively rigid amino acid 
binding pocket, conformational changes in histidinyl-tRNA synthetase (HisRS) are much 
greater and have more global repercussions on movements of other domains with respect to 
the catalytic site (Arnez, et al., 1995).  In class II synthetases, the binding of ATP in the bent 
conformation (Figure I.2) is dependent on the ordering of motif 2 and interactions with 
residues conserved in all class II synthetases.  For example, in HisRS (Arnez, et al., 1995; 
Arnez, et al., 1997), in the absence of the adenylyl moiety of either ATP or the histidinyl-
adenylate, motif 2 is poorly ordered.  Consistent with other class II synthetases, the motif 2 
loop in HisRS assumes an ordered β-hairpin conformation due to its main chain interactions 
with the adenosine base that is stacked between motifs 2 and 3 (Figure I.2).   
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I.3.  Proofreading (Editing) pathways in AARSs 
 
Fidelity in protein synthesis is important to the cell.  Mistranslation in the proteome 
can result in accumulation of misfolded proteins, thus leading to neurodegenerative diseases 
(Lee, et al., 2006; Ross and Poirier, 2004) and eventually cell death (Karkhanis, et al., 2007).  
For example, editing defects in AlaRS lead to mistranslation and accumulation of misfolded 
proteins in neurons in mouse (Lee, et al., 2006; Nangle, et al., 2006).  The accumulation of 
unfolded proteins is accompanied by up-regulation of cytoplasmic protein chaperones and 
induction of the unfolding of proteins.  The mouse-model harboring the editing-defective 
AlaRS show a marked loss of Purkinje cells in the cerebellum and developed severe ataxia 
(Lee, et al., 2006).   
  Thus, the cell has devised multiple checkpoints to maintain translational fidelity.  
These are at the level of the AARSs that catalyze formation of aminoacylated tRNAs 
(Mascarenhas, 2008), EF-Tu, the protein that carries the aminoacylated tRNA to the 
ribosome (LaRiviere, et al., 2001) and the ribosome that catalyzes peptide bond synthesis 
(Ogle, et al., 2002; Zaher and Green, 2009).  Out of these, the AARS-dependent fidelity is the 
first checkpoint and hence critical for the cell to ensure error-free protein synthesis by 
ensuring formation of the correctly charged tRNA.  Several AARS-linked neurodegenerative 
diseases have been reported (Nangle, et al., 2007; Park, et al., 2008).  
Linus Pauling, in 1957, predicted an error rate of 1 in 20 for a valine substitution in 
place of isoleucine by isoleucyl-tRNA synthetase (IleRS) (Pauling, 1958).  However, in vivo 
error rate measurement for a valine substitution in place of isoleucine, reported an estimate of  
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Figure I.7.  Scheme showing pre- and post-transfer editing pathways.  The aminoacyl 
adenylate (AA-AMP) is the substrate for pre-transfer editing, while the mischarged tRNA 
(AA-tRNA) is the substrate for post-transfer editing.   
 
approximately 1 in 3000 (Loftfield, 1963).  Such an increase in fidelity clearly indicated that 
molecular recognition of amino acids extends beyond initial substrate discrimination at the 
aminoacylation active site of AARSs.  Baldwin and Berg showed that although E. coli IleRS 
catalyzed formation of both the noncognate valyl-adenylate (Val-AMP) and the cognate 
isoleucyl-adenylate (Ile-AMP), addition of tRNA
Ile
 only led to formation of Ile-tRNA
Ile
 and 
not Val-tRNA
Ile
 (Baldwin and Berg, 1966).  It was later reported that for E. coli IleRS, the 
noncognate Val-AMP was hydrolyzed (proofread), thereby avoiding valine mischarging to 
tRNA
Ile
 (Fersht and Dingwall, 1979a).  Thus, the concept of „editing‟ or „proofreading‟ was 
introduced for AARSs to explain how they maintain the high degree of fidelity in protein 
synthesis.   
The hydrolysis pathway that targets the mixed anhydride linkage in the adenylate 
(AA-AMP) is called „pre-transfer‟ editing, while the hydrolysis pathway that cleaves the 
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aminoacyl ester bond in the (mis)charged tRNA (AA-tRNA) is termed „post-transfer‟ editing 
(Figure I.7).  Out of the twenty standard AARSs, nine enzymes are known to possess editing 
activities.  These include the class I AARSs, LeuRS (Englisch, et al., 1986; Mursinna, et al., 
2004), IleRS (Baldwin and Berg, 1966), valyl-tRNA synthetase (ValRS) (Fersht and 
Kaethner, 1976) and methionyl-tRNA synthetase (MetRS) (Fersht and Dingwall, 1979b) and 
the class II AARSs AlaRS (Tsui and Fersht, 1981), PheRS (Yarus, 1972), ProRS (Beuning 
and Musier-Forsyth, 2000), ThrRS (Dock-Bregeon, et al., 2004), and LysRS (Jakubowski, 
1999). 
 
I.3.A.  Post-transfer editing 
To explain the high level of amino acid discrimination achieved by the AARSs, Fersht 
proposed the „double sieve‟ model of fidelity (Fersht, 1977a).  Some of the AARSs face the 
challenge of discriminating between structurally similar amino acids.  For example, the 
LeuRS aminoacylation active site misactivates and mischarges structurally similar standard 
amino acids isoleucine, methionine and valine as well as nonstandard metabolic intermediates 
with amino acid backbones such as norvaline, norleucine and α-aminobutyrate (Figure I.8).  
The double sieve model predicts that one enzyme active site may not completely discriminate 
between leucine and the noncognate amino acids, but two separate active sites with distinct 
strategies for substrate recognition significantly enhance fidelity (Fersht, 1977a).  The 
aminoacylation active site of an AARS would form the adenylate (AA-AMP) by activating 
cognate amino acid and also the structurally similar smaller noncognate amino acids that fit 
the amino acid-binding pocket to a lesser extent, thereby acting as a „coarse sieve‟.  The 
second active site that would provide the „fine sieve‟ would bind the misactivated amino acid, 
while excluding the cognate amino acid.   
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Figure I.8.  Structurally similar isosteric standard amino acids and biosynthetic intermediates 
(norvaline and α-aminobutyrate) that are activated or misactivated by LeuRS. 
 
For the class I AARSs, LeuRS, IleRS and ValRS, the editing active site that catalyzes 
post-transfer editing is housed in the homologous CP1 domain.  Isolated CP1 domains from 
LeuRS, IleRS and ValRS clear noncognate amino acids from the respective mischarged 
tRNAs (Betha, et al., 2007; Lin, et al., 1996).  Co-crystal structure of LeuRS with the post-
transfer editing substrate analog 2ʹ-(L-norvalyl) amino-2ʹ-deoxyadenosine (Nva2AA) bound 
at the editing site in the CP1 domain (Figure I.9, left) (Lincecum, et al., 2003) as well as 
biochemical and computational studies (Mursinna, et al., 2001; Mursinna, et al., 2004; 
Mursinna, 2002) have provided molecular details of the post-transfer editing pocket in the 
CP1 domain.  In LeuRS, the amino acid-binding pocket in the CP1 domain-based editing site 
has been precisely located to a threonine-rich peptide (highlighted in green in Figure I.9, left) 
(Lincecum, et al., 2003; Mursinna, et al., 2001).  Within this pocket, a highly conserved 
threonine residue (Thr252 in E. coli and T. thermophilus; Thr319 in S. cerevisiae LeuRS  
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Figure I.9.  CP1-based editing active site of LeuRS.  (Left)  Post-transfer editing substrate 
analog 2ʹ-(L-norvalyl)amino-2ʹ-deoxyadenosine (Nva2AA) bound at the editing site in the 
CP1 domain of T. thermophilus LeuRS.  Editing pocket residues that make critical contacts 
with the substrate are highlighted, including the threonine-rich peptide (green) that lines the 
base of the pocket. (PDB: 10BC) (Lincecum, et al., 2003).  (Right)  Crystal structure of the T. 
thermophilus LeuRS in complex with tRNA
Leu
 in the post-transfer editing conformation.  The 
terminal A76 at the 3ʹ-end of the tRNA is shown to be positioned at the editing active site in 
the CP1 domain.  The conserved N-terminal „WIG‟ peptide and the C-terminal „RDW‟ 
peptide of LeuRS, which have critical contacts with the tRNA are highlighted in blue and 
pink, respectively. Leucine (yellow) is bound at the aminoacylation active site (PDB: 2BYT) 
(Tukalo, et al., 2005). 
 
(Figure I.9, left) acts as the discriminator that blocks leucine from entering the editing pocket, 
while allowing the noncognate amino acid side chains to gain access into the editing pocket 
(Mursinna, et al., 2001).  In this peptide, two conserved threonine residues (Thr247 and 
Thr248 in T. thermophilus LeuRS, Figure I.9, left) in total form three hydrogen bonds to the 
ribose moiety of Nva2AA (Lincecum, et al., 2003).  Biochemical studies have shown that 
these two threonine residues collaborate to maintain a functional post-transfer editing active 
site in the CP1 domain of LeuRS (Zhai and Martinis, 2005).  The Nva2AA post-transfer 
editing substrate analog is held in place by hydrogen bonding between the norvaline moiety 
and the universally conserved Asp347.   
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The CP1 domain-based editing active site is about ~35 Å distant from the 
aminoacylation active site, as revealed by crystal structures (Cusack, et al., 2000; Fukai, et 
al., 2000; Nureki, et al., 1998; Silvian, et al., 1999; Tukalo, et al., 2005).  In the co-crystal 
structure of LeuRS and tRNA
Leu
 in the editing conformation (Tukalo, et al., 2005), the 3ʹ-
CCA end of the tRNA is positioned in the editing site of the CP1 domain (Figure I.9, right).  
Thus, it is hypothesized that the (mis)charged 3ʹ-end of the tRNA translocates from the 
aminoacylation active site in the enzyme main body to the editing active site in the CP1 
domain.  Indeed a „translocation peptide‟ has been defined in E. coli LeuRS (Hellmann and 
Martinis, 2009).  Mutations within this peptide abolish or impede translocation of the 3ʹ-end 
of the (mis)charged tRNA.  Translocation of the tRNA 3ʹ-end is accompanied by a ~35° 
rotation of the CP1 domain that brings it in close proximity to the aminoacylation active site 
in the main body (Tukalo, et al., 2005).  Two conserved motifs (WIG on the N-terminus and 
RDW on the C-terminus, Figure I.9, right) in the flexible β strands facilitate the movement of 
the CP1 domain (Mascarenhas and Martinis, 2008; Mascarenhas and Martinis, 2009; Tukalo, 
et al., 2005).  The flexible β-strand linkers in LeuRS are also required for viable editing 
activity of the isolated CP1 domain (Betha, et al., 2007).  MetRS is highly homologous to 
class I LeuRS, IleRS and ValRS, but possesses a very small CP1 domain that lacks an editing 
function. Biochemical studies indicate that MetRS hydrolyzes mischarged tRNA within the 
synthetic active site.  The hydrolysis active site is however molecularly partitioned from the 
aminoacylation active site (Gruic-Sovulj, et al., 2007; Kim, et al., 1993). 
In class II AARSs, the editing domains are structurally unrelated.  The bacterial N-
terminal N2 domain of ThrRS is responsible for post-transfer editing (Dock-Bregeon, et al., 
2000).  The ThrRS N2 domain is conserved in most bacterial and eukaryotic cytoplasmic 
enzymes, but is absent in archaeal and eukaryotic mitochondrial enzymes.  The editing 
domain of AlaRS is only weakly related to the bacterial ThrRS N2 domain (Beebe, et al., 
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2003; Dock-Bregeon, et al., 2000; Dock-Bregeon, et al., 2004).  In bacterial ProRS, a novel 
insertion domain (INS) confers post-transfer editing (Wong, et al., 2002), while PheRS has 
another distinct editing domain (Roy and Ibba, 2006). 
The post-transfer editing pathway in class II ProRS introduces a novel concept of a 
„triple sieve‟ model for proofreading.  Bacterial ProRS relies on an additional free-standing 
protein (Haemophilus influenza Ybak) to clear micharged amino acids in trans (An and 
Musier-Forsyth, 2005; Ruan and Soll, 2005).  ProRS misactivates both alanine and cysteine 
at the aminoacylation active site (first sieve).  The post-transfer editing INS domain of ProRS 
(second sieve) is responsible for hydrolyzing Ala-tRNA
Pro
 in cis (Wong, et al., 2002).  
However, the INS domain of bacterial ProRS lacks a Cys-tRNA
Pro
 specific hydrolytic activity 
(Ahel, et al., 2002; An and Musier-Forsyth, 2005).  In bacteria, Cys-tRNA
Pro
 is instead 
cleared by the free-standing protein Ybak through formation of a novel 
Ybak•synthetase•tRNA ternary complex (An and Musier-Forsyth, 2005; Ruan and Soll, 
2005).  Thus, the free-standing protein introduces a „third sieve‟ in the ProRS system.  
Interestingly, an INS editing domain paralog, ProX from the bacterium Clostridium 
sticklandii has been reported to hydrolyze Ala-tRNA
Pro
 but not Cys-tRNA
Pro
 (Ahel, et al., 
2003).  The ProRS from this species does not have an INS domain.   
 
I.3.B.  Pre-transfer editing 
Editing pathways that preferentially hydrolyze noncognate adenylate AA-AMP prior 
to amino acid transfer to tRNA is referred to as pre-transfer editing (Figure I.7).  Several 
models or mechanisms have been proposed for pre-transfer editing (Figure I.10).  This 
includes enzyme-catalyzed hydrolysis of the noncognate adenylate in the aminoacylation 
active site where it is formed („enzymatic hydrolysis‟, pathway 1 in Figure I.10).  Alternately, 
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the noncognate adenylate which is significantly less stably bound by the enzyme as compared 
to the cognate adenylate (Hati, et al., 2006)] may be released into solution and non-enzymati- 
 
 
 
Figure I.10.  Scheme showing possible pre- and post-transfer editing pathways.  
Abbreviations are:  aminoacyl-tRNA synthetase (AARS), amino acid (AA), aminoacyl-
adenylate (AA-AMP) and aminoacylated tRNA (AA-tRNA). 
 
cally hydrolyzed („active site ejection‟, pathway 2 in Figure I.10).  If the rate of the adenylate 
release is faster than the rate of aminoacyl transfer, this pathway has been referred to as 
„kinetic proofreading‟ (Hopfield, 1974).  Pre-transfer editing via these two routes is largely 
independent of tRNA, although stimulation in the presence of tRNA has been also reported in 
some cases.  Another view of the pre-transfer mechanism is referred to as the „translocation 
model‟.  Based on fluorescence probe studies in class I IleRS, this model suggests that the 
noncognate adenylate (Val-AMP) is formed in the aminoacylation active site and then 
actively translocated to the  editing site in the CP1 domain, in a tRNA-dependent manner, 
where it is hydrolyzed (pathway 3, Figure I.10) (Hendrickson, et al., 2002; Nomanbhoy, et 
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al., 1999).  However, this model requires the formation of a misaminoacylated tRNA as an 
obligatory intermediate, followed by post-transfer editing.  The post-transfer editing event 
primes or initiates conformational changes that facilitate translocation of the noncognate 
adenylate from the synthetic to the editing active site in the CP1 domain, followed by 
subsequent rounds of pre-transfer hydrolysis of the noncognate adenylate (Bishop, et al., 
2002; Nomanbhoy, et al., 1999; Nordin and Schimmel, 2003).  
There has also been evidence for the selective release and enzymatic hydrolysis pre-
transfer pathways in different AARSs.  The bacterial Aquifex aeolicus LeuRS has been 
reported to possess a norvaline-specific tRNA-independent pre-transfer editing activity, that 
is primarily enzyme catalyzed in the aminoacylation active site (Zhu, et al., 2009).  In E. coli 
LeuRS, a tRNA-dependent pre-transfer editing activity within the aminoacylation active site 
is unmasked when the entire CP1 domain is deleted (Boniecki, et al., 2008).  Similarly, in 
GlnRS, which is a non-editing class I AARS and lacks a spatially separated editing domain, 
evidence has been provided for a pre-transfer editing-like reaction within the synthetic active 
site (Gruic-Sovulj, et al., 2005).  In ProRS, tRNA-independent pre-transfer editing has been 
reported against Ala-AMP (Beuning and Musier-Forsyth, 2000).  In this case, the noncognate 
adenylate is primarily hydrolyzed on the enzyme (pathway 1, Figure I.10) (Splan, et al., 
2008), with solution hydrolysis following selective release from the enzyme active site 
constituting a minor pathway (pathway 2, Figure I.10) (Hati, et al., 2006).   
The location of the active site of pre-transfer editing has been a disputed issue in the 
field.  As mentioned above, the aminoacylation active site has been implicated to have a 
critical role in both enzymatic hydrolysis of the adenylate as well as in selective release into 
solution (Boniecki, et al., 2008; Hati, et al., 2006).  On the other hand, the pre-transfer model 
that comprises of translocating the adenylate from the enzyme main body to the CP1 domain 
indicates the latter as the site of pre-transfer.  This is further supported by structural studies in 
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IleRS (Fukunaga and Yokoyama, 2006) and LeuRS (Lincecum, et al., 2003), which show that 
respective pre-transfer editing substrate analogs (NvaAMS and ValAMS) bind at sites highly 
overlapping with the site where the post-transfer editing substrate analogs bind.  In fact, in 
the LeuRS CP1 domain, pre- and the post-transfer editing substrate analogs bind in the same 
threonine-rich peptide pocket (Figure I.9, left) (Lincecum, et al., 2003).  Moreover, both the 
substrates are stabilized in the editing pocket by the universally conserved aspartic acid 
(Asp347 in T. thermophilus LeuRS) (Figure I.9, left) via hydrogen bonding (Lincecum, et al., 
2003). 
 
I.3.C.  Coexistence of multiple editing pathways for an AARS 
Many AARSs possess both pre- and post-transfer editing activities (Boniecki, et al., 
2008; Martinis and Boniecki, 2010; Williams and Martinis, 2006).  As an example, although 
class I IleRS (Fersht, 1977b) and yeast cyotoplasmic LeuRS (ycLeuRS) (Englisch, et al., 
1986) have been proposed to maintain fidelity via pre-transfer pathways, both enzymes also 
possess a fully functional post-transfer editing activity within their homologous CP1 domains 
(Eldred and Schimmel, 1972; Lincecum, et al., 2003).  The class II ProRS can not only edit 
Ala-tRNA
Pro
 by post-transfer editing catalyzed by the INS editing domain (Wong, et al., 
2002), but also hydrolyze Ala-AMP via pre-transfer editing (Beuning and Musier-Forsyth, 
2000).  In addition, ProRS also depends on a third free-standing editing protein Ybak to clear 
Cys-tRNA
Pro
 (An and Musier-Forsyth, 2005).   
The partitioning between the two pathways and predominance of one over the other 
could depend on distinct set of molecular determinants within the enzyme active site, the 
amino acid substrate and also other cellular cues (Boniecki, et al., 2008; Martinis and 
Boniecki, 2010; Sarkar and Martinis, 2011).  The human cytoplasmic LeuRS (hcLeuRS) 
activates either one pathway against nonstandard biosynthetic intermediates, dictated by the 
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identity of the noncognate amino acid – while α-aminobutyrate is cleared by pre-transfer 
editing, norvaline is cleared by the post-transfer pathway (Chen, et al., 2011).  In E. coli 
LeuRS, CP1-based mutations that selectively deactivate post-transfer editing or complete 
deletion of the CP1 domain activated an inherent aminoacylation active site-associated pre-
transfer editing (Chen, et al., 2001; Williams and Martinis, 2006).  Thus, clearly evolution 
has driven the AARS family towards possessing multiple checkpoints in order to ensure the 
highest level of fidelity in translation. 
 
I.4.  Structural overview of leucyl tRNA synthetase (LeuRS) 
 
 To date several crystal structures of LeuRS have been solved with or without 
tRNA
Leu 
and in different conformations during the aminoacylation reaction (Cusack, et al., 
2000; Fukunaga and Yokoyama, 2005a; Lincecum, et al., 2003; Rock, et al., 2007; Tukalo, et 
al., 2005) (Table I.3).  This array of structural data shows that architectural features of LeuRS 
are consistent with other class I synthetases.  The aminoacylation active site contains the 
Rossmann dicnucleotide-binding fold and also the catalytically important conserved 
sequences of HIGH and KMSKS (Figure I.11).  Comparison of native LeuRS and leucyl-
adenylate analog-bound enzyme shows that considerable local conformational changes within 
the aminoacylation active site accompany the binding of the adenosine moiety for amino acid 
activation (Cusack, et al., 2000).  In particular, these changes involve the concerted dynamics 
of the HIGH and KMSKS loops towards the leucine-binding site which itself is very little 
perturbed.   
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   Table I.3.  Compilation of solved crystal structures of LeuRS 
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Figure I.11.  Crystal structure of the T. thermophilus LeuRS with tRNA
Leu
 in the editing 
conformation (PDB:  2BYT) (Tukalo, et al., 2005).  For clarity, tRNA
Leu
 is not shown here.  
The catalytic main body (grey) houses the aminoacylation active site that binds leucine (red) 
and ATP.  Various appendages are inserted at specific points in the core main body of the 
enzyme, some of which fold into discrete domains, as highlighted.  The CP1 domain is 
highlighted in cyan, the LSD in black, the CTD in yellow, the ZBD-1 in orange and the β-
strand linkers in blue.  The catalytically important „(K)MSKS‟ and „HMGH‟ within the 
Rossmann fold are also marked.   
 
Similar to the homologous IleRS and ValRS, the aminoacylation active site of LeuRS 
is split by a polypeptide insertion (approximately 180 amino acids) that discretely folds into a 
globular domain, called the CP1 domain (Figure I.11; Figure I.12) (Cusack, et al., 2000; Hou, 
et al., 1991; Starzyk, et al., 1987).  The CP1 domain of LeuRS houses the editing active site 
which clears misaminoacylated tRNAs (Mursinna, et al., 2004).  A more novel function of 
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the LeuRS CP1 domain is in mitochondrial intron RNA splicing in the yeast mitochondrial 
enzyme (Rho, et al., 2002).  The bulk of the CP1 domain has little or no connection with the 
LeuRS main body, except for two flexible β-strands (Cusack, et al., 2000).  The flexible β- 
strands facilitate rotations of the CP1 domain with respect to the main body during the 
various stages of the aminoacylation reaction (Fukunaga and Yokoyama, 2005a; Tukalo, et 
al., 2005).  In E. coli LeuRS, the β-strands are critical to the hydrolytic editing activity of the 
protein (Betha, et al., 2007).  They are hypothesized to specifically interact with the tRNA for 
post-transfer editing of misacylated tRNA
Leu
.    
 
 
 
 
Figure I.12.  Cartoon representation of the different positions of various insertion domains in 
LeuRS.  (Top)  Bacterial and eukaryotic-mitochondrial LeuRS.  (Bottom)  Archaeal and 
eukaryotic-cytoplasmic LeuRS.  The figure has been adapted from Cusack et al. 2000. 
 
In prokaryote-like LeuRSs, another small domain inserted into the catalytic main 
body is the leucine-specific domain (LSD; approximately 50 amino acids), inserted just prior 
  
28 
 
to the KMSKS loop (Figure I.11; Figure I.12)  Although the LSD is not highly conserved in 
sequence or length, when present it has been shown to be critical to aminoacylation of 
tRNA
Leu
 (Vu and Martinis, 2007).  For example, while T. thermophilus LeuRS has one of the 
largest modules for LSD, it is completely missing in organisms such as B. subtilis, H. pylori 
and P. horikoshii. 
The C-terminal domain (CTD) of T. thermophilus LeuRS is approximately 60 amino 
acids long and consists of a compact α-β bundle, common to other class Ia enzymes 
(Cavarelli, et al., 1998; Mechulam, et al., 1999; Nureki, et al., 1998).  Unlike other members 
of class I AARSs, LeuRS does not use its CTD to recognize specific bases on the tRNA 
anticodon (Asahara, et al., 1993; Soma, et al., 1999).  However, for the S. cerevisiae 
cytoplasmic LeuRS, the tRNA anticodon base recognition is critical (Soma, et al., 1996).   
LeuRS also contains two inserted zinc-binding modules (Zn-1 and Zn-2) (Figure I.11; 
Figure I.12).  Sequence alignments suggest that LeuRSs from archaea and cytoplasm of 
eukaryotes lack the Zn-2 domain (Cusack, et al., 2000).  An interesting feature of LeuRS is 
the species-dependent variability in the point of insertion of the CP1 domain with respect to 
the Zn-1 domain.  Comparison of primary sequences show that the CP1 domain is inserted 
between the two halves of the Zn-1 binding site for archaeal and eukaryotic cytoplasmic 
LeuRSs (Fig I.12, bottom), as also for IleRS and ValRS.  Whereas, bacterial and eukaryotic 
mitochondrial LeuRSs have the CP1 domain inserted after the Zn-1 domain (Figure I.12, top) 
(Cusack, et al., 2000).  Comparison of various Pyrococcus and Thermus LeuRS-tRNA
Leu
 
complexes highlights the importance of both an ordered closed conformation as well as the 
mobility of the Zn-1 domain (Tukalo, et al., 2005).  The closed conformation is sterically 
incompatible for entry of the 3´-end of the tRNA into the catalytic site.  However, in the 
absence of tRNA, this ordered packing of the Zn-1 domain over the leucyl-adenylate bound 
in the active site may provide additional protection to the adenylate from premature 
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hydrolysis.  On the other hand, upon tRNA binding, coordinated reorientations of the Zn-1 
domain and the CP1 domain would be required to allow aminoacylation.  Similarly, 
flexibility of the Zn-1 domain would also be critical for translocation of the 3´-end of the 
tRNA from the aminoacylation to the editing active site. 
 
I.5.  Recognition of tRNA by AARS in aminoacylation and editing 
Accurate AARS:tRNA pairing relies on identity elements within the tRNA that are 
recognized by the corresponding synthetase.  AARSs mostly interact with one or more of the 
following: the discriminator base N73, the acceptor stem, and the anticodon (Figure I.13).  In 
addition, interactions of the AARS with the variable loop and the D arm (Larkin, 2002) of the 
 
 
 
Figure I.13.  Cloverleaf representations of tRNA.   A canonical tRNA with a short variable 
loop (left) and archaeal tRNA
Leu
 (right).  Dashes represent base pairs.  The AARS recognition 
identity elements are highlighted in red in both.  The archaeal LeuRS uses the long variable 
arm and the discriminator base A for tRNA
Leu
 recognition. 
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Figure I.14.  P. horikoshii LeuRS in complex with tRNA
Leu
 in the aminoacylation 
conformation (PDB:  1WZ2) (Fukunaga and Yokoyama, 2005a).  The C-terminal domain of 
LeuRS (highlighted in purple) interacts with the long variable arm of tRNA
Leu
 and the 3ʹ-
CCA end of the tRNA is seen in the aminoacylation active site. 
 
tRNA has also been observed.  Furthermore, structural elements unique to particular tRNAs 
such as G3:U70 wobble pair of tRNA
Ala
 (McClain, et al., 1988; McClain and Foss, 1988)  
and the 15:48 tertiary base pair in tRNA
Cys
 (Hou, et al., 1991; Hou, et al., 1993) have also 
been shown to act as strong recognition determinants in cognate aminoacylation.  
Occasionally, modified nucleotides can act as determinants, for example lysidine in E. coli 
tRNA
Ile 
(Muramatsu, et al., 1988), 5-[(methylamino)methyl]-2-thiouridine in E. coli tRNA
Glu
 
(Sylvers, et al., 1993) and inosine in yeast tRNA
Ile
 (Senger, et al., 1997).  Another aspect of 
tRNA recognition by the synthetase is that in some tRNA:AARS pairs, the tRNA identity 
elements are the same for aminoacylation and editing, such as in ValRS (Tardif and 
Horowitz, 2002).  In contrast in IleRS, the tRNA
Ile
 elements that impact aminoacylation are 
distinct from the ones that are required for overall editing (Hale, et al., 1997).  Although a 
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general set of recognition elements have been identified, the specific recognition elements 
vary between different AARS:tRNA pairs. 
LeuRS recognizes up to six tRNA
Leu
 isoacceptor molecules, each with a different 
anticodon.  Idiosyncratic recognition features are required for LeuRS/tRNA
Leu
 pair from 
different species.  For bacterial LeuRSs, the discriminator base A73 (Asahara, et al., 1993; 
Larkin, 2002), the configuration of the D loop and the Levitt base pair, A15:U48 (Asahara, et 
al., 1998; Larkin, 2002) are crucial identity elements for efficient leucylation.  Recognition of 
tRNA
Leu
 by LeuRS is unique in a number of ways.  Firstly, although most AARSs use the 
tRNA anticodon as a recognition element, LeuRS (along with SerRS (Biou, et al., 1994; 
Borel, et al., 1994) and AlaRS (Francklyn and Schimmel, 1989) do not depend on the tRNA 
anticodon as an identity element (Asahara, et al., 1993; Breitschopf, et al., 1995; Larkin, 
2002).  The one known exception is S. cerevisiae cytoplasmic LeuRS where the tRNA
Leu
 
anticodon is an important recognition element (Soma, et al., 1996).  A second unusual feature 
of most tRNA
Leu
 is that they contain an extra-long variable loop (Figure I.13) (type II tRNA) 
(along with tRNA
Tyr
 and tRNA
Ser
).  The long variable loop is an important identity element in 
archaeal (Figure I.14) (Fukunaga and Yokoyama, 2005b) and human cytoplasmic 
(Breitschopf, et al., 1995) LeuRS, but not for E. coli (Asahara, et al., 1993) and S. cerevisiae 
cytoplasmic (Soma, et al., 1996) LeuRS.  These observations also suggest that LeuRSs from 
different species have evolved to identify tRNA
Leu
 using different identity elements.  The 
anticodon of the tRNA does not contact the LeuRS (Figure I.14). 
The co-crystal structure of P. horikoshii LeuRS and tRNA
Leu
 (Figure I.14; Figure 
I.15) (Fukunaga and Yokoyama, 2005a) have precisely identified the interactions between the 
different domains of LeuRS and the tRNA
Leu
 in the aminoacylation conformation.  The P. 
horikoshii tRNA
Leu
 assumes an L-shaped structure with a protruding long variable arm.  The 
elements on the tRNA
Leu
 that are recognized by this LeuRS include the discriminator base  
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Figure I.15.  Two modes of discrimination of discriminator base A73 and of C74.  (Left)  P. 
horikoshii LeuRS in complex with tRNA
Leu
 in the „aminoacylation‟ state. The 3ʹ-CCA end of 
the tRNA
Leu
 is in the aminoacylation active site.  (Right)  P. horikoshii LeuRS in complex 
with tRNA
Leu
 in the „intermediate‟ state during transition from the aminoacylation to the 
editing conformation.  The 3ʹ-CCA end of the tRNALeu is partially relocated to the CP1 
editing domain (PDB:  1WZ2) (Fukunaga and Yokoyama, 2005a). 
 
A73 and the long variable arm (highlighted in red in Figure I.13).  The LeuRS interacts with 
the tip of the long variable arm (A47c and G47d) (Figure I.13) via its C-terminal domain 
(Figure I.14).   In this structure (Fukunaga and Yokoyama, 2005a), Fukunaga and co-workers 
identified two different complexes – the „aminoacylation‟ complex (Figure I.15, left) in 
which the 3ʹ-CCA end of tRNALeu is in the aminoacylation active site; and the „intermediate‟ 
complex (Figure I.15, right) in which the 3ʹ-CCA end of tRNALeu is partially turned away 
towards the CP1 editing domain.  Interestingly, they captured two different modes of 
recognition of the A73 discriminator base by the LeuRS.  In the aminoacylation complex, the 
bases A73 and C74 stack together and the discriminator base A73 hydrogen bonds with 
Asp504, Lys505, Ala507 and Glu527 (Figure I.15).  In contrast, in the intermediate complex, 
the bases A73 and C74 are perpendicular to each other and Lys505 instead of hydrogen 
bonding with C74 now hydrogen bonds with A73 (Figure I.15).  In both complexes however, 
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the terminal bases C75 and A76 interact only with the Rossmann fold in the aminoacylation 
active site.   
The bacterial LeuRSs do not use the long variable arm of tRNA
Leu
 as an identity 
element (Asahara, et al., 1993).  The accompanying co-crystal structure of the T. 
thermophilus LeuRS in complex with tRNA
Leu
 in the editing conformation (Tukalo, et al., 
2005) showed that the 3ʹ-end of the tRNA is positioned in the CP1-based editing active site 
and that neither the long variable loop nor the anticodon loop makes any contact with the 
bacterial LeuRS (Figure I.11).  The 3ʹ-end showed interactions with the universally conserved 
aspartic acid (Asp347) and the threonine-rich peptide as in the previous complexed structure 
of  T. thermophilus LeuRS and the post-transfer editing substrate analog Nva2AA (Figure 
I.11) (Lincecum, et al., 2003).  The C-terminal domain of LeuRS is critical even in the 
editing conformation as it forms direct contacts with the G19:C56 tertiary base pair.  Overall, 
this structure suggested that contact areas between LeuRS and tRNA
Leu
 are rather limited and 
much less in the editing conformation as compared to the aminoacylation conformation, 
consistent with the need to transition to an exit complex and product release.  
 
I.6. Protein-assisted RNA splicing 
I.6.A.  Overview of the multiple alternate cellular functions of AARSs 
Throughout evolution, AARSs acquired new cellular functions, that are not linked to 
protein synthesis, thus making this classic family of enzymes truly versatile with a broad 
repertoire of activities (Martinis, et al., 1999).  Such functional expansion in some of the 
eukaryotic AARS can be traced back to the progressive addition of new protein domains to 
their overall structure (Guo, et al., 2010).  Alternate functions of AARSs include protein-
assisted splicing of intron RNAs by S. cerevisiae mitochondrial LeuRS and Neurospora 
crassa mitochondrial TyrRS (Lambowitz and Perlman, 1990), translational regulation by 
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ThrRS (Romby, et al., 1996) and transcriptional regulation by AlaRS (Putney and Schimmel, 
1981).  E. coli ThrRS binds to its own mRNA leader sequence and prevents the 30S 
ribosomal subunit from binding to the ribosome-binding sequence of the mRNA, thereby 
blocking synthesis of the protein (Romby, et al., 1996).  E. coli AlaRS binds to a palindromic 
sequence flanking the transcriptional start site of its own gene, thereby repressing 
transcription.  In human TyrRS, two specifically acquired peptides or domains, Glu-Leu-Arg 
(ELR) peptide and the endothelial monocyte-activating polypeptide II (EMAPII)-like domain 
act in concert in receptor-mediated signaling pathways involved in angiogenesis (Wakasugi, 
et al., 2002a; Wakasugi, et al., 2002b).  Human TyrRS has been shown to be specifically 
secreted under apoptotic conditions and cleaved to generate two cytokines fom its N- and C-
terminal halves (Wakasugi and Schimmel, 1999).  The EMAP-II-like human TyrRS C-
terminal domain exhibits monocyte chemotaxis acitivity and also stimulates tissue necrosis 
factor α (TNFα) production (Wakasugi and Schimmel, 1999).  The human TrpRS has been 
reported to be a potent angiostatic factor (Wakasugi, et al., 2002b), in which the activity is 
regulated by an acquired WHEP domain of the synthetase.  Under proliferative conditions, 
human MetRS is transported into the nucleus to stimulate rRNA synthesis in the nucleoli 
(Ko, et al., 2000). 
 
I.6.B.  Secondary structure of group I introns 
Group I introns are present in tRNA, rRNA and protein-coding genes, particularly 
abundant in fungal and plant mitochondrial DNAs (Palmer and Logsdon, 1991).  Group I 
introns can catalyze their own splicing, but are assisted by protein factors, particularly in vivo 
(Burke, 1988; Lambowitz and Perlman, 1990).  The boundaries of group I introns are defined 
by a U residue at the 3ʹ-end of the 5ʹ exon (the 5ʹ-splice site) and a G residue at the 3ʹ-end of 
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the intron (the 3ʹ splice site) (Figure I.16).  Just like protein enzymes, the folding of group I 
introns into their catalytically active characteristic secondary and tertiary structure results in  
 
Figure I.16.  Conserved secondary structure of group I intron.  The 3´- and 5´-flanking exon 
sequences are shown in green.  Dashes indicate base pairs and dots indicate wobble base 
pairs. Dashed red lines indicate continuity of intron strand.  Tertiary interactions have been 
omitted for clarity.  The conserved U•G base pair in the internal guide sequence (IGS), near 
the 5´-splice site is highlighted in blue.  The guanosine binding site is denoted by asterisk (*).  
The figure is adapted from (Cech, et al., 1994). 
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juxtaposition of key residues that are widely separated in primary structures.  The self-
splicing ability of group I introns arises from that they all fold into highly conserved 
secondary and tertiary structures that bring the guanosine and the 5ʹ- and 3ʹ-splice sites in 
close proximity (Cech, 1988). 
The secondary structure of all group I introns consist of a common conserved core, 
made up of series of paired regions (denoted P1-P10), separated by single-stranded regions or 
loops (Figure I.16).  P1 and P10 contain the 5ʹ- and 3ʹ-splice sites, respectively and are 
formed by base pairing between an internal guide sequence (IGS) (generally located 
downstream of the 5ʹ-splice site) (Davies, et al., 1982) and the exon sequences flanking the 
splice sites (Figure I.16).  P1s of different group I introns vary in sequence, with only one 
conserved base pair between the U immediately preceding the 5ʹ-splice site and a G in the 
IGS (Cech, 1990).  In Tetrahymena intron, P3, P4, P6, P7, P8 and P9 form the catalytic core 
of the intron required for enzymatic activity (Michel and Westhof, 1990).  Extra sequences, 
often consisting of long open reading frames (ORFs), form stem-loop structures that do not 
disrupt the core, are peripheral to the core, and vary in sequence between introns.  Although 
such peripheral regions are dispensable for catalytic activity of the intron, they are not 
necessarily functionally irrelevant (Cech, 1990).  Rather, these peripheral regions can be 
critical for folding of the conserved core into a catalytically active form and are also believed 
to provide protein-binding sites in vivo.  Folding of the intron as well as the self-splicing 
reaction requires optimal Mg
2+
 ion concentration (Cech, 1990; Sugimoto, et al., 1988).  Two 
kinds of Mg
2+
-binding sites on the intron have been defined.   One class has specific 
structural roles and participates in active site chemistry, while the other class promotes the 
global folding of the intron (Tinoco and Bustamante, 1999). 
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I.6.C.  Splicing mechanism of group I introns 
The self-splicing of group I introns occurs via two consecutive transesterification 
reactions, in the presence of guanosine and Mg
2+
 ions (Cech, 1990).  The first 
transesterification reaction is initiated by guanosine or one of its phosphorylated forms 
(GMP, GDP, GTP).  The 3´-OH of the sugar moiety of guanosine attacks the 5ʹ-splice site 
and forms a 3ʹ,5ʹ-phosphodiester bond to the first nucleotide of the intron and as a result, the 
5ʹ exon is excised (Cech, 1987; Zaug, et al., 1983).  The 5ʹ exon now terminates in a free 3ʹ-
OH.  This then attacks the 3ʹ-splice site, resulting in ligation of the exons and excision of the 
intron (Figure I.17) (Cech, 1987; Zaug, et al., 1983). 
 
 
 
Figure I.17.  Splicing mechanism of group I introns. 
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Group I introns have relatively low Km values for guanosine (in the μM range) and 
hence can readily discriminate between guanosine and other nucleosides (Bass and Cech, 
1986; Cech, 1990).  Guanosine binds the intron via hydrogen bonds, interactions with the 
ribose hydroxyls and also base stacking interactions.  A single guanosine-binding site is 
characterized by the presence of a conserved G•C pair in P7 (Figure I.16) (Michel, et al., 
1989).  However, additional interactions of the guanosine with the intron are also believed to 
be important. 
 
I.6.D.  Protein facilitation of group I intron splicing 
Self-splicing of group I introns in vivo is facilitated by protein cofactors (Burke, 1988; 
Lambowitz and Perlman, 1990; Lambowitz, 1999).  These proteins are proposed to primarily 
facilitate formation of the correct catalytically active intron RNA structure (Burke, 1988; 
Cech, 1988; Cech, 1990; Tinoco and Bustamante, 1999).  The proteins that assist splicing 
include both intron-encoded proteins as well as nuclear-encoded proteins.  One of the 
prominent protein facilitators among the intron-encoded proteins required for splicing of 
group I introns are maturases.  Several group I introns in yeast mitochondrial DNA encode 
maturases that aid splicing of the intron that encodes them.  These include the cob-I2, -I3 and 
–I4.  Typically, the functioning of these maturases is intron-specific and the maturases act 
only in the splicing of the particular intron that encodes them (Lazowska, et al., 1980).  An 
exception is the cob-I4 maturase (bI4 maturase) which functions is splicing of both the cob-I4 
intron as well as another closely related group I intron, cox-I4 (De La Salle, et al., 1982; 
Dhawale, et al., 1981) (Figure I.18).  The maturases encoded by group I introns are 
characterized by two repeats of the sequence motif LAGLIDADG.  This motif is also 
characteristic of a larger family of proteins that have site-specific endonuclease activity 
(Perlman and Butow, 1989).   
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The nuclear-encoded proteins involved in splicing of group I introns include two 
mitochondrial AARSs.  LeuRS (or NAM2) (Herbert, et al., 1988; Labouesse, 1990) and 
TyrRS (or CYT-18) (Akins and Lambowitz, 1987) are required for excision of group I 
introns from essential mitochondrial genes in yeast and Neurospora crasssa.  The yeast 
mitochondrial LeuRS (ymLeuRS) is required for splicing of two closely related group I 
introns,  bI4 and aI4α respectively from the genes encoding cytochrome b (cob) and the α 
subunit of cytochrome oxidase (cox1α) (Herbert, et al., 1988).  The Neurospora crasssa 
mitochondrial TyrRS, on the other hand, is required for the splicing of a number of unrelated 
group I introns, such as the mitochondrial large rRNA intron as well as introns in the cob and 
ATPase 6 genes (Akins and Lambowitz, 1987; Cherniack, et al., 1990; Majumder, et al., 
1989).  Both LeuRS and TyrRS are believed to interact with conserved sequences or 
structures of group I introns.   
   
 
 
Figure I.18.  Schematic representation of LeuRS-assisted splicing.  The yeast mitochondrial 
LeuRS (ymLeuRS) facilitates the splicing of two related group I introns, bI4 and aI4α from 
the yeast mitochondrial cob and cox1α genes, respectively.  bI4 maturase (encoded by the 
ORF of intron bI4) and nuclear-encoded ymLeuRS act in collaboration to aid in splicing of 
these two introns.  (Color legend:  blue – group I intron; yellow – group II intron; red – exon; 
and white – intron ORFs). 
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I.6.E.  Role of AARSs in group I intron splicing 
The Neurospora crasssa mitochondrial cyt-18 gene encodes a protein which has both 
splicing as well as TyrRS aminoacylation activities.  TyrRS promotes splicing of group I 
introns by facilitating folding of the intron into a catalytically active form (Caprara, et al., 
1996; Chadee, et al., 2010; Lazowska, et al., 1980; Mannella, et al., 1979).  Biochemical and  
 
 
Figure I.19.  Structure of Neurospora crassa TyrRS bound to a group I intron RNA.  The P4-
P6 and the P3-P9 domains of the intron are highlighted in red and green respectively (PDB: 
2KJ) (Paukstelis, et al., 2008). 
 
footprinting experiments have shown that TyrRS binds initially to the P4-P6 region of the 
intron, enabling formation of a scaffold for assembly of the P3-P9 domain (Caprara, et al., 
1996).  The binding of TyrRS to the intron RNA is believed to be a two-step process, in 
which the protein first recognizes primary or secondary structural features in the P4-P6 
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region of the unfolded intron and then makes additional contacts, concurrent with formation 
of tertiary structure (Caprara, et al., 1996).  The structure of a TyrRS bound to a group I 
intron shows that the group I intron binds across the two subunits of the homodimeric protein, 
with the protein contacting both the P4-P6 and the P3-P9 catalytic core domains, but not the 
peripheral regions of the intron RNA (Figure I.19) (Paukstelis, et al., 2008).  However, 
controrary to a previous notion, this structure suggests that the protein does not use tRNA-
like features of the introns, but instead uses a distinct RNA-binding surface that is composed 
of an N-terminal extension absent in non-splicing bacterial TyrRSs. 
  
 
 
 
Figure I.20.  Homology model of yeast mitochondrial LeuRS.  The regions of the protein that 
impact splicing are highlighted. 
 
The yeast mitochondrial (ymLeuRS) was implicated in RNA splicing when a 
suppressor mutation in LeuRS rescued RNA splicing in presence of a defective maturase 
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(Labouesse, et al., 1987).  Splicing of cob and cox group I introns requires the collaborative 
functioning of the protein factors LeuRS and bI4 maturase (Figure I.18).  Each of these 
protein factors can bind independently to the bI4 intron and stimulate RNA splicing (Rho and 
Martinis, 2000).  Molecular determinants within LeuRS that impact splicing have been 
identified (Figure I.20), although the exact mechanism by which LeuRS promotes splicing of 
group I introns is still not clear.  The CP1 editing domain of ymLeuRS, isolated from the full 
length enzyme, can stimulate splicing in vivo (Rho, et al., 2002).  Regions surrounding the 
CP1 domain of LeuRS have also been implicated in RNA splicing.  The tryptophan of the 
conserved WIG peptide in the N-terminal β-strand that links the CP1 domain to the LeuRS 
main body (Figure I.20) has been mutationally shown to impact splicing.  Mutation of the 
tryptophan to a cysteine abolishes splicing, but maintains aminoacylation (Li, et al., 1996).  A 
splicing-defective suppressor mutation has also been identified at the glycine of the WIG 
peptide in the ymLeuRS (G240S) (Figure I.20) (Labouesse, et al., 1985; Labouesse, 1990; Li, 
et al., 1996).  In addition, the C-terminal domain of ymLeuRS is also critical in splicing and 
functionally diverged to accommodate the dual role of aminoacylation and splicing (Hsu, et 
al., 2006; Hsu and Martinis, 2008).  Interestingly, LeuRSs from other organisms, such as a 
prokaryotic LeuRS and the human mitochondrial LeuRS can substitute for the ymLeuRS for 
its splicing activity (Houman, et al., 2000).  This suggests that LeuRS, which unlike TyrRS 
has not acquired an idiosyncratic splicing-specific domain, uses its evolutionarily conserved 
features to interact with the intron RNA.  
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I.7.  AARSs as antibiotic targets 
The AARS family of enzymes by virtue of their universality, essentiality and 
diversity, have long been the focus of antibacterial drug discovery (Tao, 2000).  Drug design 
targeting the synthetases has relied on a general chemistry platform which synthesizes 
analogs of the AARS substrates and intermediates.  The strategy has been to find compounds 
that mimic the AARS substrates and also to selectively target the pathogen AARS, while 
sparing the human counterpart (Tao, 2000).  The latter has been possible due to evolutionary 
divergence between prokaryotic and eukaryotic AARSs.  The AARS inhibitors discovered or 
developed to date include mupirocin (Hughes and Mellows, 1978) and furanomycin (Tanaka, 
et al., 1969) against IleRS, indolmycin (Werner, et al., 1976) and chaungxinmycin (Brown, et 
al., 2002) against TrpRS, borrelidin (Nass, 1969) against ThrRS, AN2690 (Rock, et al., 2007) 
and granaticin (Ogilvie, et al., 1975) against LeuRS, cispentacin (Konishi, 1989) against 
ProRS and ochratoxin A (Konrad and Roschenthaler, 1977) against PheRS.  Mupirocin (or 
pseudomonic acid), a commercially available potent inhibitor of IleRS, is a natural product of 
Pseudomonas fluorescens (Fuller, et al., 1971) and is used as a topical agent against bacteria.  
The tail portion of Mupirocin closely resembles the isoleucyl moiety of isoleucyl adenylate 
(Ile-AMP) (Figure I.21).  Mupirocin binds in the vicinity of the KMSKS sequence in the 
aminoacylation active site of IleRS and is a bifunctional inhibitor with respect to both ATP 
and isoleucine (Silvian, et al., 1999; Yanagisawa, et al., 1994). 
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Figure I.21.  Chemical structures of mupirocin and isoleucyl adenylate (Ile-AMP) 
 
Apart from the aminoacylation active site, the editing active site is another potential 
binding site for inhibitors of AARSs that possess editing activity.  Screening libraries of 
chemically synthesized boron-containing small molecules led to the discovery of a novel 
class of dihydrobenzoxaboroles that have broad spectrum antifungal activity (Baker, et al., 
2006).  Out of these benzoxaboroles, it was found that 5-fluoro-1,3-dihydroxy-2,1-
benzoxaborole (AN2690) or its ethylamine derivative AN3018 (Figure I.22) inhibit protein 
synthesis in Saccharomyces cerevisiae by targeting the yeast cytoplasmic LeuRS (ycLeuRS) 
(Rock, et al., 2007; Seiradake, et al., 2009).  The leading candidate, AN2690 is currently in 
clinical trials for the treatment of onychomycosis, a fungal disease of the toenail.  In the 
editing pocket of LeuRS, AN2690 cross- links tRNA
Leu 
(Figure I.23), effectively preventing 
release of the charged tRNA thereby rendering this essential enzyme inactive (Rock, et al., 
2007).  The tRNA
Leu
-AN2690 adduct is formed via the boron atom of the oxaborole ring of    
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Figure I.22. Chemical structures of LeuRS inhibitors.  The atom colors are:  fluorine (green), 
boron (pink), oxygen (red) and nitrogen (blue). 
 
AN2690 and the 2ʹ,3ʹ-hydroxy groups of the terminal adenosine (A76) at the 3ʹ-end of 
tRNA
Leu
 (Figure I.23) (Rock, et al., 2007).  AN2690 occupies the noncognate amino acid-
binding pocket in the editing site of the LeuRS CP1 domain (Rock, et al., 2007) and can be 
overlaid exactly on the post-transfer editing substrate analog (Nva2AA) (Lincecum, et al., 
2003).  The inactivation of LeuRS by AN2690 is reversible, but with a very slow reactivation 
rate, that corresponds to a long half-life for the adduct of 424 min (Rock, et al., 2007).  
Interestingly, spontaneously generated AN2690-resistant mutations have been identified 
within and outside the AN2690-binding pocket in the ycLeuRS (Rock, et al., 2007). 
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Figure I.23.  T. thermophilus LeuRS in complex with tRNA
Leu
 and AN2690.  The CP1 
domain of LeuRS is shown in yellow, the main body in green and the connecting β-strands 
are highlighted in blue.  The AN2690-AMP adduct is encircled in the editing active site and 
its chemical structure shown in the inset (PDB: 2V0G) (Rock, et al., 2007). 
 
 
 
I.8.  AARSs-linked diseases 
Specific AARSs have been implicated in the etiology of various diseases, such as 
autoimmune disorders, neuronal pathologies, disrupted metabolic functions and cancer (Park, 
et al., 2008).  Charcot-Marie-Tooth (CMT) disease is characterized by muscular weakness 
and atrophy in the distal extremities and impaired sensation and reflexes.  The CMT disease 
is caused by heritable mutations in genes encoding glycyl-tRNA synthetase (GlyRS) 
(Antonellis, et al., 2003) and TyrRS (Jordanova, et al., 2006).  In GlyRS, two CMT-causing 
mutations are in the range of „kissing contact‟ across the dimer interface of the synthetase and 
hamper dimer formation (Nangle, et al., 2007).  Although these CMT-causing mutations in 
GlyRS do not affect aminoacylation, they exhibit a common defect in localization in the 
neurons.   
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Recent research hints at a possible connection between lysyl-tRNA synthetase 
(LysRS) and amyotrophic lateral sclerosis 1 (ALS1) (Kunst, et al., 1997).  In some patients, a 
mutation in the Cu/Zn superoxide dismutase 1 (SOD1) is associated with ALS1 (Banci, et al., 
2007).  LysRS associates with the mutant SOD1 (but not the wild type) and may contribute to 
aggregation of SOD1, thus inducing apoptosis of motor neurons and leading to onset of 
neurodegeneration, the hallmark of ALS1.   
It is known that several key components of the translational machinery are up- or 
down-regulated in various forms of cancer.  MetRS, which is required for translation 
initiation, is increased in human colon cancer (Kushner, et al., 1976).  The 3´-untranslated 
region (UTR) of the gene encoding MetRS contains a segement of complementary base 
sequence to the 3´-UTR of the C/EBP homologous protein (CHOP) that is critically involved 
in the onset of some tumors (Palmer, et al., 1997).  Possible link between the 
complementarity of  the 3´-UTR of these two genes is yet to be determined. 
Development of leukoencephalopathy, which has brain-stem and spinal cord 
involvement and lactate elevation (LBSL) appears to be caused by specific mutations in the 
gene encoding mitochondrial aspartyl-tRNA synthetase (AspRS) (Scheper, et al., 2007).  
Most of these AspRS mutations are located in specific exons of the gene and can cause 
abnormal splicing, frame shifts or premature termination of translation.  
Several of the AARSs have also been linked to autoimmune diseases.  In 30% of 
autoimmune patients, autoantibodies against several AARSs, including HisRS, ThrRS, 
AlaRS, phenylalanyl-tRNA synthetase (PheRS), IleRS, GlyRS and asparaginyl-tRNA 
synthetase (AsnRS) have been detected.  The „antisynthetase syndrome‟ includes interstitial 
lung diseases (ILD) and rheumatoid arthritis, among others.  In type 2 diabetic patients, a 
single nucleotide polymorphism of mitochondrial LeuRS was identified that caused an amino 
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acid substitution (H324Q) (t Hart, et al., 2005).  However, the causal relationship of this 
mutation in LeuRS to diabetes is not yet known. 
 
I.9.  Dissecting the role of LeuRS CP1 domain in amino acid editing and splicing 
The CP1 domain of LeuRS (Cusack, et al., 2000) was essentially the focus of research 
efforts in this thesis.  Mechanistic investigations of amino acid editing, RNA splicing and 
drug-binding/resistance were conducted within the confines of this domain.  The LeuRS CP1 
domain is traditionally known for its role in post-transfer editing of mischarged tRNA 
(Mascarenhas, 2008) and has also been identified as the site for binding of benzoxaborole-
based antimicrobial drugs (Rock, et al., 2007).  Drug resistance mutations that also impacted 
hydrolytic editing were isolated within and surprisingly outside the conserved editing/drug-
binding pocket in the LeuRS CP1 domain.  One such resistance site outside the CP1-based 
editing pocket was specifically targeted and experiments designed to understand the impact 
of this residue on post-transfer editing and in the process to drug resistance.  In addition, a 
cellular fluorescence-based assay was improvised that enables the quantification of 
intracellular effects of LeuRS editing defects.      
LeuRS, like many other AARSs, is challenged by structural similarities between its 
cognate and the non cognate amino acids.  As a result, it misactivates the near-cognate amino 
acids such as isoleucine and methionine.  However, efficient editing mechanisms 
(Mascarenhas, 2008) in the enzyme help preserve the high level of fidelity in protein 
synthesis.  Existence of multiple/alternate editing pathways in the ycLeuRS was investigated.   
Questions regarding the co-existence of these editing pathways and what cellular cues 
determine the shift of balance between these pathways were addressed. 
The ymLeuRS has been implicated in facilitating mitochondrial RNA splicing 
(Labouesse, 1990).  The CP1 domain, both isolated (Rho, et al., 2002) and in the context of 
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the full-length enzyme (Boniecki, et al., 2009), has been shown to stimulate RNA splicing.  
However, the detailed picture of specific molecular determinants within and around the 
LeuRS CP1domain was missing.  In addition, questions such as how the ymLeuRS has 
evolved mechanistically and/or structurally to adapt to its dual roles in splicing and 
aminoacylation and editing were unanswered.  To address these questions, dual functions of 
editing and RNA splicing in the LeuRS CP1 domain and the surrounding β-strand 
connections to the enzyme main body were investigated in an effort to isolate the overlaps 
and diversities between the two functions. 
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Chapter II:  Materials and Methods 
 
II.1.  Materials 
 
Oligonucleotide primers were synthesized by Integrated DNA Technologies 
(Coralville, IA).  Radiolabeled amino acids and nucleotides were purchased from Amersham 
Pharmacia Biotech (Piscataway, NJ) or Perkin Elmer (Waltham, MA).  Cloned Pfu DNA 
polymerase and dNTP mixture were obtained from Stratagene (La Jolla, CA).  Restriction 
endonucleases and T4 DNA ligase were procured from New England Biolabs Inc. (Ipswich, 
MA) or Promega (Madison, WI).  E. coli strains DH5α, BL21 (DE3) and BL21 (DE3) codon 
PLUS were obtained from Stratagene (La Jolla, CA), while the strain Rosetta 2 (DE3) was 
obtained from Novagen (Gibbstown, NJ).  Crude Saccharomyces cerevisiae tRNA was 
acquired from Sigma Chemical Co. (St Louis, MO).  The plasmid pGP1-2 expressing T7 
RNA polymerase was generously provided by Dr. Tracy Palmer (University of East Anglia, 
UK). 
 
II.2.  Mutagenesis 
 
Site directed mutagenesis was carried out via the polymerase chain reaction (PCR).  
Each 50 μl PCR reaction mixture contained 100 ng of template plasmid DNA, 125 ng each of 
forward and reverse primers, 0.05 mM dNTP mix and 0.05 U Pfu DNA polymerase in 
commercially available buffer.  Under the following conditions, 25 cycles of PCR were 
carried out:  95 °C for 30 sec, 55 °C for 30 sec, and 68 °C for 20 min.  To completely remove 
wild type copies of the plasmid, the final PCR mixture was restriction digested with 0.8 U 
DpnI for 4 h at 37 °C.   This restriction digested PCR mixture was used to transform E. coli 
strain DH5α.  The mutation in the gene sequence was confirmed by automated DNA 
sequencing (UIUC Core Sequencing Facility, Urbana, IL).   
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II.3.  Expression and purification of proteins 
 
N-terminal six-histidine-tagged wild type or mutant proteins were expressed from the 
plasmids bearing the respective genes in E. coli strains BL21 (DE3), BL21 (DE3) codon 
PLUS or Rosetta 2 (DE3).  A single transformant was used to inoculate 5 mL LB 
supplemented with required antibiotics and then incubated at 37 °C overnight.   The 
overnight culture was used to inoculate 1 or 2 L LB (containing required antibiotics) and cells 
were grown at permissible temperature (30 °C or 37 °C) until the OD600 reached 0.6 to 0.8.  
Cells were then induced with 1 mM IPTG and the protein was expressed at the permissible 
temperature (30 °C, 37 °C or room temperature).  Cells were harvested by an Avanti J-E 
(Beckman Coulter, Fullerton, CA) preparative centrifuge, at 6000 rpm for 15 min at 4 °C.   
Cell pellets were resuspended in 8 to 10 ml of HA-I buffer [20 mM Na2HPO4, 10 mM 
tris(hydroxymethyl) aminomethane (Tris), pH 8.0, 100 mM NaCl and 5% glycerol].  This 
was followed by sonication on ice for 2 min at 50% amplitude and a 3 sec pulse using a Vibra 
Cell sonicator (Sonics, Newtown, CT).  The 2 min cycle of sonication was repeated three 
times.  The cell lysate was centrifuged at 12,000 rpm for 30 min at 4 °C.  The protein-
containing supernatant was mixed with 5 mL of HIS-Select Nickel Affinity Gel (Sigma-
Aldrich) that had been pre-equilibrated with 30 mL of HA-I buffer.  The N-terminal six-
histidine-tagged protein in the supernatant was bound to the resin via gentle rocking at 4 °C 
for 1 h.  Following binding, the resin was washed with 100 mL of HA-II buffer [20 mM 
Na2HPO4, 10 mM Tris, pH 7.0, 500 mM NaCl and 5% glycerol] containing 10 mM imidazole 
at 4 °C.  The bound protein was then eluted from the resin using 10 mL of  HA-III buffer   
[20 mM Na2HPO4, 10 mM Tris, pH 7.5, 100 mM NaCl and 5% glycerol] containing 200 mM 
imidazole.  The eluted protein was concentrated using an Amicon Ultra centrifugal filter 
device (Millipore Corporation, Billerica, MA).  The final protein concentration was 
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determined spectrophotometrically at 280 nm using the appropriate extinction coefficient, 
estimated by the ExPASy Protparam tool (http://ca.expasy.org/tools/protparam.html).  
 
II.4.  T7 RNA polymerase-based in vitro transcription of tRNA and purification 
 
T7 RNA polymerase was expressed from the plasmid pGP1-2 (a gift from Dr. Tracy 
Palmer, University of East Anglia, UK) and purified as described (Pang and Martinis, 2009).  
E. coli tRNA
Leu
UAA, yeast mitochondrial tRNA
Leu
UAA (ymtRNA
Leu
) or H. pylori tRNA
Leu
UAG 
were transcribed in vitro from the plasmids ptDNA
Leu 
(Normanly, et al., 1986; Tocchini-
Valentini, et al., 2000), pYmtDNA
Leu 
(Rho and Martinis, 2000) or ptDNA-HP4 (Vu, 2008), 
respectively.  Approximately 450 μg plasmid DNA were digested overnight with 25 U BstNI 
at   60 °C, in a reaction volume of 1 mL to generate the linearized template for run-off 
transcription (Sampson and Uhlenbeck, 1988).  Each 1 mL transcription reaction consisted of 
60 μg template DNA, 40 mM Tris, 80 mg/mL PEG8000, 5 mM dithiothreitol (DTT),           
50 μg/mL bovine serum albumin (BSA), 0.01% of Triton X-100, 8 μg/mL pyrophosphatase 
(Sigma-Aldrich), 7.5 mM each of ATP, CTP, GTP and UTP, 0.02 U/μL RNase inhibitor 
(Eppendorf, Hamburg, Germany), 5 mM spermidine, 30 mM MgCl2 and 0.8 μM T7 RNA 
polymerase.  The reactions were carried out at 42 °C for 3 h, followed by an a second 
addition of 0.8 μM T7 RNA polymerase and then incubation for another 3 h. 
Transcribed tRNA was precipitated from the reaction mixtures overnight at -80 °C by 
adding twice the volume of 100% cold ethanol and 100 μg/mL glycogen, as an inert carrier 
molecule.  The tRNA product was purified by electrophoresis on a denaturing 10% 
polyacrylamide gel, containing 8 M urea.  Electrophoresis was carried out overnight at        
10 mA in 1X Tris-Borate-EDTA (TBE) buffer (90 mM Tris, 90 mM boric acid and 2 mM 
EDTA, pH 8.0).  The tRNA
Leu
 band was visualized via UV shadowing and the band excised 
from the gel.  The excised gel was crushed and soaked in 1X TBE.  The tRNA was extracted 
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from the gel using the Elutrap electro-elution system (Whatman Inc., Florham Park, NJ).  
Electrophoresis was carried out in 1X TBE at 200 V for 3 h.  The tRNA was then precipitated 
from the elution overnight at -80 °C by adding twice the volume of 100% cold ethanol and 
100 μg/mL glycogen.  The pellets were then washed twice with 70% ethanol, dried and 
resuspended in nuclease free water (Ambion Inc., Austin, TX).  The concentration of the 
tRNA was calculated spectrophotometrically on the basis of its extinction co-efficient 
estimated by the online Ambion oligonucleotide calculator 
(http://www.ambion.com/techlib/misc/oligo_calculator.html). 
 
II.5.  Aminoacylation and misaminoacylation assay 
 
Each aminoacylation reaction contained 60 mM Tris-HCl, pH 7.5, or 4-(2-
hydroxyethy)-1-piperazineethanesulfonic acid (HEPES), pH 7.5, 10 mM MgCl2, 1 mM 
dithiothreitol (DTT), 4 μM transcribed tRNALeu, 21 μM [3H]-leucine (150 μCi/mL) and 
catalytic concentrations of enzyme.  Each reaction was initiated with 4 mM ATP and carried 
out at room temperature or 30 °C.  At various time points, 10 μL reaction aliquots were 
quenched on Whatman filter pads that had been pre-wet in 5% trichloroacetic acid (TCA) and 
then dried.  The pads were then subjected to the following 10 min washes: three times with 
5% TCA, and once with cold 70% ethanol.  The pads were then dried under a heat lamp and 
quantitated for radioactivity in a liquid scintillation counter (Beckman LS 6500, Beckman 
Coulter, Fullerton, CA).  GraphPad Prism software was used to plot data.  Misaminoacylation 
assays were performed similarly, except that reactions contained 25 μM  [3H]-isoleucine (500 
μCi/mL) or 50 μM  [14C]-isoleucine (15.9 μCi/mL). 
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II.6.  Isolation of mischarged tRNA 
 
Misaminoacylation of transcribed tRNA
Leu
 with isoleucine was carried out by 
incubating the following reaction mixture at 25 °C for 3 h:  60 mM Tris, pH 7.5, 10 mM 
MgCl2, 1 mM DTT, 8 μM transcribed tRNA
Leu
, 23 μM [3H]-isoleucine (300 μCi/mL), 1 μM 
editing defective LeuRS and 4 mM ATP.  The reaction was quenched under acidic conditions 
with 0.18% acetic acid (Schreier and Schimmel, 1972) to stabilize the aminoacyl ester 
linkage between isoleucine and the terminal adenosine (A76) on tRNA
Leu
.  Protein was 
removed from the reaction mixture by phenol extraction using a 125:24:1 
phenol:choloroform:isoamyl alcohol mixture (pH 4.3) (Fisher Scientific, Fair Lawn, NJ).  
Mischarged tRNA
Leu
 was ethanol precipitated in the presence of 0.34 mg/mL glycogen at       
-80 °C overnight.  The recovered tRNA pellet was washed twice with 70% ethanol, dried and 
resuspended in 50 mM KPi (pH 5.0). 
 
II.7.  Post-transfer editing deacylation assay 
 
Deacylation reaction mixtures contained 60 mM Tris, pH 7.0, 10 mM MgCl2 and 
approximately 2 μM mischarged tRNALeu.  The reactions were initiated with 1 μM enzyme.  
At desired time points, reaction aliquots of 5 μL were quenched on Whatman filter pads that 
had been pre-wet in 5% TCA and dried.  Pads were washed and then quantified for 
radioactivity as described for the aminoacylation assays. 
 
II.8.  ATP/Inorganic pyrophosphate (PPi) exchange assay 
 
Reaction mixtures containing 50 mM Tris-HCl, pH 8.0 or 50 mM HEPES, pH 8.0,   
10 mM MgCl2, 1 mM DTT, 1 mM [
32
P]-PPi (100 μCi/mL), 1 mM ATP, and 1 mM leucine or 
10 mM isoleucine were initiated with 1 μM enzyme.  At different time intervals, reaction 
aliquots of 2 μL were quenched on cellulose polyethyleneimine (PEI) thin layer 
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chromatography (TLC) plates (Scientific Adsorbents Inc., Atlanta, GA) that were pre-run in 
water and dried.  Reaction products were resolved on the TLC plates in 750 mM KH2PO4,  
pH 3.5 with 1 mM urea.  Resolved radiolabeled bands on the TLC plate were 
phosphorimaged using FUJIFILM BAS Cassette 2040 (FUJIFILM Medical Systems, 
Stanford, CT) and images were scanned by a STORM 840 Molecular Dynamics scanner 
(Amersham Pharmacia Biotech, Piscataway, NJ).  Images were quantified using the 
ImageQuant software and the resulting data plotted and analyzed using the GraphPad Prism 
software. 
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Chapter III:  Characterization of Benzoxaborole-based Antifungal Resistance 
                       Mutations Demonstrates that Editing Depends on Electrostatic 
                       stabilization of the Leucyl-tRNA Synthetase Editing Cap         
 
Adapted with permission from  
Jaya Sarkar, Weimin Mao, Tommie L. Lincecum, Jr., M.R.K. Alley, and Susan A. Martinis 
(2011).  “Characterization of benzoxaborole-based antifungal resistance mutations 
demonstrates that editing depends on electrostatic stabilization of the leucyl-tRNA synthetase 
editing cap”.  FEBS Lett., 585, 2986-2991.  Copyright 2011 Elsevier.  
 
 
 
III.1.  Introduction 
 
Aminoacyl-tRNA synthetases (AARSs) are essential to all organisms and have been 
pursued as promising pharmaceutical drug targets (Schimmel, 1998).  Pseudomonic acid 
(Mupirocin) has been used for years as a topical antibiotic to selectively inhibit isoleucyl-
tRNA synthetase (IleRS) via interactions with its aminoacylation active site.  Recently, a 
novel benzoxaborole called AN2690 was discovered to block protein synthesis in yeast by 
binding to the editing site of cytoplasmic LeuRS (Rock, et al., 2007). 
Each of the AARSs establishes the genetic code via an aminoacylation reaction that 
attaches a specific amino acid to its cognate tRNA, which is then delivered to the ribosome.  
To enhance fidelity, about half of the AARSs have evolved „editing‟ or „proofreading‟ 
mechanisms (Mascarenhas, 2008).  A „post-transfer‟ editing mechanism hydrolyzes the 
misacylated tRNA to release free uncharged tRNA and amino acid.  This correction 
mechanism is carried out by AARSs that have hydrolytic domains or by free-standing tRNA 
deacylases (An and Musier-Forsyth, 2005; Fersht, 1977b; Ruan and Soll, 2005).  
Alternatively, „pre-transfer‟ editing clears misactivated aminoacyl-adenylate (Fersht, 1977b). 
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Figure III.1.  Primary and tertiary structures of LeuRS I4 „cap‟ insert within the CP1 editing 
domain. (Top left)  Crystal structure of C. albicans cytoplasmic LeuRS CP1 domain in 
complex with AN3018-AMP (orange) (PDB entry 2WFG) (Seiradake, et al., 2009).  The I4 
insert (Glu454 to Asn493 in C. albicans) is highlighted in blue with Gly490 (which 
corresponds to the Asp487 in yeast cytoplasmic LeuRS) shown in red.  Yellow balls denote 
ordered water molecules in the editing pocket.  (Top right)  Chemical structures of AN2690 
and AN3018.  (Bottom)  Multiple sequence alignment of the I4 insert within the LeuRS CP1 
domain.  The blue line highlights the I4 insert.  The Asp487 in yeast LeuRS is indicated in 
red and by the arrow.  The orange line indicates the putative „translocation‟ peptide proposed 
in Escherichia coli LeuRS (Hellmann and Martinis, 2009).  The residues boxed in orange 
within this peptide are proposed to impair translocation.  Abbreviations are: Thermus 
thermophilus (Tt), E. coli (Ec), S. cerevisiae cytoplasmic (Sc-c), C. albicans cytoplasmic 
(Ca-c) and P. horikoshii (Ph). 
 
The class I AARS canonical core of LeuRS houses the synthetic aminoacylation site.  
A discretely folded polypeptide insertion, called the connective polypeptide 1 (CP1) (Starzyk, 
et al., 1987) contains the hydrolytic editing active site (Mursinna, et al., 2001).  The 
antifungal AN2690 forms an adduct to tRNA
Leu
 in the editing pocket to trap the enzyme in a 
non-productive conformation (Figure III.1, top left).  A series of AN2690-resistant mutations 
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were isolated within the CP1 domain of yeast LeuRS that localized to the hydrolytic editing 
active site (Rock, et al., 2007).  Here, we focused on two resistance mutations at Asp487 that 
lie outside the hydrolytic editing active site in LeuRS, where AN2690 (Figure III.1, bottom) 
binds.  This resistance site is downstream of conserved motifs in the primary sequence that 
define the editing pocket. 
Sequence alignments show that Asp487 is located within an insert called I4 that is 
specifically found in eukaryotes and archae, but is absent in the bacteria (Figure III.1, 
bottom).  An X-ray crystal structure of the CP1 domain from Candida albicans LeuRS 
suggests that the I4 insert forms part of a cap over the hydrolytic active site (Seiradake, et al., 
2009).  When closed, the I4 cap in the C. albicans structure sequesters an AN2690-
benzoxaborole analog called AN3018 (Figure III.1, top) that is covalently linked to AMP.  In 
this case, the AMP portion of the bound small molecule is proposed to mimic the 3´-end of a 
tRNA molecule that is bound in the editing site (Seiradake, et al., 2009). 
Since the benzoxaborole binds in the editing site where the mischarged tRNA editing 
substrate binds in LeuRS (Lincecum, et al., 2003; Rock, et al., 2007), we postulated that 
resistance mutations at Asp487 in the I4 cap would impact hydrolytic editing.  Biochemical 
analysis of mutations at Asp487 showed that a negatively charged residue was essential to 
hydrolytic editing activity.  We hypothesize that Asp487 plays a critical role in facilitating 
the I4 cap closure over the editing active pocket during substrate binding. Our results support 
that electrostatic interactions between Asp487 and an arginine residue within the editing 
pocket facilitates the lid-like orientation of the I4 cap to stabilize bound substrate and 
promote editing. 
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III.2.  Experimental methods 
 
 
III.2.A.  Mutagenesis 
 
Mutations that are resistant to AN2690 were selected using the haploid S. cerevisiae 
strain (ATCC 201388) via methods that have been previously described (Rock, et al., 2007).  
Spontaneous ethylmethane sulfonate (EMS)-induced resistant mutants were isolated from 
YPD agar plates that contained concentrations of 2 µg/mL, 4 µg/mL, and 8 µg/mL AN2690. 
Site directed mutagenesis was carried out via the polymerase chain reaction (PCR) as 
described in Chapter II.  The plasmid p32YL-2-3 (Lincecum, et al., 2003) encoding the wild 
type S. cerevisiae cytoplasmic LeuRS was used as the template to introduce the desired 
mutations to generate the plasmids pJSycD487G, pJSycD487N, pJSycD487A, pJSycD487K, 
pJSycD487R and pJSycD487E encoding the mutant D487G, D487N, D487A, D487K, 
D487R and D487E LeuRS enzymes, respectively.  Plasmids pJSycD487G, pJSycD487N and 
pJSycD487A were then used as templates in separate PCR reactions to introduce a second 
T319A mutation in each mutant protein.  This created the plasmids pJSycD487G/T319A, 
pJSycD487N/T319A and pJSycD487A/T319A, encoding the double mutant D487G/T319A, 
D487N/T319A and D487A/T319A LeuRSs, respectively.  Plasmid pJSycD487K was utilized 
as the template to introduce the second mutation R316D or R316E generating the mutant 
D487K/R316D or D487K/R316E LeuRSs, respectively.  Similarly, plasmid pJSycD487R 
was utilized as the template to introduce the second mutation R316D or R316E generating the 
mutant D487R/R316D or D487R/R316E LeuRSs, respectively. 
 
 
III.2.B.  Protein expression and purification 
 
A 2 L LB that contained 100 μg/mL ampicillin (Amp) and 34 μg/mL chloramphenicol 
(Cm) was inoculated with a 5 mL overnight culture and cells grown at 30 °C till OD600 
reached ~0.8.  Post induction with 1 mM IPTG, the N-terminal six-histidine tagged wild type 
  
60 
 
and mutant yeast cytoplasmic LeuRSs were expressed in E. coli strain Rosetta (DE3) 
(Novagen) at 30 °C for 45 min from the respective plasmids and purified via Ni-NTA affinity 
chromatography as described in Chapter II.  The final protein concentration was determined 
spectrophotometrically at 280 nm using an extinction coefficient of 155,310 M
-1
cm
-1
, 
estimated by the ExPASy Protparam tool (http://ca.expasy.org/tools/protparam.html). 
 
III.2.C.  Aminoacylation and misaminoacylation assay 
 
The aminoacylation reactions contained 60 mM HEPES, pH 7.5, 30 mM MgCl2,      
30 mM KCl, 1 mM DTT, 4 mg/mL S. cerevisiae crude tRNA, 21 µM [
3
H]-leucine             
(150 µCi/mL) and catalytic concentrations of enzyme.  Each reaction was initiated with         
4 mM ATP.  At desired time points, reaction aliquots of 10 µL were quenched and processed 
as described in chapter II.  Kinetic parameters for the aminoacylation reaction were measured 
using 0.5 µM enzyme.  A relatively high enzyme concentration was used for the kinetic 
assays due to low activity of the yeast LeuRS enzyme at lower concentrations.  A range of 
0.1–100 mg/mL crude yeast tRNA (Sigma) was used which corresponded to 0.05–40 µM 
tRNA
Leu
.  The „Enzyme Kinetics analysis‟ module of Sigma Plot (Systat Software, Inc.) was 
used to calculate the kinetic parameters and error. 
Misaminoacylation reactions were carried out similarly, except that the reaction 
mixture contained higher concentrations of 25 µM [
3
H]-isoleucine (500 µCi/mL) or 50 µM 
[
14
C]-isoleucine (15.9 µCi/mL) and 1 to 5 µM enzyme.   
 
 
III.2.D.  Isolation of mischarged tRNA  
 
Misaminoacylation of S. cerevisiae crude tRNA with isoleucine was carried out by 
incubating the following reaction mixture at 30 °C for 3 h:  60 mM HEPES, pH 7.5, 30 mM 
MgCl2, 30 mM KCl, 1 mM DTT, 4 mg/mL S. cerevisiae crude tRNA, 23 μM [
3
H]-isoleucine 
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(300 μCi/mL), 1 μM editing defective LeuRS and 4 mM ATP.  Mischarged tRNA was 
isolated as described in Chapter II. 
 
III.2.E.  Post-transfer editing deacylation assay 
 
Deacylation reactions were carried out at pH 7.5 in 60 mM HEPES, 30 mM MgCl2, 
30 mM KCl, and approximately 2 mg/mL [
14
C]-Ile-tRNA
Leu
 or [
3
H]-Ile-tRNA
Leu
.  The 
reactions were initiated with 0.5 µM enzyme and reaction aliquots of 5 µL were quenched, 
processed, and analyzed as described in Chapter II. 
 
III.2.F.  ATP/Pyrophosphosphate (PPi) exchange assay 
 
Inorganic pyrophosphate (PPi) exchange assays were carried out with reaction 
mixtures containing 50 mM HEPES, pH 8.0, 10 mM MgCl2, 10 mM KCl, 1 mM DTT, 1 mM 
[
32
P]-PPi (100 µCi/mL), 1 mM ATP, and 1 mM leucine or 10 mM isoleucine were initiated 
with 1 µM enzyme.  Aliquots of 2 µL at specific time points were analyzed via thin-layer 
chromatography as described in Chapter II. 
 
III.2.G.  Acid gel electrophoresis  
 
Acid gel electrophoresis of misaminoacylation reaction products was performed in 
order to confirm that the amino acid is indeed present on the tRNA.  Misaminoacylation 
reactions containing 50 mM HEPES, pH 7.5, 30 mM MgCl2, 30 mM KCl, 2 mM DTT,          
4 mg/mL S. cerevisiae crude tRNA, 20.3 µM [
35
S]-methionine (300 µCi/mL) or  50 µM 
[
14
C]-isoleucine (300 µCi/mL) and 1 µM enzyme were initiated with 4 mM ATP and 
incubated for 3 h at 30 °C.  From each reaction, an aliquot of 10 µL was quenched with       
10 µL quench buffer (100 mM NaOAc, pH 5.0, 50 mM EDTA and 8 M urea) and 
electrophoresed on a 10% acid acrylamide gel (pH 5.0) containing 8 M urea.  The gel was 
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pre-equilibrated with 25 mM NaOAc, pH 5.0 and electrophoresed slowly at 5 mA in the same 
buffer.  Upon completion of separation, the gel was dried and exposed to a phosphorimager 
screen (FUJIFILM BAS Cassette 2040) for 2 to 4 weeks in case of [
14
C]-isoleucine or 2 days 
in case of [
35
S]-methionine.  Images were scanned by a STORM 840 Molecular Dynamics 
scanner and images quantified using the ImageQuant software.  
 
III.3.  Results 
 
The antifungal LeuRS inhibitor, AN2690 binds in the CP1 domain-based editing 
active site of LeuRS (Rock, et al., 2007).  The boron atom of AN2690 forms bonds with the 
cis-diol groups of the ribose ring at the 3´-end of tRNA
Leu
  to yield a tRNA-AN2690 adduct 
in the editing site of LeuRS (Rock, et al., 2007) (Figure III.1, top).  The AN2690-tRNA-
protein complex prevents enzyme turnover, ultimately leading to an arrest in protein 
synthesis. 
In yeast LeuRS, spontaneous resistant mutations were isolated in the presence of 
concentrations of AN2690 that were 4-, 8-, and 16-fold of its 0.5 µg/mL minimal inhibitory 
concentration (MIC) (Rock, et al., 2007).  The mutants were dominant and showed an 8 to 
64-fold increase in the yeast MIC.  As would be expected based on target interactions, the 
mutant LeuRSs lacked resistance to several other known antifungal agents including 
amphotericin B, cerulenin, itraconazole, aculeacin A, terbinafine, tunicamycin, ciclopirox, 
cyclohexamide, and nikkomycin Z. 
Previously, AN2690 spontaneous-resistance mutants were localized to the editing 
active site of yeast LeuRS, where AN2690 binds directly (Rock, et al., 2007).  Herein, we 
focused on missense mutations to Asp487 where mutants with a cytoplasmic LeuRS bearing 
a glycine (D487G) or asparagine (D487N) substitution conferred an increase in the MIC of 
AN2690 to 32 µg/mL compared to 0.5 µg/mL for the wild-type strain.  Because Asp487 is at 
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a site that is distal to the hydrolytic editing active site, its effect on editing or alternate 
mechanisms of action on the target LeuRS were not clear.  The Asp487 site is separated from 
the primary sequence that defines the editing pocket/AN2690 binding site and it is located in 
an insert called I4 that is specific to the archaeal and eukaryotic enzymes (Figure III.1). 
 
 
 
Figure III.2.  Norvaline sensitivity of AN2690 resistant mutations at Asp487.  The parental S. 
cerevisiae strain ATCC 201388 (Rock, et al., 2007) is labeled wild type (WT).  The 
mutations D487G and D487N correspond to the S. cerevisiae resistant strains ANA325 and 
ANA359, respectively.  The „halo‟ of cell death around the central well, which incorporates 
20 µL of norvaline (40 mg/mL), indicates that the resistant mutants are editing defective. 
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Figure III.3.  Amino acid activation by wild type ycLeuRS, assessed by ATP/PPi exchange 
assays.  A representative reaction time course TLC-based separation of [
32
P]-PPi, -ATP and -
Pi.  Reactions containing 1 mM [
32
P]-PPi (100 µCi/mL), 1 mM ATP and 1 mM leucine or 10 
mM isoleucine were initiated with 1 µM enzyme at 30 °C.  Leucine activation reactions were 
carried out upto 30 min, while reactions with isoleucine upto 90 min.  The TLC plates were 
developed in 750 mM KH2PO4, pH 3.5 with 1 M urea.   
 
Comparison of the apo crystal structure of the isolated CP1 domain from C. albicans 
LeuRS and the co-crystal structure containing AN3018, an analog of AN2690 (Figure III.1, 
top right) (Seiradake, et al., 2009) suggests that the yeast/archeal-specific I4 helix is flexible 
and can close in a „cap‟ like fashion over the editing site that is bound to the benzoxaborale 
inhibitor.  The space enclosed over the editing pocket by this I4 „cap‟ accommodates both the 
substrate and a fixed network of water molecules. We hypothesized that Asp487 of the I4 
insert orients the cap for substrate binding and stabilization in the editing site.  Halo assays 
that incorporated 20 µL of norvaline (40 mg/mL) in the central well (Rock, et al., 2007) 
support that the LeuRS D487G and D487N are editing defective resulting in norvaline 
toxicities (Figure III.2). 
 
  
65 
 
 
 
Figure III.4.  Leucine activation and aminoacylation by Asp487 LeuRS mutants.  (Top)  
Leucine-dependent pyrophosphate (PPi) exchange reaction mixtures consisted of 1 mM PPi 
(100 μCi/ml), 1 mM leucine and 1 mM ATP and were initiated with 0.5 μM enzyme.  
(Bottom)  Aminoacylation reactions included 4 mg/ml S. cerevisiae crude tRNA, 0.5 μM 
enzyme and 21 μM [3H]-leucine (150 μCi/ml) and were initiated with 4 mM ATP.  Symbols 
are: wild type (■), D487G (▲), D487N (▼), D487A (♦), D487K (□) and D487R (◊).  Error 
bars for each time point are a result of each reaction repeated in triplicate. 
 
We re-created the AN2690 resistant mutations, D487G and D487N, as well as a 
D487A mutation in the yeast cytoplasmic LeuRS.  To test the importance of a charged polar 
side chain in the I4 insert, we also replaced Asp487 with lysine, arginine and glutamic acid, 
generating the positively charged mutant D487K and D487R as well as the homologous 
mutant D487E LeuRSs, respectively.  Leucine-dependent PPi exchange assays showed that 
the resistant mutants, D487G and D487N (Figure III.3, left; Figure III.4, top left) as well as 
the positively charged D487K and D487R LeuRS mutants (Figure III.3, left; Figure III.4, top 
right) activate cognate leucine similar to the wild type enzyme.  Based on its lowered plateau, 
the D487A mutant LeuRS exhibited slightly reduced ATP formation compared to the wild 
type enzyme (Figure III.4, top left). 
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              Table III.1.  Apparent kinetic parameters for tRNA
Leu
 aminoacylation.
a
 
 
             
a
 tRNA
Leu
 concentrations were varied as described in materials and methods. 
 
We tested each yeast mutant LeuRS using commercially available crude yeast tRNA, 
since we previously determined that an in vitro generated yeast tRNA
Leu
 transcript is a very 
poor substrate for its cognate LeuRS (Lincecum, et al., 2003).  We hypothesize that 
modifications are critical in stabilizing the structure of yeast tRNA
Leu
.  Alternatively, they 
may provide an important determinant for aminoacylation by yeast LeuRS (Giegé, et al., 
1998).  These mutant LeuRSs aminoacylate tRNA
Leu
 (Figure III.4, bottom) with 
approximately 2-fold reduction in kcat/KM values (Table III.1) as compared to the wild type 
enzyme.  The decrease in the kcat/KM for the D487A and the positively charged D487 mutant 
LeuRSs is primarily due to an increase in KM (Table III.1). 
The Asp487 mutant LeuRSs were tested for their amino acid editing activity with 
yeast crude tRNA that was misaminoacylated with isoleucine using an editing-defective 
LeuRS.  The AN2690-resistant mutants, D487G, D487N and also the D487A mutant 
exhibited significantly reduced deacylation activity for Ile-tRNA
Leu
 (Figure III.5, top).  The 
positively charged Asp487 mutant LeuRSs are completely defective in hydrolyzing 
misacylated tRNA (Figure III.5, bottom).  Interestingly however, a homologous substitution 
at Asp487 by glutamic acid retains substantial editing activity (Figure III.5, bottom).  Also as 
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expected, the aminoacylation activities of the LeuRS Asp487 resistance mutants were not 
inhibited by AN2690 (Figure III.6).  The mechanism of action for AN2690 inhibition 
requires tRNA
Leu
 binding in the editing active site for it to be trapped by the benzoxaborole. 
 
 
 
 
Figure III.5.  Isoleucine editing activities of AN2690-resistant and charged Asp487 mutants 
of LeuRS.  Deacylation reactions included approximately 2 mg/ml [
14
C]-Ile-tRNA
Leu
 and   
0.5 µM enzyme.  Symbols are: wild type (■), D487G (▲), D487N (▼), D487A (♦), D487K 
(□), D487R (◊), D487E (∆) and no enzyme (x).  Error bars for each time point are a result of 
each reaction repeated in triplicate. 
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Figure III.6.  Aminoacylation activities of Asp487 LeuRS resistant mutants in the presence of 
AN2690.  Aminoacylation reactions included 4 mg/ml S. cerevisiae crude tRNA, 0.5 μM 
enzyme, 21 μM [3H]-leucine (150 μCi/ml) and 0.5 mM AN2690.  The reaction was incubated 
at 30 °C for 1 hr followed by initiation with 4 mM ATP.  Symbols are: absence of AN2690 
(■) and presence of AN2690 (▲).  Error bars for each time point are a result of each reaction 
repeated in triplicate. 
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Figure III.7.  Misaminoacylation activity of Asp487 LeuRS mutants.  (Top)  
Misaminoacylation of S. cerevisiae crude tRNA with isoleucine or methionine.  Reactions 
contained 8 mg/mL S. cerevisiae crude tRNA, 50 µM [
14
C]-isoleucine (15.9 µCi/mL) or      
20 µM [
35
S]-methionine (10 µCi/mL) and 1 µM enzyme and were initiated with 4 mM ATP 
at 30 °C.  Symbols are: wild type (■), D487G (▲), D487N (▼), D487A (♦) and D419A (●).  
Error bars for each time point are a result of each reaction repeated in triplicate.  (Bottom)  
Acid gel analysis of misaminoacylated tRNA.  Misaminoacylation reactions were carried out 
as mentioned above, except that 300 µCi/mL of respective radiolabeled amino acids were 
incorporated.  Reactions were carried out for 90 min, followed by separation on denaturing 
polyacrylamide gel that was electrophoresed in 25 mM NaOAc, pH 5.0.  Acid gel analysis 
confirms that the amino acid is attached to the tRNA and the enzyme is not self-labaled with 
the radiolabeled amino acids (Martinis and Schimmel, 1992). 
 
The yeast cytoplasmic Asp487 LeuRS mutant editing deficiencies resulted in low 
accumulations of mischarged Ile-tRNA
Leu
 in misaminoacylation assays using crude yeast 
tRNA (Figure III.7, top; Figure III.8).  These mischarging plateaus are about 8-fold lower 
than a strong mischarging LeuRS mutant, such as D419A which substitutes a universally 
conserved residue in the editing pocket that stabilizes the editing substrate via a hydrogen 
bond (Lincecum, et al., 2003).  However, these Asp487 LeuRS mutants exhibited similar 
activation of isoleucine as compared to the wild type enzyme in isoleucine-dependent PPi 
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exchange assays (Figure III.3, right; Figure III.9).  Radiolabeled amino acids may get co-
precipitated with the tRNA during TCA precipitation (see materials and methods) or remain 
trapped in the enzyme active site, leading to the enzyme being „self-labeled‟ (Martinis and 
Schimmel, 1992).  Under conditions when the enzyme‟s charging activity is weak as in case 
of mischarging, in order to confirm that the amino acid is indeed attached to the tRNA, 
products of the misaminoacylation reactions are analyzed on acidic polyacrylamide gels.  
Such acid gel analysis of misaminoacylation by the Asp487 resistant mutants in presence of 
either [
35
S]-methionine or [
14
C]-isoleucine show that these amino acids are indeed attached to 
the tRNA (Figure III.7, bottom).  As would be expected, the wild type yeast LeuRS did not 
mischarge the crude yeast tRNA with isoleucine since LeuRS, like all other AARSs, is 
specific for its cognate tRNA.  Recognition of tRNA
Leu
 by LeuRS is facilitated by specific 
determinants found within the tRNA (Giegé, et al., 1998) as well as by tertiary structure 
formed between the D and TψC-arms of tRNA (Larkin, 2002).  The yeast cytoplasmic 
enzyme is  also unusual amongst the LeuRSs in that it relies on the anticodon of tRNA
Leu
 for 
recognition (Soma, et al., 1996). 
 
 
 
Figure III.8.  Misaminoacylation activity of positively charged Asp487 mutant LeuRSs.  
Reactions included 4 mg/ml S. cerevisiae crude tRNA, 1 μM enzyme and 24 μM [3H]-
isoleucine (150 μCi/ml) and were initiated with 4 mM ATP.  Symbols are wild type (■), 
D487K (□) and D487R (◊).  Error bars for each time point are a result of each reaction 
repeated in triplicate. 
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Figure III.9.  Isoleucine activation by Asp487 LeuRS mutants.  Isoleucine-dependent PPi 
exchange assays that included 1 mM PPi (100 μCi/ml), 10 mM isoleucine and 1 mM ATP 
were initiated with 0.5 μM enzyme.  Symbols are wild type (■), D487G (▲), D487N (▼), 
D487K (□) and D487R (◊).  Error bars for each time point are a result of each reaction 
repeated in triplicate. 
 
Since a homologous substitution at Asp487 could restore the enzyme‟s hydrolytic 
activity, we wondered how this negative charge that is outside the editing pocket contributed 
towards amino acid editing.  We scrutinized the X-ray crystal structure of the C. albicans 
CP1 domain in complex with the benzoxaborale AN3018 (Seiradake, et al., 2009).  The C. 
albicans LeuRS CP1 domain has a glycine residue (Gly490) at the position comparable to 
Asp487 in S. cerevisiae LeuRS (Figure III.1, bottom).  Ironically, a glycine at this site renders 
the yeast LeuRS enzyme resistant to AN2690.  Nevertheless, we relied on the AN3018-bound 
C. albicans LeuRS structure as an opportunity to guide our investigation into the structure-
function role of Asp487 in editing by yeast LeuRS. 
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Figure III.10.  Putative electrostatic interaction between the I4 insert and the editing pocket of 
fungal cytoplasmic LeuRS.  (Top)  Crystal structure of C. albicans cytoplasmic LeuRS CP1 
domain in complex with AN3018-AMP (PDB entry 2WFG) (Seiradake, et al., 2009) 
highlighting the I4 insert (blue), Gly490 in the I4 insert and Arg318 in the editing pocket 
(analogous to Asp487 and Arg316, respectively in yeast LeuRS).  (Center) and (Bottom)  
Hydrolytic editing activities of single charged Asp487 mutants and Asp487/Arg316 double 
mutants.  Deacylation reactions included approximately 2 mg/ml [
14
C]-IletRNA
Leu
 and       
0.5 µM enzyme.  Symbols are: wild type (■), D487K (□), D487R (◊), D487K/R316D and 
D487R/R316D (o), D487K/R316E and D487R/R316E (●) and no enzyme (x).  Error bars for 
each time point are a result of each reaction repeated in triplicate. 
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When the I4 cap is closed over the AN3018-AMP bound editing pocket in the X-ray 
crystal structure of the C. albicans LeuRS CP1 domain, the α-carbon of Gly490 is in close 
proximity (~4 Å) to the guanidinium group of the arginine at position 318 (Figure III.10, top).  
We identified Arg316 in S. cerevisiae LeuRS, (corresponding to Arg318 of C. albicans 
LeuRS in the primary sequence) and hypothesized that it was also located within or near the 
editing pocket.  Interestingly, R316I has been reported to be resistant to AN2690 in S. 
cerevisiae (Rock, et al., 2007).  Although the yeast LeuRS Asp487 has a longer side chain 
than the Gly 490 found in C. albicans LeuRS that could place it closer than 4 Å to the 
arginine, we wondered if local rearrangements within the dynamic and diverse structures 
might accommodate a salt bridge between Asp487 and Arg316 in the yeast enzyme.  If 
Asp487 at the base of the I4 cap forms an electrostatic salt-bridge with Arg316 of the yeast 
LeuRS editing pocket, then we postulated that it could stabilize closure of the I4 cap to 
sequester the bound substrate in the editing pocket. 
To test this hypothesis, we mutationally swapped charges at Asp487 and Arg316 to 
construct the double mutants D487K/R316D, D487K/R316E and D487R/R316D, 
D487R/R316E.  The D487K/R316D double mutant rescued hydrolytic activity of the editing-
defective positively-charged D487K mutant to levels that were close to the wild type enzyme 
(Figure III.10, center).  The D487K/R316E double mutant did not recover any hydrolytic 
editing activity (Figure III.10, center).  We also observed that the double mutants 
D487R/R316D and D487R/R316E did not rescue hydrolytic editing of the editing-defective 
D487R mutant LeuRS (Figure III.10, bottom).  This suggests that the longer side chains of 
glutamic acid and arginine may juxtapose the residues too close to form an effective 
electrostatic interaction.  In lieu of an aspartate corresponding to position 487 in C. albicans 
LeuRS, (Figure III.1, bottom), the enzyme may depend on alternate residues to form an 
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electrostatic bridge.  It is possible that Glu489, which neighbors Gly490 (Figure III.1, 
bottom), could form a salt bridge with Arg318. 
Post-transfer editing is dependent on an intra-enzyme translocation event that moves 
the tRNA between the main body and the CP1 domain that are respectively responsible for 
aminoacylation and editing.  Mutations in the E. coli LeuRS „translocation peptide‟ (Figure 
III.1, bottom) appear to cause the mischarged tRNA to bypass the editing active site 
(Hellmann and Martinis, 2009).  The eukaryotic LeuRSs lack this bacterial LeuRS 
translocation peptide.  However, in a primary sequence alignment, Asp487 of the yeast 
cytoplasmic LeuRS is upstream to the N-terminus of the site that would correspond to the  
 
 
 
Figure III.11.  Rescue of aminoacylation of editing site mutation (T319A) by Asp487 LeuRS 
mutants.  Reactions consisted of 4 mg/ml S. cerevisiae crude tRNA, 0.5 µM enzyme and     
22 µM [
3
H]-leucine (150 µCi/ml) and were initiated with 4 mM ATP.  Symbols are: wild 
type (■), D487G/T319A (▲), D487N/T319A (▼), D487A/T319A (♦), T319A (●) and no 
enzyme (x).  Error bars for respective time points represent each reaction repeated in 
triplicate. 
 
E. coli LeuRS translocation peptide (Figure III.1, bottom).  We wondered if the Asp487 
region of the I4 cap could facilitate tRNA translocation via a distinct mechanism.  Previously, 
to test for disruptions in translocation, we relied on a conserved threonine in E. coli LeuRS 
(Thr252) which is an amino acid specificity determinant in the editing pocket that blocks 
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leucine from binding (Mursinna, et al., 2001).  When mutated to alanine, loss of specificity 
confers deacylation of Leu-tRNA
Leu
, resulting in a phenotype of weak charging activity for 
the T252A mutant LeuRS.  Disruption of translocation would restore Leu-tRNA
Leu
 
accumulation in the LeuRS mutant. 
Mutation of the threonine specificity determinant in yeast LeuRS (Thr319) also 
results in low charging activity (Figure III.11).  We combined each of the resistant mutations, 
D487G and D487N, with the editing site mutation T319A that uncouples specificity in the 
editing site of yeast LeuRS, resulting in the double mutants D487G/T319A and 
D487N/T319A, respectively.  The Asp487 double mutants rescued aminoacylation of the 
T319A mutant, resulting in accumulation of Leu-tRNA
Leu
 up to wild type levels (Figure 
III.11).  In this case, it is possible that the charged 3´-end of tRNA
Leu
 may not be stably 
binding at the editing pocket or alternatively, has reduced access to the editing site.  We 
determined that the hydrolytic editing activity of the Asp487/Thr319 double mutants was 
significantly decreased for the correctly charged product Leu-tRNA
Leu
 (Figure III.12, top) as 
well as the mischarged product Ile-tRNA
Leu
 (Figure III.12, bottom) in comparison to the 
single T319A mutant.  These results suggest that mutation of Asp487 destabilizes binding of 
the 3´-end of the tRNA in the editing pocket of the CP1 domain, rather than disrupting a 
tRNA translocation mechanism. 
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Figure III.12.  Deacylation activities of Asp487/Thr319 double mutants.  (Top)  Deacylation 
of Leu-tRNA
Leu
 included approximately 2 mg/ml [
3
H]-Leu-tRNA
Leu
 and 1 μM enzyme.  
(Bottom)  Deacylation of Ile-tRNA
Leu
 included approximately 2 mg/ml [
3
H]-Ile-tRNA
leu
 and 
1 μM enzyme.  Symbols are: wild type (■), D487G/T319A (▲), D487N/T319A (▼), 
D487A/T319A (♦), T319A (●) and no enzyme (x).  Error bars for respective time points 
represent each reaction repeated in triplicate.  
 
 
III.4.  Discussion 
 
The AARS family of enzymes by virtue of their essentiality and diversity, have been a 
focus of drug discovery to identify new antimicrobial agents.  A traditional strategy has been 
to find compounds that selectively mimic the pathogen AARS substrates, intermediates and 
transition state analogs, while sparing the human counterpart (Tao, 2000).  By screening 
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libraries of synthetic boron-containing small molecules, a new class of antifungals, the 
benzoxaboroles, were discovered (Baker, et al., 2006).  These antifungal benzoxaboroles 
inhibited LeuRS in a novel way by binding in the editing pocket of the CP1 domain and 
trapping the tRNA in the editing conformation via an adduct with the cis-diols of the terminal 
nucleotide (Rock, et al., 2007; Seiradake, et al., 2009). 
Isolation of spontaneous and EMS-generated resistant mutants to AN2690 have been 
reported within the editing pocket of LeuRS (Rock, et al., 2007), where the drug interacts 
directly with the enzyme.  Each of these resistant mutants is editing defective in norvaline-
dependent complementation assays (Rock, et al., 2007).  Herein, we characterized resistant 
mutants D487G and D487N, which lie outside the editing active site.  The C. albicans and 
yeast cytoplasmic CP1 domain have acquired species specific peripheral insertions, one of 
which (I4) appears to form a cap over the bound editing substrate (Figure III.1, top).  The 
Asp487 lies within the I4 peripheral insert.  The crystal structure of the C. albicans CP1 
domain shows that a network of water molecules, as well as the editing substrate, are 
sequestered within the space enclosed by the I4 cap over the editing pocket (Seiradake, et al., 
2009).  We hypothesize that Asp487 in the species-specific I4 insert of the yeast LeuRS could 
be mechanistically important to the cap‟s hinge motion. 
Resistance mutations highlighted that this I4 insert may be idiosyncratic, albeit an 
essential component of the editing mechanism in LeuRS for lower eukaryotes. Mutations at 
Asp487 in yeast LeuRS directly impact editing with minimal effects on aminoacylation.  
Charge reversals at Asp487 completely destabilize the editing activity.  We scrutinized the 
available crystal structure information to identify a plausible electrostatic salt bridge 
interaction between Asp487 at the base of the I4 cap and Arg316 in the editing pocket.  
Significantly, a double mutation to reverse these charges rescued editing activity of the 
D487K LeuRS mutant, which suggests that the salt bridge was restored. 
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There are relatively few synthetase-tRNA contacts in the editing complex compared 
to the aminoacylation complex (Tukalo, et al., 2005).  In addition, the yeast LeuRS active site 
has been suggested to be more open and accessible to water compared to its bacterial 
counterpart that lacks the I4 insert.  The I4 cap and this salt bridge between the cap and the 
editing active site could stabilize substrate and inhibitor binding in a more open editing site, 
as well as orient enclosed water molecules.  Ultimately, AN2690 crosslinks to the tRNA in 
the editing site resulting in a long half-life (Rock, et al., 2007).  Although the fit of the AMP-
benzoxaborole adduct in the editing pocket of LeuRS is complementary, only a few hydrogen 
bonds within the LeuRS editing active site stabilize it (Rock, et al., 2007).  The AMP-
benzoxaborole adduct is superimposable with a post-transfer editing substrate analog (Rock, 
et al., 2007).  It also directly contacts the universally conserved aspartic acid residue (Asp419 
in yeast LeuRS) in the editing active site that stabilizes the post-transfer editing substrate via 
a hydrogen bond with the α-amino group of the amino acid.  However, the benzoxaborole 
adduct lacks a key site analogous to the amino group of an aminoacylated tRNA.  Thus, a cap 
over the editing pocket could significantly and critically stabilize the bound editing substrate 
by providing or orienting either direct or water-mediated contacts between the enzyme and 
the substrate. 
We hypothesize that, in the Asp487 mutants, stabilization of the charged 3´-end of the 
tRNA is compromised.  De-stabilization of the bound substrate (the inhibitor or the charged 
3´-end of the tRNA) at the editing site would also, at least in part, explain the resistance of 
D487G and D487N to AN2690, which binds in the editing pocket.  We propose that Asp487, 
located within the I4 insert, is instrumental in inducing segmental flexibility of the I4 insert 
and enables the cap to sequester the mischarged tRNA substrate and/or AN2690. 
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Chapter IV:  Amino Acid-dependent Shift in tRNA-Synthetase Editing Mechanisms         
 
Adapted with permission from  
Jaya Sarkar and Susan Anne Martinis (2011).  “Amino Acid-dependent Shift in tRNA 
Synthetase Editing Mechanisms”.  J. Am. Chem. Soc., 133, 18510-18513.  Copyright 2011 
American Chemical Society.  
 
 
IV.1.  Introduction 
 
Translational machinery relies on aminoacyl-tRNA synthetases (AARSs) to attach 
correct amino acids to cognate tRNAs (Ibba and Sӧll, 2000).  To ensure fidelity in protein 
synthesis, about half of the AARSs, including leucyl-tRNA synthetase (LeuRS), have 
evolved editing mechanisms against structurally similar noncognate amino acids to clear 
mistakes that originate in the synthetic active site (Mascarenhas, 2008).  The absence of these 
editing mechanisms results in statistical mutations in the proteome (Li, et al., 2011). 
Many aminoacyl-tRNA synthetases prevent mistranslation by relying upon 
proofreading activities at multiple stages of the aminoacylation reaction.  Amino acid editing 
may occur either before (pre-transfer) (Baldwin and Berg, 1966; Fersht, 1977b) or after (post-
transfer) (Eldred and Schimmel, 1972) the activated amino acid is transferred to the tRNA 
(Schimmel and Schmidt, 1995).  Thus, pre-transfer editing targets the misactivated 
aminoacyl-adenylate intermediate (AA-AMP) for hydrolysis, while post-transfer editing 
cleaves mis-aminoacylated tRNA (AA-tRNA
AA
) to clear the AARSs mistakes (Ling, et al., 
2009).  For LeuRS, the post-transfer editing active site is housed in a discrete insertion 
domain, called connective polypeptide 1 (CP1), that is separated from the aminoacylation 
active site by ∼35 Å (Cusack, et al., 2000) (Figure IV.1). 
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Figure IV.1.  Amino-acid dependent partitioning between pre-and post-transfer editing 
pathways.  The structure of LeuRS in complex with tRNA
Leu
 (PDB: 2BYT) in the editing 
conformation is represented as a ribbon model, with the main body in red, the CP1 domain in 
orange and the tRNA in blue. 
 
Yeast cytoplasmic LeuRS (ycLeuRS) has been proposed to have relatively poor initial 
substrate discrimination (Englisch, et al., 1986) and mis-activates structurally similar or 
isosteric standard and nonstandard amino acids such as isoleucine, methionine, norvaline, and 
homocysteine (Englisch, et al., 1986).  An early report by Englisch et al. also suggested that 
ycLeuRS edited predominantly by a pre-transfer editing mechanism, while E. coli LeuRS 
clears mistakes exclusively by a post-transfer editing mechanism (Englisch, et al., 1986).  In 
E. coli LeuRS, we have shown that the CP1 editing domain that is responsible for post-
transfer editing masks a pre-transfer editing activity that is associated with the canonical 
aminocylation core (Boniecki, et al., 2008; Williams and Martinis, 2006).  In ycLeuRS, we 
hypothesize that both pre- and post-transfer editing mechanisms coexist and that one 
predominates, similar to E. coli LeuRS.  Here, we determined that a shift between the two 
AARS fidelity mechanisms can be dependent on the identity of the standard amino acids that 
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threaten LeuRS fidelity.  A partition of fidelity mechanisms has also been reported for the 
human cytoplasmic LeuRS (hcLeuRS) against nonstandard biosynthetic intermediates 
norvaline and α-aminobutyrate (Chen, et al., 2011).  This multi-step strategy for quality 
control could be akin to the evolution of auxiliary editing domains such as ybak to clear 
mischarged Cys-tRNA
Pro
 in trans, in addition to Ala-tRNA
Pro
 that is produced and then 
cleared by cis editing activity of prolyl-tRNA synthetase (An and Musier-Forsyth, 2005; 
Ruan and Sӧll, 2005).  We show that ycLeuRS has a robust post-transfer editing activity that 
efficiently clears tRNA
Leu
 mischarged with isoleucine.  In comparison, the enzyme‟s post-
transfer hydrolytic activity against tRNA
Leu
 mischarged with methionine is weak.  Rather, 
methionyl-adenylate is cleared robustly via an enzyme-mediated pre-transfer editing activity.  
We hypothesize that, similar to E. coli LeuRS, ycLeuRS has coexisting functional pre- and 
post-transfer editing activities.  In the case of ycLeuRS, a shift between the two editing 
pathways is triggered by the identity of the noncognate amino acid (Figure IV.1). 
 
IV.2.  Experimental methods 
 
 
IV.2.A.  Expression and purification of proteins 
 
The plasmid p32YL-2-3 (Lincecum, et al., 2003) encoding the gene for the wild type 
ycLeuRS was used to express the protein in E. coli strain Rosetta (DE3) (Novagen).  Cells 
were grown at 30 °C till OD600 reached 0.6, then induced with 1 mM IPTG and the protein 
was expressed at 30 °C for 45 min.  Protein purification was carried out as described in 
Chapter II, except that the bound protein was eluted in fractions from the resin using an 
immidazole gradient of 10 to 100 mM in HA-I.  The LeuRS containing fractions were pooled 
and concentrated using an Amicon Ultra centrifugal filter device (Millipore Corporation, 
Billerica, MA).  The final protein concentration was determined spectrophotometrically at 
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280 nm using an extinction coefficient of 155,310 M
-1
cm
-1
, estimated by the ExPASy 
Protparam tool (http://ca.expasy.org/tools/protparam.html).  
 
IV.2.B.  Cloning of the gene encoding yeast cytoplasmic tRNA
Leu
CAA (yctRNA
Leu
) 
  
The gene fragment encoding the yctRNA
Leu
CAA was amplified in a 50 μL PCR that 
contained 100 ng of pAMWt-25 template plasmid DNA, 125 ng each of forward [pTRC-
Fw(EcoRI)-yctRNA
Leu
] and reverse [pTRC-Rv(BamHI)-yctRNA
Leu
] primer containing the 
EcoRI and BamHI restriction sites respectively, 0.05 mM dNTP mix and 0.05 U Pfu DNA 
polymerase in commercial buffer.  The PCR products were digested with EcoRI and BamHI 
at 37 °C for 6 h.  The restriction-digested PCR products were separated on a 2% agarose gel 
and gel-purified using the QIAquick gel extraction kit-250 (Qiagen Inc).  The vector pTrc-99 
(Martin, et al., 1993) (a gift from G. Eriani) was also cleaved with EcoRI and BamHI, 
followed by gel-extraction.  Gel purified restriction digests of the PCR amplified gene 
fragment and the vector were ligated using T4 DNA ligase at 37 °C for 15 min to yield the 
plasmid pJS-pTrc-(EcoRI)-yctRNA
Leu
CAA-(BamHI)  The ligation reaction was used to 
transform E. coli strain DH5α.  The gene sequence was confirmed by automated DNA 
sequencing (UIUC Core Sequencing Facility, Urbana).     
 
IV.2.C.  Expression and purification of yctRNA
Leu
CAA 
 
The yctRNA
Leu
CAA was overexpressed in E. coli strain DH5α harboring the plasmid 
pJS-pTrc-(EcoRI)-yctRNA
Leu
CAA-(BamHI).  A single transformant was used to inoculate       
6 mL LB (100 μg/mL Amp) which was incubated at 37 °C overnight. The overnight culture 
was used to inoculate 2 L LB (100 μg/mL Amp) and cells were grown at 37 °C until the 
OD600 reached 0.6-0.8.  At this stage, cells were induced with IPTG, to a final concentration 
of 1 mM and the yctRNA
Leu
CAA was expressed overnight at 37 °C. Cells were harvested with 
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an Avanti J-E preparative centrifuge (Beckman Coulter, Fullerton, CA), at 6000 rpm for      
15 min at 4 °C.   
Cell pellets were resuspended in 50 mL of buffer [20 mM Tris, pH 7.5; 20 mM 
magnesium acetate].  This was followed by two extractions with 50 mL each of phenol/Tris 
saturated solution (Acros Organics, New Jersey, USA) and vigorous shaking for 20 min at 
room temperature.  The aqueous phase was collected after clarification via centrifugation at 
3000 rpm for 10 min at 10 °C and then ethanol precipitated at - 80 °C overnight.  The RNA 
was collected by centrifugation, followed by resuspension of the pellet in 500 mM Tris,      
pH 8.0 at 37 °C to deacylate the tRNA.  The tRNA was then purified on a 10% denaturing 
polyacrylamide gel by electrophoresis.  The concentration of tRNA was measured 
spectrophotometrically on the basis of its extinction co-efficient of 815,300 M
-1
cm
-1
 
estimated by the online Ambion oligonucleotide calculator 
(http://www.ambion.com/techlib/misc/oligo_calculator.html). 
   
IV.2.D.  Misaminoacylation assay 
 
Each misaminoacylation reaction contained 60 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), pH 7.5, 30 mM MgCl2, 30 mM KCl, 1 mM 
dithiothreitol (DTT), 4 μM pure yctRNALeuCAA, 25 μM [
3
H]-methionine (422 μCi/mL) and    
1 μM enzyme.  Reactions were initiated with 4 mM ATP and performed as described in 
Chapter II. 
 
IV.2.E.  Isolation of mischarged tRNA
Leu
 
 
Purified yctRNA
Leu
CAA (8 μM) was misaminoacylated with isoleucine or methionine 
by incubating the following reaction mixture at 30 °C for 3 h in 60 mM HEPES, pH 7.5,      
30 mM MgCl2, 30 mM KCl, 1 mM DTT, 23.8 μM [
3
H]-isoleucine (422 μCi/mL) or 25 μM 
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[
3
H]-methionine (422 μCi/mL), 1 μM editing defective (D419A) ycLeuRS and 4 mM ATP.  
The reactions were performed as described in Chapter II.  For each reaction, a total of six       
2 μL duplicate aliquots were spotted on TCA-soaked and dried pads.  Half of the pads were 
washed extensively (as described above) to quantitate the [
3
H]-Ile-tRNA
Leu
 and [
3
H]-Met-
tRNA
Leu 
mischarged products (Zhai, et al., 2007).  
 
IV.2.F.  Post-transfer editing deacylation assay  
  
Deacylation reaction mixtures were carried out at pH 7.5 in 60 mM HEPES, 10 mM 
MgCl2, 10 mM KCl and approximately ~2 μM [
3
H]-Ile-tRNA
Leu 
or
  
[
3
H]-Met-tRNA
Leu
.  The 
reactions were initiated with 1 μM enzyme.  At desired time points, reaction aliquots of       
10 μL were quenched on Whatman filter pads that had been pre-wet in 5% TCA and dried.  
Pads were washed and then quantified for radioactivity as described above. 
 
IV.2.G.  AMP formation assay   
 
The formation of AMP was carried out at 30 °C in a reaction mixture containing      
50 mM HEPES, pH 7.5, 20 mM MgCl2, 20 mM KCl, 5 mM DTT, 0.024 U/μL inorganic 
pyrophosphatase, 250 μM cold ATP, 0.2 μM [α-32P]-ATP (600 μCi/mL), 2.5 mM leucine or 
100 mM isoleucine or 100 mM methionine. Reactions were also measured for their 
dependence on tRNA by incorporating 29 mg/mL crude yeast tRNA, which was measured to 
contain 14.5 μM tRNALeu.  Reactions were initiated with 1 μM enzyme.  At different time 
points, reaction aliquots (2.0 μL) were quenched in 8.0 μL of 200 mM sodium acetate,        
pH 5.0.  From each quenched aliquot, 3 μL was spotted on cellulose polyethyleneimine (PEI) 
thin layer chromatography (TLC) plates (Scientific Adsorbents Inc., Atlanta, GA) that were 
pre-run in water and dried.  Separation of [α-32P]-ATP, [32P]-AMP and [32P]-AA-AMP were 
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achieved by developing the TLC plates in 0.1 M ammonium acetate, 5% acetic acid (Bullock, 
et al., 2003). Resolved radiolabeled bands on the TLC plate were phosphorimaged using 
FUJIFILM BAS Cassette 2040 (FUJIFILM Medical Systems, Stanford, CT) and images were 
scanned by a STORM 840 Molecular Dynamics scanner (Amersham Pharmacia Biotech, 
Piscataway, NJ).  At each time point, the remaining ATP was measured as a fraction, of the 
total volume intensity of all the resolved spots at that time point. A known concentration of 
[α-32P]-ATP was spotted on each TLC plate.  The concentration of AMP in each separated 
band was calculated by comparing the volume density for each [
32
P]-AMP spot to the volume 
density of the known [α-32P]-ATP spot.  Images were quantified using the ImageQuant 
software and the resulting data plotted and analyzed using the GraphPad Prism software.  The 
observed rate constants were calculated from a linear fit of the respective data sets. 
 
IV.2.H.  Inorganic pyrophosphate (PPi) release/ATP hydrolysis assay 
  
ATP hydrolysis assays to monitor PPi release were carried out at 30 °C in reactions 
containing 500 mM HEPES, pH 7.5, 20 mM MgCl2, 20 mM KCl, 5 mM DTT, 250 µM cold 
ATP, 0.1 µM [γ-32P]-ATP (600 µCi/mL) and 2.5 mM leucine or 100 mM isoleucine or 
methionine.  Each reaction was initiated with 1 µM enzyme and 2.0 µL aliquots were spotted 
at the respective time points on cellulose PEI TLC plates, developed in 750 mM KH2PO4,  
pH 3.5 and quantitated as above.   
 
IV.2.I.  Nonenzymatic hydrolysis of AA-AMP 
 
The rate of nonenzymatic hydrolysis of AA-AMP was calculated using an adapted 
chase assay (Gruic-Sovulj, et al., 2005)  where a molar excess of cold ATP (25 mM) is used 
to eject the AA-AMP from the enzyme’s active site.  Enzyme synthesized AA-AMP was 
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allowed to form and accumulate for 10 min at 30 °C in a reaction mixture containing 50 mM 
HEPES, pH 7.5, 20 mM MgCl2, 20 mM KCl, 5 mM DTT, 250 μM cold ATP,  0.6 μM [α-
32
P]-ATP (1800 μCi/mL), 100 mM methionine and 5 μM enzyme.  Following addition of 
molar excess of ATP (100 fold), hydrolysis of the AA-AMP in solution was quenched at 
various time points by mixing 2.0 μL reaction aliquot with 8.0 μL of 200 mM sodium acetate, 
pH 5.0.  Separation of reaction products on TLC plates were performed and quantified as 
described above.  The rate constants for AA-AMP hydrolysis in solution was calculated by 
fitting the respective data sets to the equation y = Ae
-kx
, using GraphPad Prism software. 
 
IV.3.  Results  
 
We cloned the gene for yeast cytoplasmic tRNA
Leu
 (yctRNA
Leu
CAA) into the pTrc-99 
vector (Martin, et al., 1993b) for overexpression in E. coli.  The yctRNA
Leu
 was extracted 
with phenol/tris saturated solution, followed by denaturing gel purification.  The ycLeuRS 
with a six-histidine tag, was purified via affinity purification (Lincecum, et al., 2003).  Using 
in vitro deacylation assays that incorporated purified yctRNA
Leu
 mischarged with [
3
H]-
isoleucine, we determined that ycLeuRS has a robust post-transfer editing mechanism that 
clears mischarged Ile-tRNA
Leu
 (Figure IV.2, top).  In comparison, this yeast enzyme 
exhibited significantly reduced hydrolytic activity against [
3
H]-Met-tRNA
Leu
 (Figure IV.2, 
top). This amino-acid-dependent difference in post-transfer editing was surprising in that it 
contrasts with other LeuRSs that effectively deacylate tRNA
Leu
 mischarged with either 
isoleucine or methionine (Chen, et al., 2000; Chen, et al., 2011; Karkhanis, et al., 2007; 
Mursinna, 2002; Zhai and Martinis, 2005; Zhai, et al., 2007).  Despite its weak post-transfer 
editing activity, we did not observe accumulation of mischarged Met-tRNA
Leu
 for wild-type 
ycLeuRS (Figure IV.2, bottom), as compared to an editing defective mutant (D419A) that we 
previously characterized (Lincecum, et al., 2003).  In ycLeuRS, mutation of the universal Asp 
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419 to alanine disrupts overall editing (pre- and post-transfer) (Lincecum, et al., 2003).  Thus, 
the mutant enzyme mischarges yctRNA
Leu
 with noncognate amino acids.  It remains unclear 
how this single site impacts both pre- and post-transfer editing.  Because of this striking 
difference in deacylation activities, we hypothesized that methionine that is misactivated by 
ycLeuRS is more efficiently cleared by an alternate fidelity pathway to post-transfer editing. 
 
 
 
 
Figure IV.2.  In vitro enzymatic activities of wild type ycLeuRS.  (Top)  Deacylation of [
3
H]- 
Ile-tRNA
Leu
 and [
3
H]-Met-tRNA
Leu
 by 1 μM ycLeuRS.  Post-transfer hydrolytic activity 
against Met-tRNA
Leu
 is significantly weaker than that against Ile-tRNA
Leu
.  (Bottom)  
Misaminoacylation of pure yctRNA
Leu
 with 25 μM [3H]-methionine (422 μCi/mL) by 1 µM 
wild type ycLeuRS.  The wild type enzyme does not exhibit accumulation of mischarged 
Met-tRNA
Leu
 in vitro.  Error bars for each time point are a result of each reaction repeated in 
triplicate. 
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Figure IV.3.  Pre-transfer editing activity of wild type ycLeuRS assessed by TLC-based 
AMP-formation assay, in absence of tRNA.  A representattive reaction time course 
chromatographic separation of [
32
P]-ATP, AMP and AA-AMP, as indicated.  Reactions 
containing 250 µM cold ATP, 0.2 µM [α-32P]-ATP (600 µCi/mL) and amino acids (2.5 mM 
leucine or 100 mM isoleucine or methionine) were initiated with 1 µM enzyme and carried 
out upto 15 min at 30 °C.  Reaction products were resolved on TLC developed in 0.1 M 
ammonium acetate, 5% acetic acid. 
 
 
Consistent with previous activation measurements of other noncognate amino acids 
by ycLeuRS (Englisch, et al., 1986), we measured a poor discrimination factor of 1/72 for 
methionine (data not shown).  Since ycLeuRS lacks a robust post-transfer editing activity to 
clear Met-tRNA
Leu
, we predicted that the methionyl adenylate intermediate might be cleared 
by pre-transfer editing.  Pre-transfer editing is typically characterized by increased 
consumption of ATP in the presence of noncognate amino acids (Chen, et al., 2011; Dulic, et 
al., 2010; Hati, et al., 2006).  We analyzed both ATP hydrolysis and AMP formation using 
TLC-based assays that utilize [α-32P]-ATP to visualize separated ATP, AMP, and AA-AMP 
(Figure IV.3).  In the absence of tRNA, ATP hydrolysis for methionine was stimulated 
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Figure IV.4.  Amino acid-dependent pre-transfer editing activity of wild type ycLeuRS in 
absence of tRNA.  (Top) ATP hydrolysis and (Bottom) AMP formation assessed by TLC-
based AMP-formation aassays that enable separation and visualization of ATP, AMP and 
AA-AMP.  Reactions containing 250 µM cold ATP, 0.2 µM [α-32P]-ATP (600 µCi/mL) and 
amino acids (2.5 mM cognate or 100 mM noncognate) were initiated with 1 µM enzyme and 
carried out upto 15 min at 30 °C.  Reaction products were resolved on TLC developed in    
0.1 M ammonium acetate, 5% acetic acid.  Error bars for each time point are a result of each 
reaction repeated in triplicate. 
 
relative to cognate leucine (Figure IV.4, top), yielding an accumulation of 25 μM of AMP 
(Figure IV.4, bottom) with kobs = 2.0 ± 0.3 min
-1
 that was 5-fold stimulated than the            
kobs = 0.4 ± 0.01 min
-1
 for cognate leucine in tRNA-independent AMP formation assays 
(Figure IV.4, bottom; Table IV.1).  By comparison, isoleucine-dependentAMP formation was 
only slightly elevated, with kobs = 0.7 ± 0.1 min
-1
 in the absence of tRNA (Figure IV.4, 
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bottom; Table IV.1).  Similar increases in AMP formation have been measured for other 
AARSs in the presence of noncognate amino acids as an indicator for tRNA independent pre-
transfer editing activity (Table IV.2).    
 
    Table IV.1.  Observed rate constants (kobs) for AMP formation 
 
 
Pre-transfer editing events of ycLeuRS against methionine in absence of tRNA were 
also measured in PPi release assays that incorporated [γ-
32
P]-ATP which allowed direct 
visualization of both ATP and PPi released on TLC plates (Figure IV.5, top).  In absence of 
tRNA, noncognate amino acids that are hydrolyzed at the adenylate stage are repeatedly 
reactivated by the synthetase, consuming ATP and hence producing PPi in eah cycle.  Thus, 
stimulated ATP hydrolysis and increased PPi formation in presence of noncognate 
methionine, but not in presence of cognate leucine suggests robust pre-transfer editing 
activity of ycLeuRS against methionine in absence of tRNA (Figure IV.5, bottom).   
The addition of tRNA in AMP formation assays enhanced ATP hydrolysis for 
methionine but failed to significantly stimulate isoleucine-dependent ATP hydrolysis (Figure 
IV.6), suggesting an increase in overall editing against methionine.  This is consistent with 
early reports where tRNA addition was reported to weakly stimulate pre-transfer editing of 
noncognate amino acids by ycLeuRS  (Englisch, et al., 1986). 
   
   
 
       
  
91 
 
Table IV.2.  Rate Constants (min
-1
) for tRNA-independent AARS pre-transfer editing  
                    activities of standard amino acids
a
 
  
  
      Enzyme-    
    dependent  
AMP formation 
   Non-enzymatic  
    hydrolysis of  
      AA-AMP 
    Fold 
difference 
Reference 
 
LeuRS Met 2.0 0.100 20 This work 
IleRS Val  3.2 0.120 30 (Dulic, et al., 2010) 
GlnRS
b
Gln 1.5 0.042 35 
(Gruic-Sovulj, et al., 
2005) 
ProRS Ala 27.2 0.113 240 
(Hati, et al., 2006; 
Splan, et al., 2008) 
ValRS Thr 22.2 0.070 300 (Dulic, et al., 2010) 
a 
For enzymatic AMP formation, kobs was reported for all systems, except  IleRS and ValRS 
activation of valine and threonine, respectively, for which kcat was reported. For non-
enzymatic solution hydrolysis, kobs was reported.  
b
 The GlnRS-Gln system requires presence of tRNA
Gln
. 
 
 
Hydrolysis of AA-AMP can be catalyzed by the enzyme or depend on a selective 
release mechanism (Hati, et al., 2006; Splan, et al., 2008).  The latter relies on enzyme 
ejection of adenylate intermediate into the aqueous environment for hydrolysis of noncognate 
AA-AMP (Hati, et al., 2006; Ling, et al., 2009; Mascarenhas, 2008).  To distinguish between 
these two possibilities for Met-AMP hydrolysis, we performed a chase assay (Dulic, et al., 
2010) using reaction conditions that were identical to the AMP formation assays described 
above.  Enzyme-synthesized AA-AMP accumulated for 10 min was followed by addition of a 
large molar excess of non-radioactive ATP (25 mM) to displace AA-AMP from the synthetic 
active site.  Enzyme-independent hydrolysis of methionyl-adenylate in solution occurred at a 
rate of 0.1 ± 0.001 min
-1
 (Figure IV.7, Table IV.1), which is 20-fold slower than the rate of 
methionine-dependent AMP formation by ycLeuRS (2.0 min
-1
) (Table IV.1).  This is 
consistent with other AARSs that have been proposed to edit by tRNA-independent pre-
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transfer editing mechanisms (Table IV.2).  We estimate that enzyme-associated hydrolysis of 
the methionyl-adenylate would account then for ∼95% of the tRNA-independent pre-transfer 
editing activity of ycLeuRS against methionine.  Similarly, the solution hydrolysis rate of 
isoleucyl-adenylate (0.01 ± 0.001 min
-1
) (Figure IV.7, Table IV.1) was also 70-fold 
diminished than the overall rate of isoleucine-dependent AMP formation (Table IV.1).  
 
 
 
Figure IV.5.  Pre-transfer editing activity of wild type ycLeuRS assessed by TLC-based PPi 
release assay.  (Top)  Reaction time courses showing chromatographic separation of [
32
P]-
PPi, ATP and Pi as indicated.  (Bottom, left)  ATP hydrolysis is enhanced by noncognate 
amino acid methionine.  (Bottom, right)  Fraction of PPi released is stimulated by noncognate 
methionine.  Reactions containing    250 µM cold ATP, 0.1 µM [γ-32P]-ATP (600 µCi/mL) 
and 2.5 mM amino acids were initiated with 1 µM enzyme and carried out upto 30 min at 30 
°C.  Reaction products were resolved on TLC plates that were developed in 750 mM 
KH2PO4, pH 3.5.  Symbols are: leucine (■), isoleucine (○), and methionine (▼).  Error bars 
for each time point are a result of each reaction repeated in triplicate. 
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Figure IV.6.  Increase in global overall editing against methionine in presence of tRNA
Leu
 for 
wild type ycLeuRS.  ATP hydrolysis was assessed in reactions containing 250 µM cold ATP, 
0.2 µM [α-32P]-ATP (600 µCi/mL), 100 mM noncognate amino acids and 29 mg/mL crude 
yeast tRNA (which was measured to contain 14.5 μM tRNALeu), initiated with 1 µM enzyme 
and carried out upto 15 min at 30 °C.  Reaction products were resolved on TLC developed in 
0.1 M ammonium acetate, 5% acetic acid.  Error bars for each time point are a result of each 
reaction repeated in triplicate. 
 
 
IV.4.  Discussion  
 
Adenylate hydrolysis by the homologous IleRS has been proposed to involve its 
translocation from the synthetic site to the CP1 domain editing site in a tRNA-dependent 
manner (Nomanbhoy, et al., 1999).  In contrast, for E. coli LeuRS, a robust pre-transfer 
editing activity was stimulated only when the CP1 domain was deleted from the enzyme 
(Boniecki, et al., 2008) or when a mutation at CP1 domain-based Ala 293 was introduced 
(Williams and Martinis, 2006).  Similarly, pre-transfer editing activity is activated in ProRS 
(Splan, et al., 2008) and ThrRS (Minajigi and Francklyn, 2010) mutants under circumstances 
where post-transfer activity was selectively inactivated.  Pre-transfer editing activities that are 
tRNA independent have also been  reported for SerRS (Gruic-Sovulj, et al., 2007), which 
lacks a specialized editing domain, as well as in GlnRS (Gruic-Sovulj, et al., 2005), which 
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apparently does not require editing activity.  In addition, MetRS clears homocysteine in a pre-
transfer editing cyclization mechanism to produce thiolactone in the synthetic active site 
(Kim, et al., 1993). 
 
 
 
Figure IV.7.  Non-enzymatic (LeuRS-independent) hydrolysis of noncognate adenylates.  
TLC-based ATP chase assays included 251 μM ATP (1800 μCi/mL), 100 mM isoleucine or 
methionine and 5 μM ycLeuRS.  The AA-AMP accumulated on the enzyme was chased from 
the active site into solution by adding 100-fold excess of non-radioactive 25 mM ATP.  Error 
bars for each time point are a result of each reaction repeated in triplicate. 
 
Segregation of amino acids to different editing pathways has been reported for 
hcLeuRS, which edits biosynthetic intermediates (α-amino butyrate and norvaline) under in 
vitro conditions via pre- and post-transfer hydrolysis, respectively (Chen, et al., 2011).  A 
tRNA-independent pre-transfer editing for Aquifex aeolicus LeuRS has also been identified to 
clear norvalyl-adenylate (Zhu, et al., 2009).  Our results demonstrate that pre- and post-
transfer editing co-exist in ycLeuRS, as also found previously for E. coli LeuRS (Boniecki, et 
al., 2008; Williams and Martinis, 2006).  Methionine-stimulated ATP hydrolysis and AMP 
formation in the absence of tRNA as well as ATP chase experiments support that quality 
control for ycLeuRS is highly dependent on pre-transfer editing under in vitro conditions.  It 
is possible that the inclusion of tRNA shifts the editing mechanism preference and increases 
overall global editing.  The same conditions that incorporate isoleucine rather than 
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methionine suggest that the ycLeuRS relies on post-transfer editing for isoleucine clearance.  
Although most in vitro enzyme experiments fail to recapitulate the dynamic cellular 
environment, direct in vitro comparison for ycLeuRS suggests that methionine and isoleucine 
partition for clearance between different editing pathways (Figure IV.1).  It remains possible 
that ycLeuRS relies on a combination of editing mechanisms, but our results support that the 
preference of editing pathways can be dependent on substrate identity. 
We hypothesize that these two fidelity mechanisms in ycLeuRS are not redundant but 
are adapted to accommodate diverse specificities of the noncognate amino acids that 
challenge LeuRS fidelity in the cell (Karkhanis, et al., 2007; Li, et al., 2011).  Under this 
scenario, ycLeuRS pre- and post-transfer editing sites would have evolved in a 
complementary way, similar to AARSs that are dependent on independent auxiliary editing 
domains.  Thus, in the case of ycLeuRS, we propose that pre- and post-transfer editing 
pathways partition in a way that is dependent on the chemical structure of the noncognate 
amino acid to ensure that all errors are efficiently targeted for clearance by ycLeuRS.  This is 
critical to the cell since disruptions or absence of editing activities in LeuRS can cause 
mistranslation and cell death (Karkhanis, et al., 2007; Li, et al., 2011).  
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Chapter V:  Split Green Fluorescent Protein-based in vivo Assay to Assess Intracellular  
                     Effects of Editing Defects in LeuRS 
 
V.1.  Introduction 
 
Dissection of a protein and its subsequent reassembly from the peptide fragments 
have been used to study evolution of large multidomain proteins, protein folding, role of 
tertiary structural elements in enzyme catalysis, macromolecular assembly and protein-
protein interactions.  Unassisted reconstitution of protein fragments in trans into functional 
proteins have been demonstrated for IleRS (Shiba and Schimmel, 1992) and ribonuclease 
(Richards and Vithayathil, 1959) among others.  Oligomerization assisted reassembly of 
protein fragments has been demonstrated in dihydrofolate reductase (DHFR) (Pelletier, et al., 
1998), ubiquitin (Karimova, et al., 1998) and β-galactosidase (Rossi, et al., 1997).  Assisted 
reconstitution of these protein fragments is dependent upon covalent fusion to soluble 
independently folding and interacting domains whose interactions promote the reassembly 
and folding of the fragments to form the active enzyme.  In addition, a viable and sensitive in 
vivo screening assay is also required to test for successful fragment reassembly.   
Antiparallel leucine zipper (LeuZ)-assisted reassembly of the N-and C-terminal 
halves of split green fluorescent protein (GFP) was demonstrated by the Regan laboratory 
(Ghosh, 2000; Magliery, et al., 2005).  The leucine zipper is one of the common motifs found 
in many gene activator/repressor DNA-binding proteins (Landschulz, et al., 1988).  This 
includes the CCAAT-binding protein or enhancer binding protein (C/EBP), the yeast gene 
regulatory protein GCN4 and the transforming proteins Fos and Jun.  The α-helical leucine 
zipper motif is characterized by the presence of a leucine residue at every seventh position, 
extending over a distance covering eight helical turns.  The leucine zipper α helix is 
amphipathic with one side of the helix predominated by hydrophobic residues (particularly 
leucine) and the other side predominated by charged side chains and uncharged polar side 
chains (Landschulz, et al., 1988).  In addition, leucine side chains protruding from one α-
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helix interdigitate with those displayed from a similar α helix of another polypeptide, thus 
facilitating dimerization into a coiled coil structure (Landschulz, et al., 1988; Lupas, 1996).  
It has also been shown that the leucine residues in each α helix are critical for dimerization of 
the leucine zipper and that a general hydrophobic interface is not sufficient for „zipping‟ up 
of the leucine zipper α helices to form the coiled coil dimer structure (Hu, et al., 1990).  
Generally three of the four hydrophobic positions (Ghosh, 2000) require leucine for the 
dimerization, as exhibited by the GCN4 leucine zipper (Hu, et al., 1990).  The parallel or 
antiparallel orientation of the leucine zippers (with respect to the N- to C-terminus of one 
helix) in the coiled coil dimer is determined by the polar and ionic interactions between the 
charged residues flanking the hydrophobic leucine core (Lupas, 1996).   
As a reporter system for reconstitution of protein fragments, GFP is an attractive tool 
by virtue of its autocatalytically generated fluorescence, which in turn, is dependent on its 
properly folded structure (Miyawaki, et al., 1997) and because it is known to express, fold 
and fluoresce in virtually every cell type (Tsien, 1998). 
  
V.1.A.  Sequence-enabled reassembly of split green fluorescent protein 
 
The Regan laboratory demonstrated that the leucine zipper sequence-enabled 
reassembly (SEER) of split GFP resulted in refolded fluorescent GFP (Ghosh, 2000; 
Magliery, et al., 2005).  In these work, GFP was split in a mobile loop (between residues 157 
and 158) that was deduced to be not an integral part of the protein structure, to result into the 
N- and C-terminal halves of GFP (NGFP and CGFP, respectively) (Figure V.1).  When 
produced in trans in bacteria, NGFP and CGFP did not associate to give reassembled 
fluorescent GFP.  Strongly interacting (nM affinity) leucine zippers were fused to the C- and 
N-termini of NGFP and CGFP, resulting in the fusion protein fragments NZGFP and CZGFP, 
respectively (Figure V.1).  When expressed in bacteria, the split GFP fragments reassembled,  
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Figure V.1.  Scheme showing LeuZ-assisted refolding of split GFP.  Intact GFP is split in a 
loop between residues 157 and 158 and antiparallel leucine zippers fused to each half, 
resulting in the fused GFP protein fragments, NZGFP and CZGFP.  When both these 
fragments are expressed in bacterial cells from compatible plasmids, the two GFP fragments 
associate via dimerization of the leucine zippers and result in fluorescence from the refolded 
GFP.  Arrows represent β-strands, squiggles represent α-helices and curved lines represent 
loops.  Colors are:  blue for NGFP, red for CGFP and grey for leucine zippers.  The figure 
has been adapted from (Ghosh, 2000). 
 
 
forming the NZ-CZ refolded GFP complex, directed by oligomerization of the leucine 
zippers.  This resulted in fluorescence.  It was demonstrated that GFP folding from its 
fragments was irreversible in vitro and the minimum interaction (KD) between the leucine 
zippers, required for this screen, was determined to be as low as approximately 1 mM.  The 
leucine zipper peptides were designed to favor antiparallel orientation by judicious placement 
of charge-charge interactions that would otherwise result in clashes in the parallel orientation 
and by introducing a polar residue (asparagine) into the canonical hydrophobic core (Ghosh, 
2000). 
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V.1.B.  Fluorescent reporter assay to assess intracellular effects of editing defects in  
            LeuRS 
 
The leucine zipper-directed complementation of the N- and C-terminal GFP 
fragments was exploited to develop an in vivo assay that would assess mistranslation by 
detecting fluorescence changes that resulted from statistical substitutions at leucine positions 
in the leucine zippers.  The synthetic active site of LeuRS must distinguish between 
structurally similar isosteric noncognate amino acids isoleucine, methionine, norvaline and 
valine from the cognate leucine.  To preserve high level of fidelity in protein synthesis, 
LeuRS and other synthetases have evolved to possess robust editing or proofreading activities 
(Mascarenhas, 2008).  The CP1 domain of LeuRS is its editing domain that is responsible for 
hydrolyzing tRNA
Leu
 mischarged with noncognate amino acids (Betha, et al., 2007).  Several 
conserved residues within the E. coli LeuRS editing active pocket in the CP1 domain have 
been implicated to be critical in the editing pathway, including Thr 252 (Mursinna, et al., 
2001), Thr 247, Thr 248 (Zhai and Martinis, 2005) and Asp 345 (Lincecum, et al., 2003).  
Three mutations (Y330A, D342A and D345A) in the conserved E. coli LeuRS editing pocket 
generates an editing-defective E. coli LeuRS mutant (YDD LeuRS) that is unable to cleave 
the mischarged tRNA substrate, thereby allowing formation of mischarged tRNA
Leu
 and then 
mistranslation at leucine codons.  Such programmed manipulation of the LeuRS editing 
pocket that attenuate the synthetase‟s editing activity has been shown to yield in vivo 
incorporation of fluorinated analogs of leucine in recombinant proteins expressed in E. coli 
(Tang and Tirrell, 2001; Tang and Tirrell, 2002; Tang, et al., 2009).   
We designed an in vivo mistranslation assay to simultaneously overexpress NZGFP 
fragment protein and editing-defective LeuRS as independent proteins from one plasmid.  
The CZGFP protein fragment was overexpressed from another plasmid in E. coli cells 
(Figure V.2).  Excess noncognate amino acids were incorporated in the growth medium.  We 
hypothesized that the editing defect in the mutant LeuRS (YDD LeuRS) would lead to 
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statistical substitutions of leucines in the leucine zippers fused to each of the N- and C-
terminal halves of GFP, with the noncognate amino acid provided in the medium.  Such 
substitutions would decrease/abolish dimerization of the leucine zippers to form coiled coils.  
The disruption of leucine zipper dimerization will hamper refolding of the N- and C-terminal 
halves to GFP and this will be reflected in decreased observable fluorescence.  Thus, 
observation and quantification of fluorescence changes would provide a valuable tool in 
studying intracellular effects of editing defects in LeuRS.  The precise extent of the impact of 
specific molecular determinants in editing could be deduced using this assay. 
 
 
 
 
Figure V.2.  Design of plasmids for in vivo fluorescent reporter assay in E. coli BL21(DE3) 
host cells.  Genes encoding LeuRS and one of the fused GFP fragments, NZGFP were 
subcloned in independent multiclonal sites on pETDuet vector to result in the plasmids pJS-
Duet1-NZGFPexact(MCS1)-WTecLRS(MCS2) or pJS-Duet1-NZGFPexact(MCS1)-
YDDecLRS(MCS2).  The other fusion fragment of GFP, CZGFP was expressed from the 
plasmid pMRBAD-CZGFP. 
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V.2.  Experimental methods 
 
V.2.A.  Cloning, mutagenesis and plasmid construction 
 
Cloning of NZGFP gene in MCS1 of pDuet-1:  The gene encoding the protein 
fragment NZGFP was PCR-amplified in a 50 μL reaction mixture containing 100 ng of the 
template plasmid pET11a-NZGFP (gift from Lynne Regan), 125 ng each of the forward 
primer FP BamHI NZGFP Ampl [5ʹ-TTATGGATCCGGCGCGAGCAAAGG-3ʹ] and the 
reverse primer RP EcoRI NZGFP Ampl [5ʹ-CGAT GAATTCTTACTGCGCCAGTT C-3ʹ], 
0.05 mM dNTP mix (Stratagene, La Jolla, CA) and 0.05 U Pfu DNA polymerase in 
commercial buffer.  The amplified PCR products and the vector pETDuet-1 were separately 
digested with BamHI and EcoRI at 37 °C for 6 h.  The restriction-digested PCR products and 
the vector were separated on a 1% agarose gel and gel-purified using the QIAquick gel 
extraction kit-250 (Qiagen Inc).   
Gel purified restriction digests of the PCR amplified gene fragment and the vector 
were ligated using T4 DNA ligase at 16 °C overnight.  Sequencing the NZGFP gene 
fragment in the pDuet1 vector identified a random mutation and also that the gene was out of 
frame.  First, the random mutation in the NZGFP gene was corrected in a PCR reaction using 
the forward primer FP Corr T to C in clone 13 [5ʹ-
CACACAACGTTCCCATCATGGCAGAC-3ʹ] and the reverse primer RP Corr T to C in 
clone 13 [5ʹ-GTCTGCCATGATGGGAACGTTGTGTGs-3ʹ].  Next, the NZGFP gene 
fragment was made in frame by a PCR reaction using the forward primer FP Insr A in cl 13 
to in frame [5ʹ-CAGCCAGGATCCAGGCGCGAGCAAAG-3ʹ] and the reverse primer RP 
Insr A in cl 13 to in frame [5ʹ-CTTTGCTCGCGCCTGGATCCTGGCTG-3ʹ].  Thus, this 
resulted in the plasmid pJS-Duet1-NZGFP(MCS1), that contained the gene encoding the six 
histidine-tagged protein fragment NZGFP in MCS1 between the restriction sites BamHI and 
EcoRI.   
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Since the NZGFP protein fragment expressed from the plasmid pJS-Duet1-
NZGFP(MCS1) did not show fluorescence with the other half of GFP (CZGFP), the 
following three modifications were made in the NZGFP insert of pJS-Duet1-NZGFP(MCS1), 
as highlighted in Figure V.3:  (1)  the glycine (adjacent to the first methionine) was mutated 
to an alanine; (2) one serine residue was deleted; (3)  the tetrad Ser-Gln-Asp-Pro, 
immediately following the six histidine tag, was deleted.  These modifications resulted in the 
NZGFP gene construct within the pDuet1 vector to exactly mimic the same construct in the 
original system of pET11a vector (Ghosh, 2000).  We speculated that these modifications 
would facilitate interactions of NZGFP with CZGFP and hence aid the re-folding process.  
First, modification 1 was made in a PCR reaction containing the template plasmid pJS-Duet1-
NZGFP(MCS1), the forward primer FP NZGFP/Duet-Corr 1 [5ʹ-
GGAGATATACCATGGCCAGCCATCAC-3ʹ] and the reverse primer RP NZGFP/Duet-
Corr 1  [5ʹ-GCTGTGGTGATGATGGTGATGGCTG-3ʹ].  Next, modifications 2 and 3 were 
carried out in a single PCR reaction using the forward primer FP NZGFP/Duet-Corr 2 [5ʹ-
GCCATCACCATCATCACCACGGCGC-3ʹ] and the reverse primer RP NZGFP/Duet-Corr 
2 [5ʹ-GTTCTTCTCCTTTGCTCGCGCCGTGG-3ʹ].  These modifications resulted in the final 
plasmid pJS-Duet1-NZGFPexact(MCS1) bearing the six histidine-tagged NZGFP gene in 
MCS1.  This plasmid was used in the further cloning steps.  It is important to note here that in 
the process of the three above mentioned modifications, the BamHI restriction site in MCS1 
has been deleted. 
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Figure V.3.  Construction of the plasmid pJS-Duet1-NZGFPexact(MCS1)-
WTecLRS(MCS2).  (Top)  Amino acid sequence of NZGFP protein fragment, the gene for 
which has been cloned in MCS1 of pETDuet-1 vector, using BamHI and EcoRI restriction 
sites.  In the final NZGFP gene sequence, the BamHI restriction site has been deleted and the 
XhoI site within the NZGFP sequence has been removed by conservative mutations.  The 
colors indicate:  red, six-histidine tag; blue, NGFP sequence, grey; leucine zipper; orange, 
spacer between NGFP and the leucine zipper; and green, residues which have either been 
mutated or removed to result in the final sequence.  (Bottom)  The construct pJS-Duet1-
NZGFPexact(MCS1)-WTecLRS(MCS2).  The gene encoding NZGFP is cloned in MCS1 
and that encoding LeuRS is cloned in MCS2 between BamHI and XhoI.     
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Cloning of E. coli LeuRS gene in MCS2 of pJS-Duet1-NZGFPexact(MCS1):  Two 
restriction sites were introduced into pJS-Duet1-NZGFPexact(MCS1) to produce pJS-Duet1-
NZGFPexact(MCS1)-modified via two sequential PCR mutations.  First, the BglII restriction 
site in MCS2 was mutated to a BamHI site, using the forward primer FP BglII-
BamHI/MCS2/pD [5ʹ-GATATACATATGGCGGATCCCAATTG-3ʹ] and the reverse primer 
RP BglII-BamHI/MCS2/pD [5ʹ-CGATATCCAATTGGGATCCGCCATAT-3ʹ].  Next, a XhoI 
restriction site in the spacer region of the NZGFP gene sequence (Figure V.3) was removed 
by mutations that did not alter the amino acid sequence of the gene using the forward primer 
FP del XhoI (pDuNZGFP) [5ʹ-GGTGGCTCTGGCTCTGGTTCTTCCGC-3ʹ] and the reverse 
primer RP del XhoI (pDuNZGFP) [5ʹ-CTTTTTTGAGGGCGGAAGAACCAGAG-3ʹ].   
The gene encoding the full length wild type E. coli LeuRS was PCR-amplified in a  
50 μL reaction mixture containing the template plasmid p15ec3-1 (Martinis and Fox, 1997), 
forward primer FP Ampl/ecLRS/BamHI [5ʹ-GATATACATATGGCGGATCCAATTG-3ʹ] 
and reverse primer RP Ampl/ecLRS/XhoI [5ʹ-GTAACTCGAGTTAGCCAACGACCAGA-
3ʹ] as described before in this section.  The amplified insert and the plasmid vector pJS-
Duet1-NZGFPexact(MCS1)-modified was separately digested with restriction enzymes 
BamHI and XhoI at 37 °C for 3 h.  The restriction digests were then inactivated by heating to 
80 °C for 20 min.  The restriction-digested plasmid vector pJS-Duet1-NZGFPexact(MCS1)-
modified (8 µg) was treated with 22 U of calf intestinal phosphatase (CIP) (New England 
BioLabs Inc., Beverly, MA) at 37 °C for 1 h.  This was followed by agarose gel separation 
and purification of the insert and the vector using the QIAquick gel extraction kit-250 
(Qiagen Inc).  Gel purified restriction digests of the PCR amplified gene fragment and the 
vector were ligated using T4 DNA ligase as described previously in this section.  A frame 
shift mutation was corrected in a separate PCR reaction containing the forward primer Fwd-
In fr ec-pD1(NZ+ecL) [5ʹ-CATATGGCGGATCCGATGCAAGAGC-3ʹ] and reverse primer 
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Rev-In fr ec-pD1(NZ+ecL) [5ʹ-GCTCTTGCATCGGATCCGCCATATG-3ʹ] yielding the 
final plasmid pJS-Duet1-NZGFPexact(MCS1)-WTecLRS(MCS2).   
The salient features of the plasmid pJS-Duet1-NZGFPexact(MCS1)-
WTecLRS(MCS2), as enumerated in Figure V.3, are:  (i)  The plasmid contains the NZGFP 
gene in MCS1.  (ii)  The BamHI restriction site of MCS1 (that was originally used, along 
with the EcoRI site to clone the NZGFP gene) has been deleted.  (iii)  The XhoI restriction 
site originally present in the NZGFP sequence has been removed by conservative mutations 
that did not alter the amino acid sequence of NZGFP.  (iv)  The NZGFP gene sequence in this 
construct is identical to the gene sequence in the pET11a-NZGFP construct (Magliery, et al., 
2005).  (v)  The plasmid contains the wild type E. coli LeuRS gene in MCS2 between the 
restriction sites BamHI and XhoI. 
The editing defective mutations in E. coli LeuRS were introduced in the plasmid pJS-
Duet1-NZGFPexact(MCS1)-WTecLRS(MCS2) in two sequential PCR reactions resulting in 
the plasmid pJS-Duet1-NZGFPexact(MCS1)-YDDecLRS(MCS2), bearing the editing 
defective (YDD) E. coli LeuRS gene in MCS2 and the NZGFP gene in MCS1.    First, the 
mutations D342A and D345A were constructed using the forward primer 
FPecD342A/D345A [5ʹ-GTACCGGGGCACGCCCAGCGCGCCT-3ʹ] and reverse primer 
RPecD342A/D345A [5ʹ-GCAAACTCGTAGGCGGGCTGGGCGT-3ʹ].  Next, the mutation 
Y330A was introduced by using the forward primer FPecY330A [5ʹ-
GTATTGATGGAGGCCGGCACGGGCG-3ʹ] and reverse primer RPecY330A [5ʹ-
CTGCGCCCGTGCCCGCCTCCATCAA-3ʹ].  All gene sequences and mutations were 
confirmed by DNA sequencing at the UIUC Core Sequencing Facility (Urbana, IL). 
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V.2.B.  Screening of refolded NZ-CZ GFP complex  
 
Competent E. coli strain BL21(DE3) cells were co-transformed with compatible pairs 
of plasmids (Table V.1):  Positive control - plasmid pJS-Duet1-NZGFPexact(MCS1)-
WTecLRS(MCS2) encoding the NZGFP fusion protein fragment and the wild type LeuRS, 
and plasmid pMRBAD-CZGFP, encoding the CZGFP fusion protein;  Test system - plasmid 
pJS-Duet1-NZGFPexact(MCS1)-YDDecLRS(MCS2), encoding the NZGFP fusion protein 
fragment and the editing-defective YDD mutant LeuRS, and plasmid pMRBAD-CZGFP, 
encoding the CZGFP fusion protein; negative control - plasmid pET11a-NGFP and plasmid 
pMRBAD-CGFP, encoding the protein fragments NGFP and CGFP, respectively.  Cells were 
grown overnight on LB-agar media that had 100 μg/mL Amp and 35 μg/mL kanamycin 
(Kan), at 37 °C.  
 
 Table V.1.  Pairs of plasmids used to transform E. coli cells to screen re-folded NZ-CZGFP 
                    complex  
 
 
A 3 mL LB culture, containing 100 μg/mL Amp and 35 μg/mL Kan was inoculated 
with a single colony from each plate and grown overnight at 37 °C.  The proteins were 
expressed by plating of a 1:10,000 dilution of each saturated overnight culture on LB-agarose 
plates that had 100 μg/mL Amp, 35 μg/mL Kan, 10 μM IPTG and 0.2% arabinose.  Cells 
were then grown at 30 °C overnight, followed by room temperature for 2 to 3 days.  
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Alternately, protein expression was induced at the log phase as follows:  A 3 mL LB media 
containing 100 μg/mL Amp and 35 μg/mL Kan was inoculated with 50 to 100 μL of the 
respective overnight cultures and grown at 37 °C until the OD600 reached ~0.6.  This was 
followed by induction of the log phase liquid culture with 10 μM IPTG and 0.2% arabinose, 
with subsequent plating of a 1:1,000 dilution of the culture on LB-agar plates that contained 
100 μg/mL Amp, 35 μg/mL Kan, 10 μM IPTG and 0.2% arabinose.  The cells were grown at 
30 °C overnight and then at room temperature for 2 to 3 days.   
Cells that fluoresced were observed with a hand-held UV transilluminator at 365 nm.  
Alternately, fluorescence was observed by fluorescence microscopy.   Microscope slides 
were prepared as follows:  A single fluorescent colony from the respective plate, was 
resuspended in 10 μL 1X phosphate buffered saline (PBS) and spread evenly on poly-D-
lysine-treated microscope slides (Fischer Scientific), covered by a glass slip (Corning) and 
allowed to dry.  The cells were then observed under the microscope (Carl Zeiss, Jena, 
Germany), using the GFP filter (λexcitation = 468 nm, λemission = 505 nm) and image acquisition 
of the fluorescing cells was performed with the AxioVision software.   
 
V.2.C.  Fluorescent reporter assay 
 
E. coli strain BL21 (DE3) was co-transformed with compatible pairs of plasmids as 
described in the previous section (Table V.1).  For each set of transformations, two 1 mL 
overnight cell cultures were harvested separately in a table top centrifuge (Eppendorf 5417C).   
Each cell pellet was washed twice with 1 mL of minimal standard (MS) media (Leu
-
) (Low, 
et al., 1971).  The cell pellet was resuspended in 100 μL of MS media (Leu-), mixed with 
0.7% soft agar along with 10 μM IPTG and 0.2% arabinose and evenly plated on MS media 
(Leu-)-agarose plates that contained 100 μg/mL Amp and 35 μg/mL Kan.  A central well was 
bored into each plate after the soft agarose solidified and filled with 100 to 150 μL of         
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100 mM of either isoleucine or norvaline.  The cells were allowed to grow overnight at 30 °C 
and then at room temperature for 2 to 3 days.  The halo of cell death or decreased 
fluorescence, when present, was observed by fluorescence microscopy. 
 
 
V.2.D.  Affinity purification of refolded NZ-CZGFP protein complex. 
 
Fluorescing E. coli BL21 (DE3) cells harboring the refolded NZ-CZGFP complex 
were screened on solid media as described in section V.2.B.  A single fluorescent colony was 
used to inoculate 3 mL LB (100 μg/mL Amp and 35 μg/mL Kan) and grown overnight at    
30 ° C.  The overnight culture was then used to inoculate 250 mL LB (100 μg/mL Amp and 
35 μg/mL Kan) and grown until OD600 reached 0.6.  Protein expression was induced during 
log phase (or at the overnight phase) with 10 μM IPTG and 0.2% arabinose with an overnight 
incubation at 30 ° C overnight, followed by room temperature for 2 to 3 days, with shaking.   
Cells were harvested using an Avanti J-E preparative centrifuge (Beckman Coulter, 
Fullerton, CA) at 6000 rpm for 15 min at 4 °C.  The cell pellet was resuspended in lysis 
buffer [(50 mM Tris-HCl, pH 8.0, 200 mM NaCl and 2 mM β-mercaptoethanol (BME) 
containing (10 mM imidazole, 0.1% triton-X-100, 1 μL DNase I, 1 μL RNase, 1mg/mL hen 
egg white lysozyme, 5 mM MgCl2 and 0.5 mM CaCl2)] (Magliery, et al., 2005; Wilson, et al., 
2004) and incubated on ice for 30 min, followed by brief sonication.  The protein-containing 
supernatant was mixed with 1 mL of HIS-Select Nickel Affinity Gel (Sigma-Aldrich) that 
had been pre-equilibrated with 10 mL of GFP buffer [50 mM Tris-HCl, pH 8.0, 200 mM 
NaCl and 2 mM BME].  The N-terminal six-histidine tagged refolded NZ-CZGFP complex in 
the supernatant was bound to the resin via gentle rocking at 4 °C for 1 h.  Following binding, 
the resin was washed with 10 mL of GFP buffer containing 20 mM imidazole.  The bound 
NZ-CZGFP protein complex was then eluted in fractions from the resin using 6 mL of GFP 
buffer containing 300 mM imidazole. 
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V.3.  Results and Discussion 
V.3.A.  Design of in vivo fluorescent assay 
 
  The split-GFP complementation system (Magliery, et al., 2005) is comprised of two 
fragments of GFP, each fused to a leucine zipper.  The NZGFP and CZGFP fragments are 
expressed from plasmids pET11a (Amp resistance) and pMRBAD (Kan resistance).  A third 
plasmid (Amp resistance) expressing LeuRS was coexpressed in the E. coli strain BL21 
(DE3).  However, it was determined not to be feasible because of plasmid incompatibility and 
overlapping antibiotic selection marker (Figure V.2).  Hence, the gene encoding the NZGFP 
fragment and the gene encoding LeuRS (wild type or editing defective) were cloned into one 
vector, pDuet-1, at two different multiclonal sites (MCS).  The expression of each was under 
the control of the T7-lac promoter.  This resulted in the plasmid pJS-Duet1-
NZGFPexact(MCS1)-WTecLRS(MCS2) (Figure V.3), encoding NZGFP fragment and wild 
type LeuRS or the plasmid pJS-Duet1-NZGFPexact(MCS1)-YDDecLRS(MCS2), encoding 
NZGFP fragment and editing-defective LeuRS.  The plasmid pMRBAD-CZGFP was used to 
express the CZGFP protein fragment (Figure V.2).   
E. coli BL21 (DE3) cells were co-transformed with pairs of compatible plasmids for 
the test system, and positive and negative controls (Table V.1).  The expression of the 
independent recombinant proteins NZGFP (or NGFP) and LeuRS was induced with 10 μM 
IPTG and that of CZGFP (or CGFP) was induced with 0.2% arabinose, in the background of 
endogenous wild type LeuRS.  Cells were grown on MS media (Leu
-
) in the presence of    
100 mM of noncognate amino acids (isoleucine or norvaline) on plates.  Decreases in 
fluorescence in this assay rely on statistical substitutions of leucines due to editing defects in 
LeuRS.  Thus, it is anticipated that even in the background of the wild type LeuRS, statistical 
fidelity mistakes can be detected because the editing-defective mutant of LeuRS is 
overexpressed.   
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V.3.B.  Expression of individual recombinant proteins and affinity purification of the  
            refolded NZ-CZGFP complex 
 
 
Figure V.4.  SDS-PAGE analysis of expression of LeuRS and the GFP fusion fragments, 
NZGFP and  CZGFP.  (Left)  Expression of LeuRS and NZGFP from the plasmid pJS-Duet1-
NZGFPexact(MCS1)-WTecLRS(MCS2).  (Right)  Expression of CZGFP from the plasmid 
pMRBAD-CZGFP.  The extreme left lanes in both gels represent the protein ladder.  The 
calculated molecular weights of the protein fragments are:  (His)6-NZGFP, 23 kD; CZGFP, 
13 kD; and E. coli LeuRS, 98 kD. 
 
Small scale (3 mL culture) expressions were carried out to check the expression of the 
individual recombinant proteins from the respective plasmids.  E. coli BL21 (DE3) cells were 
transformed with either plasmid pJS-Duet1-NZGFPexact(MCS1)-WTecLRS(MCS2), co-
expressing NZGFP protein fragment and wild type LeuRS as independent proteins or with 
plasmid pMRBAD-CZGFP, expressing CZGFP protein fragment.  Cells were grown at 37 °C 
and then induced with 10 μM IPTG or 0.2% arabinose when the OD600 reached 0.6.  The cells 
were harvested after 3 h of protein expression at 30 °C, followed by resuspension and 
sonication.  Analysis of the lysate by SDS-PAGE clearly showed that both the NZGFP 
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fragment and LeuRS were expressed from the plasmid pJS-Duet1-NZGFPexact(MCS1)-
WTecLRS(MCS2) and the fragment CZGFP was expressed from the plasmid pMRBAD-
CZGFP (Figure V.4). 
 
 
 
Figure V.5. Purification of re-folded GFP.  Affinity purification of six-histidine-tagged GFP 
fragment NZGFP (left) and refolded NZ-CZGFP complex (right).  The complex components 
NZGFP (23 kD) and CZGFP (13 kD) are visible.  The extreme left lanes in both gels 
represent the protein ladder.    
 
 
The refolded NZ-CZGFP complex was purified from cells that fluoresced using the six-
histidine tag at the N-terminus of the NZGFP fragment.   The purification was facilitated by 
the stability of the refolded GFP complex.  Fluorescent cells harboring the refolded NZ-
CZGFP complex were grown in liquid cultures for 2 to 4 days at room temperature or 30 °C 
and the six histidine-tagged GFP complex affinity purified from the soluble fraction of the 
cell lysate, yielding strong bands on an SDS-PAGE gel that corresponded to the complex 
components, (His)6-NZGFP (23 kD) and CZGFP (13 kD) (Figure V.5).  Cells that were 
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fluorescent were also visualized on MS media-agar plates either with a hand-held UV 
illuminator at 365 nm or under the microscope using a GFP filter (Figure V.6).  
 
 
 
Figure V.6.  Visualization of fluorescence of LeuZ-assisted refolded GFP.  (Left)  
Fluorescence is visualized on solid MS media-agar plates using a hand-held UV illuminator 
at 365 nm.  (Right)  Fluorescing E. coli BL21(DE3) cells visualized under the microscope 
using GFP filter.  Abbreviations are as follows:   N, negative control- cells in which NGFP 
and CGFP have been coexpressed; P-log, positive control- cells in which coexpression of 
NZGFP, CZGFP and wild type LeuRS were induced at log phase (OD600 0.6) of cell growth; 
P-o/n, cells in which coexpression of NZGFP, CZGFP and wild type LeuRS were induced at 
the overnight (13 h) phase of cell growth.  
 
 
 
 
  
113 
 
V.3.C.  Editing-dependent fluorescence reporter changes 
 
Competent E. coli BL21(DE3) cells were transformed with compatible pairs of 
plasmids (Table V.1), expressing NZGFP, CZGFP, and wild type LeuRS or editing-defective 
YDD LeuRS.  The cellular fluorescent assay was performed with cells that expressed either 
 
 
 
Figure V.7.  Scheme of LeuRS editing-dependent in vivo fluorescent reporter assay.  NZGFP, 
LeuRS (wild type – left; or editing-defective – right) and CZGFP are overexpressed 
simultaneously in E. coli BL21(DE3) cells from compatible plasmids in presence of 
exogenously supplied non-leucine amino acid X (isoleucine or norvaline) on solid MS media 
(Leu-)-agarose.  The non-leucine amino acid incorporated into the central well of the MS 
media plate will diffuse into the solid growth medium.  GFP fluorescence from cells near the 
central well (C) or at the periphery of the plate (P) was observed by fluorescence microscopy 
using a GFP filter.   
 
wild type or editing-defective LeuRS.  For both sets, cells from discrete points on the MS 
media-agar plate („C‟, near the noncognate amino acid-containing central well; or „P‟, at the 
periphery of the plate) (Figure V.7) were visualized under the microscope, using GFP filter.  
Multiple snap shots of fluorescing cells were acquired under the microscope (Figure V.8).  In 
the presence of the wild type LeuRS and noncognate amino acid, cells from the „C‟ and „F‟ 
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points on the plate show similar fluorescence (Figure V.8, top).  This suggested that leucine 
zipper-assisted refolding of the NZ- and CZGFP fragments has not been affected by the 
presence of the noncognate amino acids, as long as the wild type enzyme is present.  Thus, 
the leucine zipper fused to each of the GFP protein fragments would be expected to have 
been translated error-free.  Hence, enabled by the wild type leucine zipper dimerization, the 
N- and C-terminal halves of GFP have reassembled in a stable way to show fluorescence.   
 
 
 
 
Figure V.8.  LeuRS editing-dependent fluorescence changes.  Miscroscope snap shots of 
fluorescent cells using a GFP filter, from the center (C) or periphery (P) of MS media-agar 
plates.  (Top) Uniform fluorescence in presence of overexpressed wild type LeuRS.  
(Bottom)  In presence of overexpressed editing-defective YDD LeuRS, the cells from the 
center point C are not fluorescing due to disrupted dimerization of the leucine zippers.  Cells 
from the peripheral point P show relatively increased fluorescence.  The grey images 
represent cells visualized by differential interference contrast (DIC) microscopy.  
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The editing-defective LeuRS mutant (YDD) was also overexpressed in cells that 
produced the GFP fragments.  The center „C‟ point on the MS media-agar plate showed 
nearly no fluorescent cells under the microscope, while the peripheral „P‟ point showed 
relatively increased number of cells that fluoresced (Figure V.8, bottom).  The absence or 
reduction in fluorescence suggested that overexpression of the editing-defective LeuRS, in 
the background of endogenous wild type LeuRS resulted in mistranslation of the leucine 
zippers. This impairs their dimerization and hence reassembly of the GFP fragments.  The 
increase in fluorescence moving from the center to the periphery of the plate suggested that 
statistical leucine substitutions in the leucine zippers was likewise increased in cells growing 
near the central well that contained the non-leucine amino acid.   
  
 
 
Figure V.9.  Fluorescence intensity analysis of one microscope snap shot.  Fluorescent E. coli 
BL21(DE3) cells coexpressing NZGFP, CZGFP and wild type LeuRS are visualized by 
microscopy, using GFP filter. (Top, left to right)  Each snap shot is treated like a grid; each 
cell in the snap shot is localized to a position (i, j) in the grid and intensity measured using 
MATLAB.  (Below)  The intensity distribution of all the fluorescing cells in one snap shot. 
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A scheme was designed to analyze these observed fluorescence changes (Figure V.9, 
Figure V.10.)  Cells in the area covered by the cover slip were scanned as a grid under the 
microscope and snap shots were captured for each cover slip, followed by fluorescence 
analysis of individual snap shots.  In each snap shot, fluorescing cells were located to a 
position in the grid (i, j).  Its fluorescence intensity was calculated (Ik) and then the 
distribution of fluorescence intensity over the cells in that snap shot were plotted (Figure 
V.9.).  This would be followed by calculation of average fluorescence intensity per snap shot, 
 
 
 
 
 
Figure V.10.  Quantification of LeuRS editing-dependent fluorescence intensity changes.   
Cells from discrete points on the MS media-agar plate were viewed on a glass slide-cover slip 
under the microscope. The cover slip was scanned and multiple (n) snap shots captured for 
one cover slip.  The intensity at a discrete distance from the central well (Id) on the plate was 
calculated as the average intensity over the total n number of snap shots captured for that 
point.  Plotting Id versus distance from the central well (d) would give the fluorescence 
intensity changes of refolded GFP due to editing-defects in LeuRS.   
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averaging over the number of cells (c) in that snap shot (As) (Figure V.10.).  Finally, the 
fluorescence intensity at a distance (d) from the noncognate amino acid-containing central 
well would be calculated by averaging fluorescence intensity over the total number of snap 
shots (n) captured for cells from that point on the plate.  Cellular fluorescence intensity 
(averaged over the number of the cells in a snap shot and also over the number of snap shots 
captured for that distance/point on the plate) was plotted against the distance (d) of the point 
from the central well (Figure V.10.)  
 
 
V.3.D.  Concluding remarks 
 
The fluorescent reporter assay to assess the effects of editing defects in LeuRS relies 
on fluorescence that results due to LeuZ-assisted reassembly of GFP fragments.  Co-
expression of the multiple protein fragments and full length proteins from compatible 
plasmids yielded a robust working system that monitors LeuRS editing-dependent 
fluorescence changes in vivo.  This reporter assay could quantitatively analyze the 
fluorescence changes to gauge the cellular impact of LeuRS editing defects.   
Further optimization of the experimental parameters in the fluorescent reporter assay 
would be required in order to capture the finer differences in fluorescence intensity changes 
of reassembled GFP.  As an example, judicious manipulation of the noncognate amino acid 
concentration incorporated in the central well could lead to better observable fluorescence 
intensity changes, moving from the center to the periphery of the plate.  Alternately, using a 
LeuRS-knockdown bacterial strain to perform the fluorescent reporter assays would ensure 
complete removal of any endogenous editing activity.  Mass spectrometric analysis of the 
purified leucine zippers from the system that allows mistranslation due to editing defects in 
LeuRS will provide molecular level insights into the nature of the statistical mutations. 
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In short, the fluorescent reporter assay has provided a superior and more sophisticated 
way of investigating intracellular effects of editing defects.  Previously, a similar, but non-
fluorescent „halo‟ assay has been utilized for studying mistranslation in vivo (Hellmann and 
Martinis, 2009; Karkhanis, et al., 2006; Sarkar, et al., 2011).  However, the non fluorescent 
halo assay relied on an „all or none‟ effect of mistranslation on cell viability.  Because the 
current fluorescent assay monitors small changes in fluorescence intensity, it provides a 
tighter handle on studying the precise impact of LeuRS editing defects on cell survival.  The 
molecular determinants of post-transfer editing in LeuRS are well established (Lincecum, et 
al., 2003; Mursinna, et al., 2001; Pang and Martinis, 2009; Sarkar, et al., 2011; Zhai and 
Martinis, 2005).  Although there are multiple common in vitro methods to study these editing 
determinants, their quantitative cellular impact is largely unknown.  The fluorescent reporter 
assay described here essentially fills in that void by providing a sensitive in vivo tool to 
quantify the impact of LeuRS edting defects on cell viability.        
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Chapter VI:  A Specific Insert in LeuRS Enhances tRNA-Protein Interactions  
 
 
VI.1.  Introduction 
 
LeuRS is a class I AARS, characterized by a Rossmann dinucleotide binding fold in 
the synthetic active site.  The synthetic active site in class I AARSs is further marked by 
signature sequences „HIGH‟ (Webster, et al., 1984) and „KMSKS‟(Hountondji, et al., 1986). 
These sequences interact with ATP (Arnez, et al., 1997; Fersht, et al., 1988; Perona, et al., 
1993) and stabilize the transition state of the aminoacylation reaction by utilizing ATP 
binding energy for amino acid activation.  Structural studies on TyrRS (Kobayashi, et al., 
2005) and TrpRS (Retailleau, et al., 2007) show elaborate energetically favorable 
conformational flexibility within the mobile KMSKS loop associated with the ATP-
dependent activation of amino acid at the synthetic active site. 
 
 
 
Figure VI.1.  T. thermophilus LeuRS in complex with 5´-O-[N-(leucyl)-sulfamoyl] adenosine, 
a sulfamoyl analog of leucyl adenylate (LeuAMS) in the synthetic active site (Cusack, et al., 
2000) (PDB:  1H3N).  The LSD is inserted before the catalytically important conserved 
„(K)MSKS‟ loop. 
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 The core of the LeuRS main body contains several appendages of varying sizes 
(Cusack, et al., 2000).  Exclusive to LeuRS, a small domain (~50 amino acid), called the 
leucine-specific domain (LSD) is inserted into the catalytic core just prior to the catalytically 
important „KMSKS‟ loop (Figure VI.1).  In T. thermophilus LeuRS, the well-ordered LSD is 
comprised of five β-strands and two α-helices and is positioned at the entrance to the active 
site.  It is connected to the enzyme‟s main body by flexible β-linkers, suggesting that it can 
re-orient during distinct stages of the aminoacylation reaction (Cusack, et al., 2000).  The 
crystal structure of the T. thermophilus LeuRS in complex with tRNA
Leu
 in the editing 
conformation shows that the LSD rotates by about 19° upon tRNA binding, although no 
direct contact with the tRNA has been captured in the editing conformation (Tukalo, et al., 
2005).  A model of tRNA
Leu
 docked to the T. thermophilus LeuRS shows the LSD to be 
poised to interact with the base of the acceptor stem and the core of the tRNA (Cusack, et al., 
2000).  
 
 
 
Figure VI.2.  Multiple sequence alignment.  The leucine-specific domain (LSD) is present in 
some bacterial LeuRSs, inserted prior to the „KMSKS‟ loop, while is completely absent in 
some bacterial and archaeal LeuRSs.  Abbreviations are:  Tt, T. thermophilus; Hp, H. pylori; 
Ph, Pyrococcus horikoshii; Ec, E. coli; Vc, Vibrio cholera; and Xf, Xylella fastidiosa.   
 
Although this domain is unique to prokaryote-like LeuRSs, it is neither conserved in 
sequence nor in length across LeuRSs from different organisms as seen in a multiple 
sequence alignment (Figure VI.2).  While in E. coli LeuRS, the LSD is critical to 
aminoacylation (Vu and Martinis, 2007), some bacterial and archaeal LeuRSs, including the 
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H. pylori, B. subtilis, and P. horikoshii LeuRS completely lack the LSD (Figure VI.2).  We 
asked why LeuRS of some organisms evolved to incorporate the LSD while others did not.  
For this purpose, we constructed a chimeric swap of the E. coli LeuRS LSD into the H. pylori 
LeuRS, which completely lacks the domain to result in the chimeric HP-LSD (Figure VI.3).  
Biochemical analysis of the chimeric H. pylori enzyme HP-LSD shows that introduction of 
the LSD results in tighter E. coli tRNA
Leu
 binding and enhances aminoacylation.  
 
 
 
Figure VI.3.  Chimeric H. pylori LeuRS construct (HP-LSD LeuRS) containing the E. coli 
LSD inserted prior to the „KMSKS‟ loop. 
 
 
VI.2.  Experimental methods 
 
 
VI.2.A.  Cloning and plasmid construction 
 
The gene encoding H. pylori LeuRS (HPLeuRS) was amplified from the genomic 
DNA of H. pylori J99 via PCR in a 50 μL reaction mixture that contained 17.3 ng of template 
DNA, 125 ng each of forward and reverse primers containing NdeI and BamHI restriction 
sites, respectively, 0.05 mM dNTP mix and 0.05 U Pfu DNA polymerase in commercially 
available buffer.  The amplified PCR product was then subcloned into the vector pET-14b 
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(Novagen, Gibbstown, NJ) to yield the plasmid pMTV-LeuRSHP3d.  The gene encoding H. 
pylori tRNA
Leu
UAG  was also amplified from the genomic DNA of H. pylori strain J99 via 
PCR as described above for the pUC-19 plasmid vector (Thermo Scientific, Glen Burnie, 
MD) using forward and reverse primers containing BamHI and PstnI restriction sites, 
respectively, to yield the plasmid ptDNA-HP4.              
 
 
 
Figure VI.4.  Schematic representation of overlap extension PCR (OE-PCR).  In step 1, the 
gene encoding H. pylori LeuRS (blue) (HPLeuRS) was used as a PCR template to amplify 
the gene fragments HPLeuRS-N and HPLeuRS-C, encoding the N and C-terminus of 
HPLeuRS, respectively and the gene encoding the E. coli LeuRS (red) to amplify the gene 
fragment E. coli LSD.   The circled numbers denote the primers used.  Primers 1 and 4 
contain the restriction sites NdeI at the 5’ end and BamHI at the 3’ end (green), respectively.  
Primers 2 and 3 contain overlapping DNA sequences of 18 nucleotides with the E. coli 
LeuRS gene segment encoding the LSD.  Similarly, primers 5 and 6 contain overlapping 
sequences with the HPLeuRS gene.  In step 2, the three amplified gene fragments are 
assembled in a PCR reaction with primers 1 and 4 to generate the complete gene fragment 
HP-LSD LeuRS. 
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Overlap extension PCR (OE-PCR) (Grandori, et al., 1997) followed by ligation-
dependent PCR  was used to generate the recombinant gene expressing the chimeric protein 
HP-LSD LeuRS.  This work was performed by Hyeryoung Yoon.  In the first step of OE-
PCR (Figure VI.4.), in two separate PCR reactions, the gene fragments HPLeuRS-N 
(encoding the N-terminal half of HPLeuRS) and HPLeuRS-C (encoding the C-terminal half 
of HPLeuRS) were amplified via PCR using the template pMTV-LeuRSHP3d and primers 1 
and 2 and primers 3 and 4 respectively.  In a third PCR reaction, the gene fragment E. coli 
LSD (encoding the leucine-specific domain of E. coli LeuRS) was also amplified using the 
template p15ec3-1 (Martinis and Fox, 1997) and the primers 5 and 6.  Primers 1 and 4 were 
designed to include the restriction sites NdeI and BamHI, respectively.  Primer 2 contains 
overlapping DNA sequence (18 nucleotides) with the 5’ end and primer 3 with the 3’ end of 
the E. coli LeuRS gene segment encoding the LSD.  Primers 5 and 6 also contain overlapping 
DNA sequences of 18 nucleotides with the HPLeuRS gene (Figure VI.4.).  Each PCR 
reaction was set up as described above, except that 100 ng of template DNA was used.  
Under the following conditions, 30 cycles of PCR were carried out:  95 °C, 1 min; 55 °C,      
1 min; 72 °C, 5 min.  In the second step of the OE-PCR technique, the amplified gene 
fragments were joined together via PCR.  Pre-amplification was carried out in a reaction 
mixture containing 500 ng of each of the three amplified gene fragments, HPLSD-N, 
HPLSD-C and E. coli LSD, 0.05 mM dNTP mix and 2.5 U Pfu DNA polymerase, without 
any primer for 5 cycles under similar conditions as mentioned above.  This was followed by 
35 cycles of PCR with primers 1 and 4 to amplify the full-length HP-LSD LeuRS gene.  The 
amplified full-length HP-LSD LeuRS gene was then made to replace the wild type HPLeuRS 
gene in the plasmid pMTV-LeuRSHP3d via ligation-dependent PCR, resulting in the plasmid 
pHPLSD.  The reaction mixture included 500 ng of pMTV-LeuRSHP3d and 200 ng of the 
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full-length recombinant HP-LSD LeuRS gene to act as primer, apart from the other PCR 
components as described above.  
 
VI.2.B.  Expression and purification of proteins 
 
The wild type HPLeuRS and the chimera HP-LSD LeuRS were expressed from the 
plasmids pMTV-LeuRSHP3d and pHPLSD, respectively in E. coli strain BL21 (DE3) codon 
PLUS.  A single transformant was used to inoculate 5 mL LB supplemented with 100 μg/mL 
Amp and 34 μg/mL Cm, followed by overnight incubation at 37 °C.   The overnight culture 
was used to inoculate 1 L LB (100 μg/mL Amp and 34 μg/mL Cm) and cells were grown at 
37 °C until the OD600 reached 0.6 to 0.8.  Cells were then induced with 1 mM IPTG and the 
protein was expressed at 37 °C for 3 h.  N-terminal six-histidine tagged proteins were purified 
via Ni-affinity chromatography as described in Chapter II.  Final protein concentrations were 
determined spectrophotometrically at 280 nm using the respective extinction coefficients 
(146 x 10
3
 M
-1
cm
-1
 for wild type HPLeuRS and 155.62 x 10
3
 M
-1
cm
-1
 for HP-LSD LeuRS) 
estimated by the ExPASy Protparam tool (http://ca.expasy.org/tools/protparam.html). 
 
VI.2.C.  In vitro transcription and purification of tRNA
Leu
 
 
The E. coli tRNA
Leu
UAA and the H. pylori tRNA
Leu
UAG  were transcribed in vitro in a 
T7 RNA polymerase-dependent reaction from the plasmids ptDNA
Leu 
(Normanly, et al., 
1986; Tocchini-Valentini, et al., 2000) and  ptDNA-HP4, respectively as described in Chapter 
II.  The concentration of the tRNA was calculated spectrophotometrically on the basis of its 
extinction co-efficient (840,700 and 817,500 M
-1
 cm
-1
, for E. coli and H. pylori tRNA, 
respectively), as estimated by the online Ambion oligonucleotide calculator 
(http://www.ambion.com/techlib/misc/oligo_calculator.html). 
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VI.2.D.  Aminoacylation assay 
 
Each aminoacylation reaction contained 60 mM Tris-HCl, pH 7.5, 10 mM MgCl2,      
1 mM dithiothreitol (DTT), 4 μM transcribed tRNALeu, 21 μM [3H]-leucine (150 μCi/mL) 
and 100 nM enzyme.  Each reaction was initiated with 4 mM ATP.  The assay was performed 
as described in Chapter II.   
 
VI.2.E.  Isolation of mischarged Ile-tRNA
Leu
  
 
Misaminoacylation of 8 μM H. pylori tRNALeu with isoleucine was carried out by 
incubating the tRNA transcript with 60 mM Tris, pH 7.5, 10 mM MgCl2, 1 mM DTT, 23 μM 
[
3
H]-isoleucine (300 μCi/mL), 1 μM editing defective E. coli  LeuRS and 4 mM ATP at      
25 °C for 3 h.  The mischarged tRNA was isolated as described in Chapter II. 
 
VI.2.F.  Post-transfer editing deacylation assay 
 
Deacylation reaction mixtures contained 60 mM Tris, pH 7.5, 10 mM MgCl2 and 
approximately 2 μM [3H]-Ile-H. pylori tRNALeu.  The reactions were initiated with 1 μM 
enzyme and were carried out at 25 °C as described in Chapter II.   
 
VI.2.G.  Leucine-dependent ATP/PPi exchange assay  
 
The assay was carried out as described in Chapter II.  Reaction mixtures containing  
50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM DTT, 1 mM [
32
P]-PPi (100 μCi/mL), 1 mM 
ATP, and 1 mM leucine were initiated with 1 μM enzyme. 
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VI.2.H.  Nitrocellulose filter binding assay 
   
Binding of E. coli tRNA
Leu
UAA to the wild type HPLeuRS and to the chimeric HP-
LSD LeuRS were assessed in 50 μL reaction mixtures containing 60 mM Tris, pH 7.5,        
10 mM MgCl2, 1 mM dithiothreitol (DTT), 20 μM leucine, 0.1 μM 5’-[
32
P]-labeled E. coli 
tRNA
Leu
UAA and enzyme concentrations ranging from 0.1 to 10 μM for wild type HPLeuRS 
and 0.1 to 4 μM for HP-LSD LeuRS.  The reactions were incubated at 37 °C for 8 min and 
quenched by spotting the entire 50 μL on a nitrocellulose membrane (Whatman, Dassel, 
Germany), pre-soaked in non-specific RNA (1 mg/mL) for 1 h and then assembled on a 
MINIFOLD-1 Spot Blot apparatus (Schleicher and Schuell, Keene, NH).  The spots on the 
nitrocellulose membrane were washed with 200 μL of binding buffer (60 mM Tris, pH 7.5, 
10 mM MgCl2, 1 mM DTT) to remove any tRNA that is not bound to protein.  The 
nitrocellulose membrane was phosphorimaged and radiolabeled products visualized and 
quantified as described in Chapter II. 
 
VI.3.  Results and Discussion 
 
Many prokaryote-like LeuRSs bear the unique LSD insert of about 50 amino acids 
immediately prior to the catalytically important „KMSKS‟ loop in the catalytic domain.  
Some bacterial and archaeal LeuRSs do not possess this insertion domain, including H. 
pylori, B. subtilis as well as P. horikoshii LeuRSs.  Although the LSD has been shown to be 
critical to aminoacylation, it still remains unclear as to why some LeuRSs evolved to acquire 
this domain, whereas others did not.  To gain better insight into the functional role of the 
LSD and its evolutionary advantage, we designed a chimeric swap of the E. coli LeuRS LSD 
into the H. pylori LeuRS, which lacks the domain altogether.  Thus, we introduced the E. coli 
LeuRS LSD just upstream of the conserved „KMSKS‟ sequence (Figure VI.3).  
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Figure VI.5.  Enzymatic activities of chimeric H. pylori (HP-LSD) and wild type (WT) 
LeuRS.  (Left)  Activation of leucine.  ATP/PPi exchange reactions were carried out with      
1 mM leucine, 1 mM [
32
P]-PPi (100 μCi/mL), 1 mM ATP, and initiated with 1 μM enzyme.  
(Right)  Aminoacylation of H. pylori tRNA
Leu
.  Reactions containing 4 μM transcribed H. 
pylori tRNA
Leu
, 21 μM [3H]-leucine (150 μCi/mL) and 100 nM enzyme were initiated with   
4 mM ATP. Symbols are:  (■) wild type (WT) H. pylori and (▲) chimeric HP-LSD LeuRS.  
Error bars for each time point result from each reaction repeated in triplicate. 
 
 
The chimeric H. pylori LeuRS bearing the E. coli LSD (HP-LSD LeuRS) is active in 
leucine activation (Figure VI.5, left) and in aminoacylating the H. pylori tRNA
Leu 
(Figure 
VI.5, right), albeit with less efficiency as compared to the wild type H. pylori LeuRS.  
However, HP-LSD LeuRS can hydrolyze mischarged H. pylori tRNA
Leu
 similar to the wild 
type H. pylori LeuRS (Figure VI.6), suggesting that the LSD critically impacts 
aminoacylation activity, but not editing activity.  This is consistent with the analysis of LSD 
mutants where deletion of the domain abolished aminoacylation by E. coli LeuRS (Vu and 
Martinis, 2007).   
We tested LSD-dependent tRNA specificity by incorporating E. coli tRNA
Leu
 
transcript into aminoacylation reaction of the chimeric HP- LSD LeuRS.  The insertion of the 
E. coli LeuRS LSD clearly stimulated aminoacylation of the chimeric enzyme compared to 
the wild type H. pylori LeuRS (Figure VI.7).  The kcat/KM of HP-LSD LeuRS (5.2 μM
-1
sec
-1
) 
was increased 3-fold over the wild type H. pylori LeuRS (1.9 μM-1sec-1) for the E. coli 
tRNA
Leu
 due to a decrease in KM (Table VI.1).  We also measured the KD of E. coli tRNA
Leu
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binding, which was 5-fold tighter for the chimeric HP-LSD LeuRS (1.2 μM) compared to the 
wild type H. pylori LeuRS (5.6 μM) (Figure VI.8, Table VI.1), suggesting significantly 
tighter enzyme-E. coli tRNA
Leu
 binding interactions in presence of the LSD that originated 
from E. coli LeuRS.   
 
 
Figure VI.6.  Deacylation activity of wild type and chimeric H. pylori LeuRSs.  Hydrolysis of 
approximately 2 μM [3H]-Ile-H. pylori tRNALeu  was initiated with 1 μM enzyme.  Symbols 
are: (●) no enzyme; (■) wild type (WT) H. pylori; and (▲) chimeric HP-LSD LeuRS.  Each 
reaction was measured in triplicate.   
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Figure VI.7.  Aminoacylation of E. coli tRNA
Leu
 by wild type and chimeric H. pylori 
LeuRSs.  Reactions containing 4 μM transcribed tRNALeu, 21 μM [3H]-leucine (150 μCi/mL) 
and 100 nM enzyme were initiated with 4 mM ATP. Symbols are:  (■) wild type (WT) H. 
pylori and (▲) chimeric HP-LSD LeuRS.  Error bars for each time point result from each 
reaction repeated in triplicate. 
 
Based on our biochemical analysis, we hypothesize that the LSD enhances LeuRS-
tRNA
Leu
 interactions and binding and this provides an advantage in aminoacylating tRNA
Leu
.  
The LSD was inserted in LeuRSs from some organisms, most likely to confer an advantage to 
tRNA recognition and thus catalysis.  Although crystal structures for P. horikoshii and T. 
thermophilus LeuRS to date have failed to capture any direct contact between the LSD and 
the tRNA, a model of tRNA
Leu
 docked to T. thermophilus LeuRS suggests LSD interactions 
with the base of the acceptor stem (Cusack, et al., 2000).  Thus, it is possible the domain has 
important interactions to stabilize the 3´ end of tRNA
Leu
 during a transient stage of the 
aminoacylation reaction.   This might include substrate-binding, tRNA translocation and/or 
product release.   
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                     Table VI.1.  Apparent aminoacylation kinetic parameters and  
                                         binding constants of E. coli tRNA
Leu
* 
Enzyme 
KM 
(µM) 
kcat 
(sec
-1
) 
kcat/KM 
(µM
-1
sec
-1
) 
KD 
(µM) 
WT 1.1 ± 0.2 2.0 ± 0.01 1.9 ± 0.3 5.6 ± 1.0 
HP-LSD 0.4 ± 0.05 1.8 ± 0.3 5.2 ± 1.7 1.2 ± 0.2 
                     * tRNA
Leu
 transcript concentrations ranged from 0.025 to 16 μM in 
                     aminoacylation reactions, and from 0.4 to 10 µM in binding assays. 
 
In fact, the most recently solved E. coli LeuRS-tRNA
Leu
 co-crystal structure 
(Palencia, 2012) captures direct interaction between the LSD and tRNA
Leu
 in the editing 
conformation.  This direct interaction is however lost when the enzyme transitions from the 
editing to the aminoacylation conformation, due to a major rotation of the LSD towards the 
synthetic active site.   
In addition, the LSD may also impact the mobility of the neighboring catalytically 
critical „KMSKS‟ loop (Vu and Martinis, 2007).  The role of the mobile „KMSKS‟ loop in 
amino acid activation and aminoacylation has been extensively studied in the class I 
synthetases, TyrRS (Kobayashi, et al., 2005), TrpRS (Retailleau, et al., 2007) and more 
recently in LeuRS (Palencia, 2012).  The „KMSKS‟ loop that directly interacts with tRNALeu 
moves as an integral part of the LSD when the latter rotates during transition of LeuRS from 
the editing to the aminoacylation conformation.  This movement brings the „KMSKS‟ loop 
closer to the aminoacylation active site, enabling more intimate interactions with the tRNA
Leu
 
acceptor stem.  These interactions between the „KMSKS‟ loop and the tRNA optimally 
position the tRNA for transfer of the aminoacyl moiety.  Furthermore, comparison of 
aminoacylation and editing structures of LeuRS-tRNA
Leu
 reveals the „KMSKS‟ loop to be in 
a relatively open or relaxed state in the editing conformation. 
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Figure VI.8.  Binding of E. coli tRNA
Leu
 to wild type or chimeric H. pylori LeuRS.  (Top)  
Phosphorimage of a representative nitrocellulose membrane showing tRNA:protein complex 
formation when protein concentrations were varied from 0 to 10 µM.  The chimeric HP-LSD 
LeuRS showed greater amount of complex formation with E. coli tRNA
Leu
 than the wild type 
H. pylori LeuRS.  (Bottom)  Binding curve for the chimeric HP-LSD LeuRS.  Error bars for 
each time point result from each reaction repeated in triplicate. 
 
 
The crystal structure of the E. coli TyrRS catalytic domain in complex with tyrosine 
and a tyrosine adenylate analog has captured extensive local induced-fit local conformational 
changes.  These conformational changes span over the flexible „KMSKS‟ loop and within the 
substrate-binding pock.  Such local flexibility is the basis for stabilizing ATP-binding and 
using the ATP-binding energy to activate amino acid (Kobayashi, et al., 2005).  The events 
captured in this ensemble of snapshots include:  tyrosine binding at the active site in the 
„open‟ conformation of the KMSKS loop; ATP-binding at the active site inducing a transition 
of the KMSKS loop to the „semi-open‟ conformation; adenylate formation in the „closed‟ 
conformation of the KMSKS loop; the KMSKS loop reverting to the „semi-open‟ 
conformation to allow entry of the 3ʹ-end of the tRNA for transfer of the aminoacyl moiety, 
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because in the „closed‟ conformation of the KMSKS loop, the 3ʹ-adenosine of the tRNA 
cannot reach the catalytic site.   
Thermodynamic calculations in the B. stearothermophilus TrpRS reveal modest 
enthalpy changes, consistent with the idea of entropy-driven ATP binding accompanying the 
induced-fit assembly at the substrate-binding site (Retailleau, et al., 2007).  The same study 
also highlights the criticality of movements in the KMSKS loop in stabilization of transition 
state during the aminoacylation reaction.   
The flexible LSD of LeuRS could assist in facilitating conformational changes of the 
KMSKS loop that are critical to aminoacylation.  It is highly plausible that coordinated 
movements of the LeuRS LSD and the KMSKS loop not only orchestrate substrate binding 
for catalysis but also induce more intimate inertactions with tRNA
Leu
. 
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Chapter VII:  The Yeast Mitochondrial Leucyl-tRNA Synthetase CP1 Domain has  
                         Functionally Diverged to Accommodate RNA Splicing at the Expense of  
                         Hydrolytic editing  
 
This research was originally published in J. Biol. Chem.   
Jaya Sarkar, Kiranmai Poruri, Michal T. Boniecki, Katherine K. McTavish, and Susan A. Martinis. 
The yeast mitochondrial leucyl-tRNA synthetase CP1 domain has functionally diverged to 
accommodate RNA splicing at the expense of hydrolytic editing. J. Biol. Chem. 2012; 
doi:10.1074/jbc.M111.322412. © the American Society for Biochemistry and Molecular 
Biology. 
 
 
VII.1.  Introduction 
 
The diverse family of aminoacyl tRNA-synthetases (AARSs) have been recruited to 
host alternate activities in the cell (Lambowitz and Perlman, 1990; Martinis, et al., 1999) in 
addition to their housekeeping function in protein synthesis (Ibba and Sӧll, 2000).  This 
includes aiding splicing of group I introns in the mitochondria, which is essential to certain 
lower eukaryotes.  Two fungal mitochondrial AARSs, leucyl-tRNA synthetase (LeuRS or 
NAM2p) (Herbert, et al., 1988; Labouesse, et al., 1985; Labouesse, 1990) and tyrosyl-tRNA 
synthetase (TyrRS or CYT-18p) (Akins and Lambowitz, 1987; Paukstelis and Lambowitz, 
2008) are required splicing factors to facilitate splicing of group I introns in Neurospora 
crassa and Saccharomyces cerevisiae respectively.   
Yeast mitochondrial LeuRS (ymLeuRS) was originally implicated in group I intron 
splicing when suppressor mutations in LeuRS rescued RNA processing in the absence of a 
functional bI4 maturase (Labouesse, et al., 1987).  In addition to the bI4 maturase (De La 
Salle, et al., 1982; Labouesse, et al., 1984) and also Mss116p (Huang, et al., 2005), LeuRS 
aids splicing of the related bI4 and aI4α group I introns from the mitochondrial genes 
encoding cytochrome b (cob) and the α subunit of cytochrome oxidase (cox1α). We have 
demonstrated that LeuRS and bI4 maturase bind independently to the bI4 intron and stimulate 
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RNA splicing (Rho and Martinis, 2000).  However, the mechanistic details of how LeuRS 
promotes splicing remain unclear. 
 
Figure VII.1.  Primary and tertiary structure of the LeuRS CP1 domain.  (Top)  Homology 
model of ymLeuRS (Rho, et al., 2002).  (Bottom)  Multiple sequence alignment of LeuRS 
CP1 domain and flanking regions containing both the N and C-terminal β-strand linkers and 
extensions.  The CP1 domain, β-strand linkers and β-strand extensions are shown in blue, red 
and green respectively.  Bracketed numbers indicate the number of amino acids of a peptide 
insert.  The E. coli LeuRS A293 residue (Li, et al., 1999; Williams and Martinis, 2006) is 
highlighted in orange and the corresponding peptide by an orange line.  It is absent in the 
ymLeuRS.  Each of the yeast mitochondrial CP1 domain constructs are indicated at the top of 
the figure as follows: CP1 (Ile260 to Glu431), CP1-β (Trp238 to Leu442) and CP1-βext 
(Lys232 to Tyr452).  Abbreviations are: Saccharomyces cerevisiae mitochondrial (Scm), 
Escherichia coli (Ec) and Mycobacterium tuberculosis (Mt). 
 
 
The connective polypeptide 1 (CP1) domain (Hou, et al., 1991; Starzyk, et al., 1987) 
of LeuRS have been proposed to play a role in RNA splicing (Hsu, et al., 2006; Rho, et al., 
2002).  The approximately 170 amino acid CP1 insertion splits the ATP-binding Rossmann 
fold that characterizes the aminoacylation active site of class I AARSs (Hou, et al., 1991) and 
folds discretely into a separate domain.  The CP1 domain is connected to the rest of the 
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enzyme via two flexible β-strands (Figure VII.1) (Cusack, et al., 2000).  Although the LeuRS 
CP1 domain is best known for its role in proofreading or editing misacylated tRNA
Leu 
(Betha, 
et al., 2007; Boniecki, et al., 2008), genetic rescue experiments identified splicing sensitive 
sites within and around the CP1 domain (Labouesse, et al., 1987; Li, et al., 1996).  We had 
also shown that the isolated CP1 domain from ymLeuRS stimulated bI4 intron RNA splicing 
in vivo (Rho, et al., 2002). 
Herein, we utilized a LeuRS-dependent in vitro splicing assay (Boniecki, et al., 2009) 
to isolate and characterize molecular determinants within the ymLeuRS CP1 domain and the 
connecting β-strands that directly impact splicing.  We show how the LeuRS CP1 domain 
adapted to and functionally diverged to accommodate its dual essential activities in 
aminoacylation and splicing. In some cases, LeuRS adaptations for splicing appear to have 
evolved at some expense to the enzyme‟s housekeeping function in aminoacylation.    
 
VII.2.  Experimental methods 
 
 
VII.2.A.  Cloning, mutagenesis and plasmid construction 
 
The plasmid pBETeCP1-2-35 (Betha, et al., 2007) contains the gene fragment 
encoding the CP1 domain of  E. coli LeuRS and was used for in vitro expression of the 
protein ecCP1-βext LeuRS.  The ymLeuRS gene fragment encoding the ymCP1-β LeuRS 
fragment was amplified in a 50 μL polymerase chain reaction (PCR) that contained 100 ng of 
pYM3-17 (Rho and Martinis, 2000) template plasmid DNA, 125 ng each of forward 
[ymCP1-β-Fwd(NdeI)(W238-L442)] and reverse [ymCP1-β-Rev(BamHI)(W238-L442)] 
primer containing the NdeI and BamHI restriction sites respectively, 0.05 mM dNTP mix and 
0.05 U Pfu DNA polymerase in commercial buffer.  The PCR products were digested with 
NdeI and BamHI at 37 °C for 6 h.  The restriction-digested PCR products were separated on a 
1% agarose gel and gel-purified using the QIAquick gel extraction kit-250 (Qiagen Inc).  The 
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vector pET-14b (Novagen, Gibbstown, NJ) was also cleaved with NdeI and BamHI, followed 
by gel-extraction.  Gel purified restriction digests of the PCR amplified gene fragment and 
the vector were ligated using T4 DNA ligase at 37 °C for 15 min to yield the plasmid 
p14MBymCP1+N+C(RDWL).  The ligation reaction was used to transform E. coli strain 
DH5α.  Plasmid DNA was isolated from a 3 mL overnight culture of a single transformant 
using the QIAprep Spin mini prep kit-250 (Qiagen Inc).   
The plasmid p14MBymCP1+N+C(RDWL) was used as template to generate the 
plasmid p14JSymCP1-βext, encoding the LeuRS protein fragment ymCP1-βext.  This site 
directed PCR-based insertion mutagenesis used primers ymCP1-βext-Cter-Fwd-(W238-
R449), ymCP1-βext-Cter-Fwd-(W238-Y452), ymCP1-βext-Nter-Fwd-(Q235-Y452) and 
ymCP1-Nter-βext-Fwd-(K232-Y452).  Mutations were introduced into the template plasmid 
as described above via PCR. The final PCR mixture was restriction digested with 0.8 U DpnI 
for 4 h at 37 °C and then used to transform E. coli strain DH5α.  The plasmid p14JSymCP1-
βext, was used as template to introduce the W238C point mutation with primer ymCP1-βext-
Fwd-(W238C) to generate plasmid p14JSymW238C-CP1-βext, encoding the ymCP1-βext 
LeuRS that contained a W238C mutation. Likewise, the wild type full length ymLeuRS 
encoding plasmid pYM3-17 (Rho and Martinis, 2000) was used as template to generate the 
plasmids pEXW238A, pEXW238C, pEXW238F and pEXW238Y, encoding the mutant 
proteins W238A, W238C, W238F and W238Y full length ymLeuRSs.  Mutations were 
confirmed by DNA sequencing (UIUC Core Sequencing Facility, Urbana, IL or Seq Wright, 
Houston, TX).   
For in vivo studies in yeast strains HM410 and HM402 (Li, et al., 1992; Seraphin, et 
al., 1987) the plasmid pKIRAN (Karkhanis, et al., 2006) and ymLeuRST (Houman, et al., 
2000) were used to express wild type E. coli LeuRS and wild type ymLeuRS proteins, 
respectively.  Both these plasmids contain a constitutive ADH promoter along with a 5’ tag 
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encoding a mitochondrial import sequence and also a TRP marker for their selection in the 
HM410 and HM402 yeast strains.  The plasmid ymLeuRST was used in site directed PCR 
mutagenesis to generate the plasmids pMPW238A, pMPW238C, pMPW238F and 
pMPW238Y.  
 
VII.2.B.  In vitro transcription of yeast mitochondrial tRNA
Leu
 
 
Yeast mitochondrial tRNA
Leu
UAA (ymtRNA
Leu
) was transcribed from the plasmid 
pymtDNA
Leu 
(Rho and Martinis, 2000) as described in Chapter II.  The concentration of the 
tRNA was calculated spectrophotometrically on the basis of its extinction co-efficient (Table 
VII.1) as estimated by the online Ambion oligonucleotide calculator 
(http://www.ambion.com/techlib/misc/oligo_calculator.html). 
 
VII.2.C.  Precursor RNA Transcription 
 
Plasmid pM96Δhj1-3 (Boniecki, et al., 2009) encodes the gene for the shortest bI4 
intron deletion mutant, bI4Δ1168 precursor RNA (pre-RNA), that has been shown to be 
catalytically active in vitro.  A custom made RNA ladder, ranging from 250 to 50 base pairs 
(Boniecki, et al., 2009) was used for analyzing the splicing products by gel electrophoresis.  
Plasmids pUC8MB-250, pUC8MB-200, pUC8MB-150, pUC8MB-100 and pUC8MB-50 
(Boniecki, et al., 2009) encode specific RNAs ranging from 250-50 base pairs.  Each plasmid 
was isolated from E. coli strain DH5α using a QIAGEN Plasmid Mega Prep kit-25 (Qiagen 
Inc).  The isolated DNA was then restriction digested using 50 U BamHI for the bI4Δ1168 
RNA or SalI for the ladder RNAs, overnight, at 37 °C.  RNA was transcribed from the 
respective restriction digested DNA template using the MEGAscript T7 transcription kit 
(Ambion Inc., Austin, TX).  Transcription reactions were carried out using 1 μg template 
  
138 
 
DNA in a 20 μL reaction mixture, at 37 °C, for 4 h, according to manufacturer‟s protocol.  
The transcribed RNA was radiolabeled by including 10 μCi [α-32P]-UTP in the transcription    
 
                             Table VII.1.  Extinction Coefficients of protein and RNA 
 
                                      a
Calculated by Ambion oligonucleotide calculator  
                             (http://www.ambion.com/techlib/misc/oligo_calculator.html) 
                                      b
Calculated by ExPASy Protparam  
                             (http://ca.expasy.org/tools/protparam.html). 
 
 
reaction.  The bI4Δ1168 pre-RNA was isolated on Chroma Spin+TE-200 columns (Clontech, 
Mountain View, CA).  RNA concentration was estimated spectrophotometrically, based on 
its extinction co-efficient, calculated by the online Ambion oligonucleotide calculator 
(http://www.ambion.com/techlib/misc/oligo_calculator.html) (Table VII.1).  The bI4Δ1168 
pre-RNA was folded in vitro, in the presence of 1 mM MgCl2, at 50 °C for 2 min, followed 
by cooling at 32 °C for 10 min.  The ladder RNAs were isolated by 
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phenol:chloroform:isoamyl alcohol [125:24:1] extraction, followed by ethanol precipitation.  
The recovered RNA pellet was washed with 70% ethanol, vacuum dried and then dissolved 
in 50-100 μL nuclease-free water (Ambion Inc., Austin, TX).  A 2 µL aliquot of each RNA 
was visualized on denaturing analytical polyacrylamide gel to ensure successful transcription 
(Figure VII.2).   
 
 
 
Figure VII.2.  T7 RNA polymerase-based transcription of bI4Δ1168 pre-RNA and a custom-
made RNA ladder ranging from 50 to 250 base pairs (bp). 
 
 
VII.2.D.  In vitro expression and purification of N-terminal six histidine-tagged proteins 
  
Wild type and mutant proteins were expressed from their respective plasmids in E. 
coli strain BL21 (DE3) codon PLUS as described in Chapter II, except that both the buffers 
HAI and HAII contained 50 mM and 250 mM KCl, respectively. The final protein 
concentrations were determined spectrophotometrically at 280 nm using the respective 
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extinction coefficients, estimated by the ExPASy Protparam tool 
(http://ca.expasy.org/tools/protparam.html). (Table VII.1).  
 
VII.2.E.  In vitro expression and purification of GST-tagged bI4 maturase ptotein   
 
The gene sequence encoding N-terminal GST-tagged bI4 maturase in the plasmid 
pGEX2T-MAT2 (Delahodde, et al., 1989) was corrected for a missing asparagine residue 
(Asn253) at the C-terminus of the bI4 maturase protein sequence, in a PCR reaction using the 
forward (Flong-fixN253) and reverse (Rlong-fixN253) primers to result in the final plasmid 
pGEX2T-MAT2-bI4matfix, which encodes the N-terminal GST-tagged bI4 maturase protein 
with a thrombin cleavage site at the junction of the GST tag and the N-terminus of the bI4 
maturase protein. 
E. coli strain Rosetta (DE3) was transformed with the plasmid pGEX2T-MAT2-
bI4matfix and a single transformant used to inoculate 3 mL LB supplemented with             
100 μg/mL Amp and 34 μg/mL Cm and then incubated at 37 °C overnight.  In order to find 
out the optimal conditions for protein expression, the overnight culture was used to inoculate 
small 3 mL LB with antibiotics, cells grown at 37 °C until the OD600 reached 0.6 to 0.8, 
followed by induction with 0.5 or 1 mM IPTG.  Expression was allowed for 45 min, 2 h, 4 h 
or overnight at room temperature or overnight at 37 °C.  Cells were harvested by 
centrifugation in a table-top centrifuge, resuspended in 1X phosphate buffered saline (PBS; 
140 mM NaCl, 10 mM Na2HPO4 and 1.8 mM KH2PO4), followed by cell lysis by sonication.  
The soluble fraction was separated from the cell debris or insoluble fraction by 
centrifugation.  SDS-PAGE analysis of the soluble and the insoluble fractions (Figure VII.3) 
showed that optimal expression conditions for the N-terminal GST-tagged bI4 maturase 
protein was induction of protein expression with 1 mM IPTG, followed by expression  at 
room temperature for 4 h to overnight. 
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Figure VII.3.  SDS-PAGE analysis of small scale expression of N-terminal GST-tagged bI4 
maturase.  (Left) Induction of protein expression with 0.5 mM IPTG.  (Right)  Induction of 
protein expression with 1 mM IPTG.  The 56 kD bI4 maturase expression on the gel has been 
highlighted by red arrows.  Lanes are:  On both gels, lanes 2 to 7 contain soluble fractions 
and lanes 8 to 13 contain insoluble fractions of the cell lysate.  Lane 1 corresponds to protein 
ladder, with the 50 kD band marked; (2 and 8), (3 and 9), (4 and 10), (5 and 11), and (6 and 
12) correspond to protein expression for 45 min, 2 h, 4h, overnight at room temperature, and 
overnight at 37 °C, respectively; (7 and 13) correspond to non-induced.   
 
The optimal conditions deduced from the small scale expression were used to express 
bI4 maturase on a large scale (4 x 0.5 L LB containing antibiotics).  Cells were induced with   
1 mM IPTG and protein expressed at room temperature for 5 h.  Harvested cell pellets were 
resuspended in 1X PBS containing 1 mg/mL hen egg white lysozyme (Sigma-Aldrich, St 
Louis, MO), incubated on ice for 30 min followed by brief sonication.  The cell lysate was 
centrifuged at 12,000 rpm for 30 min at 4 °C.  The protein-containing supernatant was mixed 
with 4 mL of glutathione-agarose beads in water, pre-equilibrated with 1X PBS.  Protein 
binding was allowed at 4 °C for 4 h.  The protein-bound glutathione-agarose resin was 
washed with 30 mL 1X PBS and the GST-tagged bI4 maturase protein (56 kD) was eluted 
from the resin in four 1 mL fractions with 1X PBS containing 10 mg/mL (33 mM) 
glutathione in 50 mM Tris-HCl, pH 9.0 to 10.0 (Figure VII.4., left).  Alternately, in order to 
isolate N-terminal GST-cleaved bI4 maturase (30 kD), the protein-bound glutathione-agarose 
resin was incubated with 20 U of thrombin protease in 2 mL buffer (10 mM tris-HCl, pH 7.5, 
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100 mM NaCl, 5 mM MgCl2, 1 mM EDTA and 30% glycerol) with gentle rocking at room 
temperature overnight.  The N-terminal GST-cleaved bI4 maturase-containing supernatant 
was collected and analyzed by SDS-PAGE to show the band corresponding to the protein 
(Figure VII.4, right).  The GST tag (26 kD) bound to the glutathione-agarose resin was finally 
eluted by incubating the resin with 1 X PBS containing 10 mg/mL (33 mM) glutathione 
(Figure VII.4, right).  In each case, protein concentration was measured 
spectrophotometrically at 280 nm using extinction coefficient as estimated by the ExPASy 
Protparam tool (http://ca.expasy.org/tools/protparam.html). 
 
 
 
Figure VII.4. Purification of bI4 maturase.  (Left)  SDS-PAGE analysis of N-terminal GST-
tagged bI4 maturase eluted from glutathione-agarose beads with 10 mg/mL glutathione in 50 
mM Tris-HCl, pH 9 to 10.  (Right)  SDS-PAGE analysis of N-terminal GST-cleaved bI4 
maturase by thrombin treatment.  The solid red arrow corresponds to bI4 maturase with GST 
tag (56 kD, left) or without GST tag (30 kD, right).  The green dashed arrow corresponds to 
GST (26 kD).  A reference lane containing only thrombin protease has also been shown. 
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VII.2.F.  Circular Dichroism 
 
CD measurements were performed using a Jasco J-720 spectropolarimete.  A sample 
containing 1 µM protein in 5 mM KPi, pH 7.5 was measured in the far-ultraviolet region 
using a 0.1 cm path cell.  Background signals from the cell and the buffer were subtracted 
from each spectrum.  
 
VII.2.G.  Aminoacylation assay 
 
Each aminoacylation reaction contained 60 mM Tris, pH 7.5, 10 mM MgCl2, 10 mM 
KCl, 1 mM dithiothreitol (DTT), 4 μM transcribed ymtRNALeu, 21 μM [3H]-leucine         
(150 μCi/mL) and 1 μM enzyme.  Each reaction was initiated with 4 mM ATP and performed 
as described in Chapter II. 
 
VII.2.H.  Isolation of mischarged Ile-tRNA
Leu
  
 
Misaminoacylation of ymtRNA
Leu
 with isoleucine was carried out by incubating the 
following reaction mixture at 25 °C for 3 h:  60 mM Tris, pH 7.5, 10 mM MgCl2, 10 mM 
KCl, 1 mM DTT, 8 μM transcribed ymtRNALeu, 23 μM [3H]-isoleucine (300 μCi/mL),  1 μM 
editing defective E. coli LeuRS and 4 mM ATP and performed as described in Chapter II. 
 
VII.2.I.  Post-transfer editing deacylation assay 
 
Deacylation reaction mixtures contained 60 mM Tris, pH 7.5, 10 mM MgCl2, 10 mM 
KCl and approximately 2 μM [3H]-Ile-ymtRNALeu.  The reactions were initiated with 1 μM 
enzyme and were carried out at 25 °C as described in Chapter II. 
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VII.2.J.  LeuRS-dependent in vitro splicing assay 
 
The in vitro splicing reaction (Boniecki, et al., 2009) included 1 μM [32P]-bI4Δ1168 
pre-RNA (0.13 μCi/μL),  1 μM LeuRS, 150 mM KCl, Stop RNase inhibitor (5 Prime, Inc., 
Gaithersburg, MD) in 1X binding buffer (10 mM Tris, pH 7.5, 100 mM NaCl, 5 mM MgCl2, 
1 mM ethylenediaminetetraacetic acid (EDTA) and  10% glycerol.  The reaction was carried 
out at 37 °C and initiated with 1 mM guanosine.  Aliquots of 10 μL were quenched in 10 μL 
of 5 M urea, 30 mM EDTA and mixed with 5 μL of RNA-loading dye for incubation at       
65 °C for 10 min.   
Each aliquot was electrophoresed on a 6% denaturing urea-polyacrylamide gel, 
overnight at 10 mA, in 1X TBE buffer.  The gel was dried and phosphorimaged using a 
FUJIFILM BAS Cassette 2040 (FUJIFILM Medical Systems, Stanford, CT) and products 
were visualized by scanning the images using a STORM 840 Molecular Dynamics scanner 
(Amersham Pharmacia Biotech, Piscataway, NJ).  Images were quantified using ImageQuant 
software.   Bands corresponding to the bI4Δ1168 precursor RNA, excised intron and ligated 
exons, for each time point were normalized by measuring the fraction of each relative to the 
sum of the intensities of the three bands for the respective time points.  Background intensity 
was deducted, based on the zero time point.   The fraction of bI4Δ1168 pre-RNA remaining 
and extent of reaction for both the products, bI4 and B4-B5 were plotted using the GraphPad 
Prism software. 
 
VII.2.K.  In vivo yeast complementation assay 
 
The yeast complementation assays utilized the yeast strains HM410 and HM402 (Li, 
et al., 1996; Seraphin, et al., 1987).  Both HM410 (MATα ade2-1 his-11,15 leu2-3, 112 trp1-1 
ura3-1 can1-100 nam2Δ::LEU2 [777-3A]) and HM402 (MATα ade2-1 his-11,15 leu2-3, 112 
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trp1-1 ura3-1 can1-100 nam2Δ::LEU2 [Δ introns]) are yeast null strains that contain a 
genomic/allelic disruption of the nam2 gene, encoding ymLeuRS, but contain a LEU marker 
insertion.  Wild type ymLeuRS fused to mitochondrial import sequence, is expressed via a 
maintenance plasmid YEpGMCO63 that bears a URA3 marker.  The ade2 mutation enables 
the cells to develop a red pigment when mitochondria are functional.  The strain HM410 
contains all thirteen mitochondrial introns.  All of these introns have been deleted in HM402. 
Yeast HM410 and HM402 competent cells were transformed with the plasmids 
pMPW238A, pMPW238C, pMPW238F or pMPW238Y, encoding the respective mutant 
ymLeuRSs or with pKIRAN, encoding the wild type E. coli LeuRS, fused to an N terminal 
mitochondrial import sequence.  As positive and negative controls, yeast cells were also 
transformed with the plasmid ymLeuRST, encoding the wild type ymLeuRS, fused to a 
mitochondrial import sequence and the empty vector pQB153T, respectively.  All these 
plasmids bear a TRP marker.  Selection of transformants that contain both the maintenance 
plasmid YEpGMCO63 with a URA3 marker and the mutant or heterologous LeuRS 
expressing plasmid with a TRP marker was carried out on synthetic complete (SC) Leu
-
Ura
-
Trp
-
 dropout media.  The selected transformants were then grown on glucose containing 5-
flouroorotic acid (FOA).  This negative selection step selects for cells that have lost the 
maintenance plasmid YEpGMCO63 with URA3 marker, expressing wild type ymLeuRS.  
Thus, cells that grow on glucose-FOA media are Ura
-
 segregants that now contain only the 
plasmid with TRP marker that express the mutant or heterologous LeuRSs.  The FOA 
resistant colonies were then grown on SC Leu
- 
Trp
-
 dropout media, containing either 2% 
glucose or glycerol to test for complementation activity (Houman, et al., 2000). 
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VII.2.L.  Northern blot analysis 
 
Total cellular RNA was extracted from yeast null strain HM410, expressing wild type 
ymLeuRS and W238A, W238C mutant ymLeuRSs.  The cells were selectively grown in     
25 mL SC Leu
- 
Trp
- 
dropout media containing FOA until the OD600 reached 1.5.  The cultures 
were then harvested and pellets washed with ice cold water.  The washed pellets were 
resuspended in 400 μL TES (10 mM Tris, pH 7.5, 10 mM EDTA and 0.5% SDS) followed by 
hot acid phenol extraction at 65 °C for 1 h.  The aqueous layer was extracted twice with 
chloroform.  The recovered RNA was precipitated overnight with 40 μL 3 M CH3COONa, 
pH 5.3 and 100% chilled ethanol (that was stored at -20 °C).  This was followed by washing 
with 70% ethanol before drying the pellet and dissolving the same in nuclease-free water 
(Ambion Inc., Austin, TX). 
Upto 100 μg of total cellular RNA were electrophoresed on a 1% agarose gel 
containing 1.85% formaldehyde and 40 mM 3-(N-morpholino) propanesulphonic acid 
(MOPS), 0.1 mM EDTA, 0.5 mM CH3COONa MOPS buffer.  The RNA was transferred to a 
nitrocellulose membrane in 5X sodium salt citrate (SSC: 0.75 M NaCl and 0.075 M 
NaH2C6H5O7) overnight.  RNA was UV cross-linked to the nitrocellulose membrane for        
1 min.  The membrane was then prehybridized for 1 hr at 42 °C with 25 mL hybridization 
buffer (0.5 M NaPi, pH 7.2, 7% SDS, 1% BSA and 0.04% EDTA). 
A DNA oligomer that represents the ligated B4-B5 exon junction (5’-
GAATATAGTTATCAGGATGACCTAAAGTATTAGGTGAATAG-3’) was radiolabeled in 
a reaction containing 0.3 μg of the oligo, 50 μCi [γ-32P]-ATP and 10 U T4 polynucleotide 
kinase (Promega, Madison, WI).  The radiolabeled probe was added to the prehybridized 
membrane and hybridization was carried out overnight at 42 °C.  The membrane was then 
washed three times for 10 min with 1X SSC and 0.1% SDS, followed by drying.  The dried 
membrane was exposed to FUJIFILM BAS Cassette 2040 (FUJIFILM Medical Systems, 
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Stanford, CT) and the image scanned using a STORM 840 Molecular Dynamics scanner 
(Amersham Pharmacia Biotech, Piscataway, NJ).  
 
VII.2.M.  RT-PCR detection of spliced product 
 
Denaturation of 25 μg of total cellular RNA was carried out by incubation at   95 °C 
for 5 min.  This was followed by an annealing reaction at 48 °C for 1 hr with 10 pmoles of 
forward (bI4-F-5’-GGCATTACATATTCATGGTTCATC-3’) and reverse (bI5-R-5’-
GGTGTTACTAAAGGATTACCAGGAA-3’) primers followed by reverse transcription at 
37 °C for 90 min using 10 U of AMV Reverse Transcriptase (Promega, Madison, WI).  The 
PCR reaction was carried out by subsequent addition of 10 pmoles of forward and reverse 
primers along with 5 U of Go Taq Flexi DNA polymerase (Promega, Madison, WI).  
Subsequent to denaturation for 5 min at 95 °C, 30 cycles of PCR were carried out as follows:  
94 °C, 1 min; 50 °C, 1 min; and 72 °C for 2 min with a final extension for 10 min at 72 °C. 
The yeast complementation assays and Northern blot and RT-PCR analysis of the 
spliced products were performed by Kiranmai Poruri, alumnus of Professor Susan A. 
Martinis‟s research group. 
 
VII.3.  Results 
 
Isolated ymCP1 domain splices in vitro, unlike its E. coli counterpart.  The isolated 
ymLeuRS CP1 domain is sufficient to support in vivo splicing activity of the bI4 intron RNA 
(Rho, et al., 2002).  To investigate CP1 adaptations that confer splicing activity in vitro, we 
designed three ymLeuRS protein fragments that contained the CP1 domain and various 
lengths of its flanking extensions (Figure VII.1).  These constructions were based on 
available LeuRS crystal structures as well as biochemical investigations.  Our goal was to 
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incorporate the LeuRS protein fragments into a recently developed in vitro splicing assay for 
the bI4 intron (Boniecki, et al., 2009) to distinguish adaptations of this housekeeping protein 
that are important to RNA splicing.  The full-length wild type ymLeuRS was found to 
support splicing of the minimized bI4Δ1168 pre-RNA in this in vitro assay (Boniecki, et al., 
2009), as shown by identification of the products on a denaturing polyacrylamide gel and also 
by quantification of the processing of the pre-RNA and formation of products – the spliced  
 
 
 
Figure VII.5.  In vitro splicing activity of full-length wild type ymLeuRS in absence or 
presence of bI4 maturase.  (Top left)  Products of the in vitro splicing reaction were resolved 
on a 6% denaturing polyacrylamide gel and identified by comparing the position of the bands 
with a custom-made RNA marker („M‟).  The pre RNA (B4-bI4-B5), and the products bI4 
and B4-B5 have been marked by arrows.  The splicing of 1 μM [32P]-bI4Δ1168 pre-RNA 
(0.13 μCi/μL) in presence of proteins was initiated by addition of 1 mM guanosine and the 
reaction carried out at 37 °C for 120 min.  (Top right)  Processing of the bI4Δ1168 pre-RNA.  
(Bottom left)  Extent of the splicing reaction with respect to excised bI4 intron formed.  
(Bottom right)  Extent of the splicing reaction with respect to ligated B4-B5 exons formed.  
Symbols are:  (■) LeuRS; (▼) LeuRS + bI4 maturase.  Error bars for each time point result 
from each reaction repeated in triplicate. 
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bI4 intron and the B4-B5 ligated exons, albeit less efficiently as compared to splicing of the 
pre-RNA in presence of both LeuRS and bI4 maturase proteins (Figure VII.5).   
The CP1 domain is defined as a polypeptide insertion that splits the ATP binding 
Rossmann fold (Starzyk, et al., 1987).  However, several X-ray crystal structures show that  
 
 
 
Figure VII.6.  Representative isolated LeuRS CP1domain-dependent in vitro splicing 
reactions analyzed on 6% denaturing poyacrylamide gels.  The excised bI4 intron and ligated 
B4-B5 exon were identified on the gel by comparison with a custom-made RNA marker 
(„M‟).  The pre-RNA, bI4 intron and B4-B5 ligated exon are marked by black, red and blue 
arrows, respectively. 
 
the primary structure of CP1 folds as a discrete domain (Cusack, et al., 2000).  The CP1 
domain is linked to the LeuRS main body via the flexible N and C-terminal β-strands 
(Cusack, et al., 2000).  In ymLeuRS, the isolated CP1 domain (CP1; Figure VII.1) extends 
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from Ile 260 to Glu 431.  Previously, we showed that the β-strands are required for 
deacylation of mischarged tRNA in the E. coli enzyme (Betha, et al., 2007).  Thus, we 
constructed a CP1-containing fragment that included the β-strands, extending from Trp 238 
to Leu 446 (CP1- β; Figure VII.1).  We had also determined that inclusion of short extensions  
 
 
Figure VII.7.  In vitro splicing activity of ymLeuRS. Evaluation of in vitro bI4Δ1168 pre-
RNA splicing with respect to (A) processing of substrate pre-RNA, (B) fraction of bI4 
excised intron and (C) fraction of the ligated   B4-B5 exons.  Splicing reactions incorporated 
1 μM of substrate pre-RNA and 1 μM LeuRS and were initiated with 1 mM guanosine.  
Symbols are:  full-length ymLeuRS (■) and isolated ymCP1-βext (▲).  Error bars for each 
time point result from each reaction repeated in triplicate.   
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Figure VII.8.  Species-specific LeuRS CP1 domain-dependent in vitro splicing of the 
bI4Δ1168 presursor RNA.  The processing of the bI4Δ1168 presursor RNA (pre-RNA) was 
evaluated with respect to (Top) substrate pre-RNA processing, (Center) fraction of excised 
bI4 intron formed and (Bottom) fraction of ligated B4-B5 exons formed.  Calculations were 
based on the intensity of the phosphorimaged bands for the substrate, products bI4 and B4-B5 
as well as other alternate bands that emerged during the reaction.  Splicing reactions 
incorporated 1 μM of pre-RNA and 1 μM LeuRS and were initiated with 1 mM guanosine.  
Symbols are:  ecCP1-βext (▲) and ymCP1-βext (♦).  Error bars for each time point are the 
result of each reaction repeated in triplicate. 
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from the β-strands to the aminoacylation core that contained conserved „WIG‟ and „RDW‟ 
motifs, enhanced tRNA deacylation by the isolated E. coli CP1 domain (Betha, et al., 2007).  
In addition to the β-strands, these extensions have been shown to be important for tRNALeu-
protein interactions in E. coli LeuRS (Mascarenhas and Martinis, 2008; Nawaz, et al., 2007).  
We hypothesized that they might also be important for interacting with the bI4 intron RNA.  
Based on the E. coli LeuRS model (Betha, et al., 2007), we designed a similar fragment for 
the ymLeuRS CP1 domain that includes extensions of the β-strands (CP1-βext; Lys 232 to 
Tyr 452; Figure VII.1) to assess its contributions to RNA splicing. 
We analyzed the LeuRS CP1 domain-dependent splicing activity in vitro using a 
minimized bI4 intron (bI4Δ1168) (Boniecki, et al., 2009) that was comprised primarily of its 
catalytic core.  The isolated ymCP1-βext LeuRS that contained the CP1 domain, the β-strands 
and the extensions, was active in processing the bI4Δ1168 pre-RNA (Figure VII.6, top left; 
Figure VII.7, top) and produced the expected bI4 intron and fused B4-B5 exon products, 
comparable to the full-length wild type ymLeuRS (Figure VII.7).  The extent of the splicing 
reaction based on relative yields of the excised intron bI4 (Figure VII.6, top left; Figure 
VII.7, middle) and the ligated exons B4-B5 (Figure VII.6, top left; Figure VII.7, bottom) 
were comparable. 
LeuRSs from diverse origins can splice (Houman, et al., 2000) and because this 
includes LeuRSs that do not encounter group I introns in their natural environment, we also 
tested the homologous CP1-βext (Val 216 to Ala 430) construct from E. coli LeuRS.  These 
two CP1 domain protein fragments from ymLeuRS and E. coli LeuRS share ~34% homology 
(Herbert, et al., 1988).  The E. coli based ecCP1-βext LeuRS protein fragment, in contrast to 
its counterpart from ymLeuRS, showed significantly reduced processing of the bI4Δ1168 
intron (Figure VII.6, bottom left; Figure VII.8).  Thus, even though it has been suggested that 
LeuRS uses its broadly conserved evolutionarily features to function in RNA splicing 
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(Houman, et al., 2000), the ymLeuRS CP1 domain, as we hypothesized, is more highly 
adapted for RNA splicing.   
Full length E. coli LeuRS supports splicing of bI4 RNA in vivo.   Because the CP1 
domain of E. coli LeuRS failed to support splicing of the bI4 intron in vitro, we wondered if 
the full length E. coli LeuRS could substitute for the yeast enzyme in RNA splicing, similar 
to other LeuRSs that originated from M. tuberculosis or human mitochondria (Houman, et al., 
2000).  We transformed yeast null strains, HM410 and HM402 that have an allelic disruption 
of the nuclear encoded gene for the endogenous ymLeuRS, with the plasmid expressing full 
length E. coli LeuRS fused to an N-terminal mitochondrial import sequence.  The strain 
HM410 contains all thirteen mitochondrial introns and would require both the splicing and 
aminoacylation functions of LeuRS.  In contrast, the intronless strain HM402 would require 
only aminoacylation for growth.  The full length E. coli LeuRS supported growth of both 
HM410 and HM402 on glycerol media, indicating that the enzyme was active in both 
aminoacylation and splicing (Figure VII.9).  The full-length E. coli protein was also active   
 
 
 
Figure VII.9.  In vivo presursor RNA splicing activity of full length E. coli LeuRS.  
Complementation assays were performed using yeast null strains HM410 (with all 13 
mitochondrial introns) and HM402 (intronless) (Li, et al., 1996).  Complementation is 
indicated by darker colonies grown on glucose (Glu) media and by growth on glycerol (Gly) 
media. The arrow indicates that the full length E. coli LeuRS supports growth of HM410 on 
Gly media.  Both stains were transformed with the parent vector pQB153T or with plasmids 
expressing the wild type ymLeuRS (pymLRST) or the wild type E. coli LeuRS (pKIRAN). 
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Figure VII.10.  In vitro splicing activity of E. coli LeuRS. The processing of the bI4Δ1168 
presursor RNA (pre-RNA) was evaluated with respect to (Top) substrate pre-RNA 
processing, (Center) fraction of excised bI4 intron formed and (Bottom) fraction of ligated 
B4-B5 exons formed.    Splicing reactions incorporated 1 μM of substrate pre-RNA and 1 μM 
LeuRS and were initiated with 1 mM guanosine.  Symbols are:  full-length E. coli LeuRS (■) 
and isolated ecCP1-βext (▲).  Error bars for each time point result from each reaction 
repeated in triplicate.  
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when incorporated in the in vitro splicing assay (Figure VII.10).  Because the isolated E. coli 
LeuRS CP1 domain failed to support splicing in vitro, we hypothesize that the ymLeuRS 
contains evolutionary adaptations that are specific to the CP1 domain.  This would allow its 
CP1 domain to be more robust in splicing in the absence of the full-length protein, compared 
to the E. coli CP1 domain. 
Functional divergence of the LeuRS CP1 domain to accommodate RNA splicing and 
protein synthesis in yeast mitochondria.  The CP1 domains from isoleucyl-tRNA synthetase  
 
 
 
Figure VII.11.  Deacylation activity of the ymLeuRS CP1 domain.  Deacylation reactions 
included approximately 2 μM [3H]-Ile-tRNALeu and 1 μM enzyme.  Symbols are: wild type 
(▲), ymCP1-β (o), ymCP1-βext (♦) and no enzyme (■).  Error bars for each time point are 
the result of each reaction repeated in triplicate. 
 
 
(IleRS), valyl-tRNA synthetase (ValRS) and E. coli LeuRS that are independent from the rest 
of the enzyme, effectively clear misacylated tRNAs (Betha, et al., 2007; Lin, et al., 1996).  
The β-strands of the E. coli LeuRS CP1 domain are required for hydrolytic editing activity 
(Betha, et al., 2007).  As highlighted above, short extensions of the β-strands into the main 
body significantly enhance the hydrolytic activity of the E. coli CP1 domain. They are 
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hypothesized to bind and position the 3’ end tRNALeu for editing (Betha, et al., 2007).  We 
tested whether the β-strands and extensions of the ymLeuRS CP1 domain were similarly 
important to deacylation activity.  In contrast to the E. coli LeuRS CP1 domain, inclusion of 
the β-strands in the ymCP1-β LeuRS failed to confer deacylation activity to the CP1 domain 
(Figure VII.11), although both isolated protein fragments fold with overlapping significant α-
helical character, as the wild type enzyme (Figure VII.12).  The kobs for deacylation by the 
ymCP1-β LeuRS was 0.3 ± 0.07 min-1 compared to 1.0 ± 0.11 min-1 for the full-length wild 
type ymLeuRS (Table VII.2).    
Addition of the extensions in ymCP1-βext LeuRS only hydrolyzed misacylated Ile-
tRNA
Leu
 at low levels (kobs = 0.3 ± 0.1 min
-1
 for 1 μM enzyme) (Table VII.2) compared to the 
full-length ymLeuRS, albeit the extension additions increase the extent of the reaction 
(Figure VII.11).  Increasing enzyme concentrations up to 5 μM did not show any significant 
increase in the observed rate constants for deacylation (Table VII.2). 
 
 
Figure VII.12.  CD spectra of isolated ymCP1 constructs.  The red squares represent the 
protein fragment ymCP1-β and the blue diamonds represent the protein fragment ymCP1-
βext. 
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  Table VII.2.  Observed rate constants (kobs) for deacylation of Ile-tRNA
Leu 
by full-length or  
                        isolated LeuRS CP1 protein constructs. 
Enzyme No enzyme 
Full-length  
wild type 
ymLeuRS* 
ymCP1-β* ymCP1-βext 
      1 µM            2 µM           5µM 
kobs 
(min
-1
) 
0.36 ± 0.17 1.0 ± 0.11  0.3 ± 0.07 0.3 ± 0.1    0.33 ± 0.16   0.37 ± 0.2 
  *Reported kobs were measured using 1 µM enzyme.  In addition, substrate preparations 
   contain uncharged tRNA, as well as mischarged tRNA. 
 
 
We hypothesize that the ymLeuRS has functionally diverged at the CP1 domain to 
facilitate RNA splicing.  This may have occurred at a cost to the enzyme‟s CP1-based editing  
activity, since the full length ymLeuRS clears misacylated tRNA
Leu
 via its CP1 domain 
(Karkhanis, et al., 2006)  (Figure VII.11).  Interestingly, editing defects in yeast had minimal 
effects on cell viability and mitochondrial function, although they are lethal to E. coli 
(Karkhanis, et al., 2006).  It is possible that the cell as well as the mitochondrial LeuRS have 
adapted to accommodate both translational fidelity requirements and RNA splicing which is 
essential to mitochondrial function.  Although the β-strands failed to enable amino acid 
editing by the isolated CP1 domain from ymLeuRS, we wondered if they would be sufficient 
in stimulating RNA splicing in vitro.  As shown in Figure VII.7., the ymCP1-βext LeuRS 
fragment, which includes the β-strands as well its extensions, is active in processing the 
bI4Δ1168 pre-RNA in vitro, comparable to the full-length wild type ymLeuRS.  To 
determine if the β-strands alone can render the ymCP1 domain active in RNA splicing, we 
tested the ymCP1-β LeuRS protein fragment that includes only the β-strands, but not the 
extensions (Figure VII.1).  It exhibited significantly reduced processing of the bI4Δ1168 pre-
RNA as compared to the ymCP1-βext LeuRS fragment that includes both the β-strands and 
the extensions (Figure VII.13).  The observed rate of formation of both the spliced bI4 intron 
(46 x 10
-3
 min
-1
) and the ligated exons B4-B5 (26 x 10
-3
 min
-1
) in presence of ymCP1-β were 
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2 to 3 fold decreased as compared to product formation in presence of ymCP1-βext (Table 
VII.3). 
 
Figure VII.13.  LeuRS CP1 domain extension-dependent splicing activity.  In vitro bI4Δ1168 
pre-RNA splicing was determined with respect to (Top) processing of the substrate pre-RNA, 
(Center)  fraction of the excised bI4 intron formed and (Bottom)  fraction of the ligated B4-
B5 exons formed.  Splicing reactions incorporated 1 μM of pre-RNA and 1 μM LeuRS and 
were initiated with 1 mM guanosine.  Symbols are:  ymCP1-β (■) and ymCP1-βext (♦).  
Error bars for each time point are the result of each reaction repeated in triplicate. 
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  Table VII.3.  Observed rates (kobs) for splicing of bI4Δ1168 pre-RNA 
 
 
 It is noteworthy that the ymCP1-β LeuRS protein fragment contains the conserved 
„WIG‟ and „RDW‟ motifs at the end of the N and C-terminal β-strands respectively (Figure 
VII.1).  Thus, although these motifs provide critical interactions with the tRNA (Nawaz, et 
al., 2007), they are not sufficient to confer optimal splicing activity to the ymLeuRS CP1 
domain, isolated from the rest of the enzyme.  Thus, we hypothesize that short extensions of 
the β-strands into the enzyme catalytic core domain are essential, not only to confer 
hydrolytic editing activity but also to confer RNA splicing activity to the isolated CP1 
domain of LeuRS.  
‘WIG’ peptide extension of ymLeuRS is adapted for RNA splicing.  Genetic rescue 
experiments originally implicated Gly 240 as a critical factor in LeuRS‟s splicing activity (Li, 
et al., 1996).  This site is located in a peptide that contains a conserved „WIG‟ motif (Figure 
VII.14) (Hou, et al., 1991) in the extension of the N-terminal β-strand (Figure VII.1) that 
links the CP1 domain of LeuRS to its aminoacylation core.  Mutation of Gly 240 to serine 
suppresses splicing defects when the bI4 maturase is inactivated (Herbert, et al., 1988; 
Labouesse, 1990).  Mutation of the Trp 238 to cysteine in the „WIG‟ motif abolishes splicing, 
but retains aminoacylation activity in the ymLeuRS (Li, et al., 1996). 
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Figure VII.14.  Primary sequence alignment of the „WIG‟ peptide in LeuRS.  Abbreviations 
are:  Escherichia coli (Ec), Mycobacterium tuberculosis (Mt), Helicobacter pylori (Hp), 
Saccharomyces cerevisiae mitochondrial (Scm), Candida albicans mitochondrial (Cam), 
Neurospora crassa mitochondrial (Ncm), Homo sapiens mitochondrial (Hsm), Thermus 
thermophilus (Tt).  
 
 
To distinguish the effects of Trp 238 on splicing and aminoacylation functions of 
LeuRS, we transformed wild type (HM410) and intronless (HM402) yeast strains with 
plasmids encoding the full length wild type, W238A, W238C, W238F and W238Y 
ymLeuRSs fused to an N-terminal mitochondrial import sequence.  As expected, the full-
length wild type and all the mutant ymLeuRS complemented growth of the intronless strain 
HM402 on glycerol media (Figure VII.15, top left), supporting that they are all active in 
aminoacylation.  The full-length mutant W238F and W238Y ymLeuRSs also complemented 
the intron containing HM410 strain (Figure VII.15, top left).  However, the full-length 
W238A and W238C ymLeuRS mutants failed to support growth of the wild type strain 
HM410 on glycerol media (Figure VII.15, top left, indicated by arrows).  Analysis of cell 
extracts from HM410 expressing full length wild type or W238A or W238C ymLeuRSs, via 
RT-PCR (Figure VII.15, top right) and Northern blot (Figure VII.15, bottom left), failed to 
detect the B4-B5 spliced product.  As would be expected from the complementation assays, 
the full-length W238A and W238C mutants retained aminoacylation activity in vitro, albeit at  
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Figure VII.15.  Analysis of ymLeuRS Trp238 mutants in vivo splicing activity.  (Top left)  
Complementation assays used yeast null strains HM410 and HM402 and is indicated by 
darker colonies grown on glucose (Glu) media and by growth on glycerol (Gly) media. The 
arrows indicate that the W238A and W238C mutant ym LRSs can support growth of HM402, 
but not of HM410 on Gly media.  Both strains were transformed with the parent vector 
pQB153T or with plasmids expressing the wild type (pymLRST) or W238A (pMPW238A), 
W238C (pMPW238C), W238F (pMPW238F) and W238Y (pMPW238Y) mutant ymLeuRSs.  
(Top right)  RNA amplification via RT-PCR of total cellular RNA from yeast null strain 
HM410 expressing wild type and W238 mutant ymLRSs was carried out.  A 250 base pair 
(bp) amplified product on a 1% agarose gel indicates the B4-B5 ligated exon product.  
(Bottom left)  Northern blot of 100 μg of total cellular RNA isolated from HM410 yeast cells 
expressing wild type and W238 mutant ym LRSs.  Hybridization was carried out with a [
32
P]-
labeled B4-B5 exon junction probe.  Presence of the band indicates B4-B5 spliced product.  
(Bottom right)  In vitro aminoacylation by the full-length wild type or Trp238 mutant 
ymLeuRSs.  Aminoacylation reactions included 4 μM transcribed ymtRNA, 1 μM enzyme 
and 21 μM [3H]-leucine (150 μCi/ml) and were initiated with 4 mM ATP.  Symbols are: wild 
type (■), W238A (▼), W238C (Δ), and W238F (Ο).  Error bars for each time point result 
from each reaction repeated in triplicate. 
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significantly lower levels than the wild type enzyme (Figure VII.15, bottom right).  Thus, even 
these reduced levels of aminoacylation still meet an in vivo threshold that is necessary to support cell 
viability.  It is also possible that the availability of appropriately modified native tRNA in the 
mitochondria elevates aminoacylation activity in vivo to an acceptable threshold levels.   
Since the W238C ymLeuRS mutant failed to support mitochondrial splicing in vivo, 
we wondered if it would also compromise splicing in the isolated CP1 domain.  We 
introduced the W238C mutation into ymCP1-βext LeuRS and tested its effect in our in vitro 
splicing assay.  The W238C mutation significantly impeded processing of the bI4Δ1168 pre-
RNA (Figure VII.16, top) and extent of formation of the products, bI4 (Figure VII.16, center) 
and B4-B5 (Figure VII.16, bottom), in vitro.  Thus, the W238C mutation which abolished 
RNA splicing in the full length ymLeuRS, in vivo, is also critical to the isolated ymCP1 
splicing domain.  These combined results show that the Trp238 site in the splicing sensitive 
„WIG‟ peptide requires a bulky aromatic residue for optimal interaction with the bI4 intron 
RNA.  We hypothesize that the β-strand extension functionally diverged in ymLeuRS to 
adapt to its secondary alternate role in role in splicing, while maintaining essential 
aminoacylation activity at sufficient levels for allowing cell viability.  
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Figure VII.16.  The Trp 238 mutation in the „WIG‟ peptide abolishes splicing but maintains 
sufficient aminoacylation activity. Evaluation of in vitro bI4Δ1168 pre-RNA splicing with 
respect to (Top) processing of substrate pre-RNA, (Center)  fraction of bI4 excised intron and 
(Bottom)  fraction of the ligated   B4-B5 exons.  Splicing reactions incorporated 1 μM of 
substrate pre-RNA and 1 μM LeuRS and were initiated with 1 mM guanosine.  Symbols are:  
WT ymCP1-βext (▲) and W238C ymCP1-βext (●).  Error bars for each time point result 
from each reaction repeated in triplicate.   
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VII.4.  Discussion 
 
The bifunctional LeuRS is not only required for protein synthesis, but also as an 
auxiliary protein factor in the excision of two related bI4 and aI4α group I introns for the 
expression of the mitochondrial cob and cox1α genes.  The nuclear encoded LeuRS and the 
intron encoded bI4 maturase work in concert in a ternary complex formed on the bI4 intron.  
A direct role of LeuRS in splicing of these two introns has been established, whereby LeuRS 
can independently bind to the bI4 intron and promote splicing (Rho and Martinis, 2000).  
Three different regions of the ymLeuRS have been reported to be important in the protein‟s 
RNA splicing activity: the CP1 amino acid editing domain (Rho, et al., 2002), the conserved 
„WIG‟ signature sequence (Figure VII.1) (Li, et al., 1996) and the C-terminal domain (Hsu, et 
al., 2006; Li, et al., 1996)  The yeast mitochondrial CP1 domain, isolated from the rest of the 
enzyme, has been shown to independently stimulate group I intron splicing in vivo (Rho, et 
al., 2002).  We utilized the isolated CP1 domain from ymLeuRS with different lengths of its 
flanking β-strands to probe the adaptations of the protein that facilitate aminoacylation and 
RNA splicing.  
The isolated ymCP1-βext LeuRS processed a minimized bI4 intron in vitro, unlike its 
counterpart from the E. coli enzyme.  Interestingly however, the full-length E. coli LeuRS 
rescued bI4 intron splicing activity in vivo, similar to LeuRSs from other origins such as M. 
tuberculosis and human mitochondria (Houman, et al., 2000).  Thus, although RNA splicing 
activity was proposed to be based on LeuRS‟s broadly conserved evolutionary features, the 
CP1 domain of the splicing ymLeuRS appears to be adapted to facilitate RNA processing 
compared to its non-splicing counterpart from E. coli LeuRS. 
To accommodate its RNA splicing activity, our results suggested that the ymLeuRS 
CP1 domain had functional diverged. In vitro, the isolated ymCP1-β LeuRS failed to 
hydrolyze misacylated Ile-tRNA
Leu.  Inclusion of the short β-extensions in the isolated 
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ymCP1-βext LeuRS enabled deacylation activity, but at significantly lower levels as 
compared to the editing active full-length protein.  This contrasts with the homologous 
isolated CP1 construct from E. coli LeuRS (Betha, et al., 2007), where, inclusion of the β-
strand extensions retained deacylation activity that was comparable to the full-length enzyme 
(Betha, et al., 2007).  Previously, we showed that the robust and viable post-transfer editing activity 
of full-length ymLeuRS appears to be dispensable to cell viability (Karkhanis, et al., 2006).  It is 
possible that yeast mitochondria have evolved to tolerate increased infidelity during translation.  
Alternatively, they may possess distinct alternate mechanisms to suppress mistakes, such as precisely 
controlling mitochondrial amino acid concentrations or increased discrimination between cognate and 
noncognate amino acids.  Interestingly and unlike TyrRS (CYT18) (Cherniack, et al., 1990; 
Paukstelis, et al., 2008) LeuRS has not acquired an idiosyncratic domain or peptide insert that 
is dedicated to RNA splicing.  Thus, we hypothesize that evolutionary pressures on ymLeuRS 
CP1 domain for dual functions in the cell compromised it amino acid editing to facilitate its 
secondary, but essential role of RNA splicing.   
The β-strands and its extensions provide critical contacts between the discretely 
folded CP1 domain and the LeuRS main body (Cusack, et al., 2000).  They also provide 
flexibility to the CP1 domain to facilitate transitions of the enzyme between the different 
stages of the aminoacylation reaction (Fukunaga and Yokoyama, 2005a; Tukalo, et al., 2005).  
In our investigation of the structure-function relationships that are responsible for LeuRS 
CP1-based adaptations for RNA splicing, we determined that the β-strand extensions of the 
CP1 domain significantly enhance in vitro RNA processing activity.  Because inclusion of 
these short extensions had opposite effects on deacylation and RNA splicing in the ymCP1-
βext LeuRS, we hypothesize that this region of LeuRS is differentially adapted to favor RNA 
splicing in ymLeuRS and in contrast, deacylation in the non-splicing E. coli LeuRS.  Further 
mutational analysis in the aminoacylation-critical conserved „WIG‟ peptide at the end of the 
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N-terminal β-strand, demonstrated that a bulky aromatic residue is a requirement at this site 
to maintain RNA splicing activity of the ymLeuRS CP1 domain.  
Significantly, the mitochondrial and bacterial LeuRS conserved „WIG‟ peptide was not 
sufficient to confer optimal splicing to the isolated ymCP1 domain and required the extensions of the 
β-strands into the canonical core to generate a splicing-active construct (ymCP1-βext).  In the E. coli 
enzyme, these extensions contain flexible hinge motifs that have critical interactions with the tRNA 
during post-transfer editing (Tukalo, et al., 2005) and are essential to confer deacylation activity to the 
isolated CP1 domain (Betha, et al., 2007).  In lieu of a splicing-specific peptide or domain in LeuRS, 
it is possible that the „WIG‟ peptide and/or hinge regions intimately contact the intron RNA in the 
context of the isolated CP1 domain and full-length ymLeuRS. Direct or indirect interactions may 
facilitate RNA folding into a catalytically competent form. Because inclusion of these short 
extensions had only small effects on deacylation by ymCP1-βext LeuRS, yet significantly enhanced 
its RNA splicing activity, we hypothesize that this region of LeuRS is differentially adapted to favor 
RNA splicing in ymLeuRS.  Significantly, this contrasts with our results with the non-splicing 
adapted E. coli LeuRS, which relied on these extensions for tRNA deacylation.   
Previously, we had shown that the leucine-specific C-terminal domain (CTD) 
differentially adapted to accommodate RNA splicing and tRNA
Leu
 aminoacylation (Hsu, et 
al., 2006).  While in the non-splicing LeuRSs, deletion of the CTD abolishes aminoacylation, 
in the splicing ymLeuRS, the deletion enhances aminoacylation, but results in a splicing-
inactive ternary complex of CTD-deletion mutant LeuRS : maturase : bI4 intron (Hsu, et al., 
2006).  Together, these results suggest that common regions of the protein, such as the β-
strands, its extensions, the conserved „WIG‟ peptide and the C-terminal domain are critical to 
interactions with both tRNA
Leu
 and the bI4 intron and these have been the points where 
splicing LeuRSs have undergone differential adaptations. 
The only other splicing-active AARS, TyrRS, uses newly acquired intron RNA-
binding insertions to recognize highly conserved secondary and tertiary structural features of 
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group I introns.  These insertions are distinct from the regions of the protein that bind 
tRNA
Tyr 
(Paukstelis, et al., 2008).  In contrast, LeuRS has not acquired any splicing-specific 
domain or peptide insertion.  Key sites for editing remain intact.  This LeuRS splicing factor relies on 
canonical features such as the CP1-domain-based „WIG‟ peptide and the β-strand extensions, which 
are evolutionarily conserved among bacteria and mitochondrial LeuRSs (Figure VII.14).  It is 
possible that within the pre-existing domains of LeuRS, splicing-sensitive molecular 
determinants are distinct from the ones that the protein uses for tRNA
Leu
-binding.  
Interestingly also, while TyrRS is required for the splicing of a number of unrelated group I 
introns (Akins and Lambowitz, 1987; Cherniack, et al., 1990; Majumder, et al., 1989).  
LeuRS is required for the splicing of only two closely related yeast mitochondrial group I 
introns.  Hence, it is possible that LeuRS recognizes idiosyncratic features of the bI4 and aI4α 
introns in addition to general structurally conserved features of the intron RNA substrate, 
facilitating formation of a catalytically-active RNA structure.  Thus, to accommodate dual 
essential functions in aminoacylation and splicing, we propose that the ymLeuRS 
functionally diverged within the confines of the CP1 domain and other regions, including the 
C-terminal domain and the consensus „WIG‟ motif.  
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Chapter VIII:  Conclusion 
Maintenenace of fidelity during protein synthesis involves the combined effort of 
several players, such as the AARSs (Mascarenhas, 2008) , EF-Tu (LaRiviere, et al., 2001) 
and the ribosome (Ogle, et al., 2002; Zaher and Green, 2009).  Among these, the AARSs 
serve as the first and primary checkpoint.  This ancient family of enzymes has remained 
conserved evolutionarily across species to perform the housekeeping functions of 
aminoacylating cognate tRNA (Ibba and Sӧll, 2000) and then when necessary, proofreading 
in order to ensure the production of correctly charged tRNAs (Mascarenhas, 2008).  Although 
all AARSs essentially catalyze the aminoacylation reaction via overlapping 2-step reaction 
mechanisms, they are classified into class I and II enzymes, based on active site architectural 
and sequence differences (Arnez and Moras, 1997).  Interestingly, several of the AARSs have 
also evolved to acquire secondary essential functions in the cell (Martinis, et al., 1999), such 
as the involvement of LeuRS and TyrRS in mitochondrial RNA splicing.   
About half of the synthetases have evolved editing mechanisms that include both pre- 
(Baldwin and Berg, 1966; Fersht, 1977b) and post-transfer (Eldred and Schimmel, 1972; 
Fersht and Kaethner, 1976) editing.  Interestingly, in LeuRSs across different species, distinct 
sets of molecular determinants drive the balance between pre- and post-transfer editing 
pathways (Martinis and Boniecki, 2010).  My thesis research addressed key questions on the 
editing mechanisms and this balance between coexisting editing pathways in the ycLeuRS 
and also in the E. coli enzyme.  In addition, I also studied the alternate but essential cellular 
role of the ymLeuRS in protein-assisted splicing of group I introns.  Crystal structures 
(Cusack, et al., 2000) show that LeuRS possesses an exclusive domain, called the leucine-
specific domain (LSD) that is critical in aminoacylation (Vu and Martinis, 2007).  Utilizing a 
chimeric H. pylori LeuRS that contained the E. coli LSD, I also examined the interactions 
between this specific domain and tRNA
Leu
 during aminoacylation.     
  
169 
 
LeuRSs contain a highly conserved threonine-rich editing pocket in the CP1 domain. 
Residues within this pocket serve as critical specificity determinants during the post-transfer 
editing reaction (Lincecum, et al., 2003; Mursinna, et al., 2001; Pang and Martinis, 2009; 
Zhai and Martinis, 2005).   Mutations at specific sites within the conserved editing pocket 
give rise to editing-defective LeuRS mutants that lead to formation and accumulation of 
mischarged tRNA
Leu
 and hence mistranslation.  Accumulation of misfolded proteins have 
resulted in neurodegeneration in mouse (Lee, et al., 2006).  Hence, in order to gain a better 
understanding of the intracellular effects of the editing defects in LeuRS, I devised a 
fluorescence-based in vivo assay that relies on split-GFP reassembly.  The N- and C-terminal 
halves of GFP, each fused to a leucine zipper reassemble when expressed in trans in bacteria 
(Ghosh, 2000; Magliery, et al., 2005).  The assay was designed such that proteins 
incorporated noncognate amino acids when the cells were grown on solid growth medium on 
Petri plates.  The fluorescence of refolded GFP fragments was monitored in the presence of 
overexpressed LeuRS, either the wild type or an editing-defective mutant.  In the case of the 
editing-defective LeuRS, mistranslation would lead to statistical substitutions of leucines 
within the leucine zippers by the noncognate amino acid that is incorporated in the growth 
medium.  Since three of the four leucine positions absolutely require a leucine for 
dimerization of the zippers (Hu, et al., 1990), these statistical substitutions disrupt 
dimerization and hence, reassembly of the GFP fragments.  This effect is manifested in 
decreased observable fluorescence.   
Similar halo assays that rely on a zone of cell death around central wells filled with 
excess noncognate amino acids on solid growth media, have been previously used to study 
editing defects in LeuRS (Hellmann and Martinis, 2009; Karkhanis, et al., 2006; Rock, et al., 
2007; Sarkar, et al., 2011).  Importantly, these assays relied on an „all or none‟ effect of 
LeuRS editing defects on cell viability.  However, the GFP fluorescence-based halo assay 
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provides a more sophisticated and sensitive handle on studying a varied range of editing 
defective LeuRS mutants by allowing us to quantify the extent of mistranslation via 
fluorescence intensity changes.  Furthermore, mass spectrometric analysis of the 
mistranslated leucine zipper peptides would furnish information about the products formed 
during such mistranslation.  Thus the GFP fluorescence-based halo assay provides a valuable 
tool to quantitatively inspect the extent of editing defects for the different molecular 
determinants that are known to impact editing in LeuRS.   
Drug design targeting the synthetases has exploited both the aminoacylation and the 
editing active sites of the enzymes.  A novel class of benzoxaborole-based antifungals halts 
protein synthesis by targetting ycLeuRS.  These new drugs are in clinical trials for the 
treatment of onychomycosis, a fungal disease of the toenail (Rock, et al., 2007).  The 
conserved editing pocket of LeuRS also happens to be the drug-binding site for these 
antimicrobials.  Our collaborators identified drug-resistant mutants within (Rock, et al., 2007) 
and outside (Sarkar, et al., 2011) the drug-binding/editing pocket.  This provided us with the 
unique opportunity to dissect the role of elements outside the conserved core of the CP1 
domain, in maintaining a functional editing activity in this enzyme.   
My project focused on one such resistant site in the ycLeuRS, Asp 487 that lies 
outside the conserved editing/drug-binding pocket in a peptide insert, called I4 that is specific 
to fungal and archaeal LeuRSs, but absent in the bacterial enzymes.  Biochemical 
experiments determined that drug-resistant mutants at this site (D487G and D487N) are also 
defective in hydrolyzing mischarged tRNA
Leu
.  In addition, while mutations at Asp 487 to 
positively charged arginine and lysine render the enzyme defunct in post-transfer editing, a 
homologous substitution by a glutamic acid rescues editing activity. Based on available 
crystal structures (Seiradake, et al., 2009) and our biochemical data, we identified a plausible 
salt-bridge interaction between Asp 487 and an arginine residue (Arg 316) within the editing 
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pocket.  Double mutants that included charge swapping between these two positions rescued 
editing activity for only the D487K/R316D mutant ycLeuRS, suggesting that the longer side 
chains of an arginine or glutamic acid at either of these positions may juxtapose them in an 
orientation unsuitable for an effective salt-bridge interaction.  From these results, I 
hypothesized that ycLeuRS relies on Asp 487 to form an electrostatic interaction with the 
arginine residue within the editing pocket, when the flexible I4 insert closes over the 
substrate-bound editing pocket in a cap-like fashion (Sarkar, et al., 2011).   
Importantly, because the I4 insert is absent in the bacterial LeuRSs, this finding 
highlights a unique molecular determinant exclusively used by the fungal LeuRS and not by 
the bacterial enzyme.  It also stresses the importance of evolutionarily acquired eukaryotic 
CP1 domain-based peptide insertions in finer mechanistic adaptations such as substrate 
stabilization within the CP1 domain editing pocket.  Reliance of ycLeuRS on an idiosyncratic 
substrate stabilizing mechanism and plasticity within the editing/drug-binding pocket also 
presents exciting opportunities for designing more efficacious drugs that specifically target 
the pathogen editing pocket, while excluding the human counterpart.  
Early reports suggested that while the E. coli LeuRS clears mistakes via the post-
transfer editing pathway, ycLeuRS edits by the pre-transfer route.  However, work in our‟s 
and other labs have shown that three distinct sets of mutations in the E. coli LeuRS, including 
one that completely deletes the CP1 editing domain, unmask an inherent pre-transfer editing 
activity in the enzyme (Boniecki, et al., 2008; Chen, et al., 2001; Williams and Martinis, 
2006).  On the other hand, the ycLeuRS effectively hydrolyzes mischarged tRNA
Leu
 
(Lincecum, et al., 2003).  These findings raise questions about the redundancy of multiple 
coexisting editing pathways in the same enzyme.  Which pathway, if any, predominates and 
what cellular cues or molecular determinants within these enzymes control the balance 
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between these editing pathways are important questions that need to be addressed in an 
enzyme and species-specific manner.   
In a second project on the ycLeuRS editing pathways, I determined that the identity of 
the noncognate amino acid can dictate the shift between co-existing pre- and post-transfer 
editing pathways (Sarkar and Martinis, 2011).  While, the ycleuRS misactivates both the 
noncognate isoleucine and methionine, the enzyme effectively clears tRNA
Leu
 mischarged 
with isoleucine, but its post-transfer editing activity against tRNA
Leu
 mischarged with 
methionine was significantly impaired in vitro.  However, no significant accumulation of 
Met-tRNA
Leu
 was detected in vitro.  Instead, we observed robust enzyme-catalyzed pre-
transfer editing activity against the methionyl-adenylate, in the absence of tRNA.  The 
presence of cognate tRNA
Leu
 increased the overall editing activity of ycLeuRS against 
methionine, but not against isoleucine.   
Similar to the E. coli enzyme, the ycLeuRS also possesses functional pre- and post-
transfer editing and we hypothesize that these multiple pathways are not redundant but 
provide multiple checkpoints to the cell to maintain fidelity against the chemically distinct 
noncognate amino acids that the enzyme misactivates.  However, the location and the precise 
molecular determinants of pre-transfer editing in ycLeuRS remain unclear.  Nonetheless, this 
finding reflects the immense diversity of editing activities in the ancient AARSs, acquired 
throughout a long evolutionary period.  It is critical to decipher the cellular cues that regulate 
the balance between the multiple pathways, since that will provide us high resolution insights 
into the natural pressures of AARS evolution. 
The ymLeuRS is one of the two AARSs known to assist group I intron splicing in 
vivo (Labouesse, 1990).  The other splicing AARS is TyrRS (Akins and Lambowitz, 1987).  
Our lab has shown that the two proteins required for splicing group I introns, the nuclear-
encoded ymLeuRS and the intron-encoded bI4 maturase, can independently bind to the group 
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I intron and stimulate splicing (Rho and Martinis, 2000).  Several splicing-sensitive sites have 
been implicated in the ymLeuRS, including the CP1 domain (Rho, et al., 2002) and the C-
terminal domain  (Hsu, et al., 2006).   
A part of my thesis research efforts was dedicated towards identifying and 
understanding the adaptations that the ymLeuRS has undergone in and around the CP1 
domain to accommodate its dual roles of splicing and aminoacylation (Sarkar, et al., 2012).  
Previous work from our lab had shown that the isolated CP1 doamin stimulated RNA splicing 
in vivo (Rho, et al., 2002).   
In my project, I determined that the connecting β-strands and its extensions into the 
LeuRS main body are absolutely essential to confer splicing activity to the isolated ymCP1 
domain, possibly because these long extensions enable the intron RNA to fold or conform 
into a competent splicing-active structure.  However, these linkers and the extensions failed 
to confer splicing activity to the homologous isolated E. coli CP1 domain, although the full-
length E. coli enzyme rescued splicing activity, similar to other nonsplicing LeuRSs 
(Houman, et al., 2000).  This suggested that although LeuRS uses its evolutionarily 
conserved features for splicing, the ymCP1 domain is specifically adapted to accommodate 
the secondary role.   
Significantly however, the isolated ymCP1 domain was inactive in hydrolyzing 
mischarged tRNA
Leu
, unlike its E. coli counterpart.  The inclusion of the β-strands and its 
extensions only weakly stimulated the hydrolytic editing activity.  We hypothesized that, in 
order to accommodate splicing, the ymCP1 has functionally diverged within the CP1 domain 
and the connecting β-strands and extensions, at some expense to the enzyme‟s hydrolytic 
editing activity.   
We further scrutinized the conserved „WIG‟ peptide at the N-terminal β strand, and 
determined that mutation of the tryptophan to a cysteine generated a splicing-inactive mutant 
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ymLeuRS (Li, et al., 1996) that maintained threshold levels of aminoacylation sufficient to 
support cell viability.  I hypothesized that the „WIG‟ peptide is critical to the ymLeuRS‟s 
splicing activity because it has important interactions with the intron RNA and also correlates 
with the β-strand enabled movements of the CP1 domain with respect to the main body.  
Thus, the „WIG‟ peptide which has important interactions with the tRNA in nonsplicing 
LeuRSs, continues to be important in splicing.  Interestingly however, in the splicing 
ymLeuRS, this peptide appears to be more critical to splicing than aminoacylation, unlike the 
nonsplicing LeuRSs where mutations within the „WIG‟ peptide abolish aminoacylation.  
Thus, these results show that the ymLeuRS, which has not acquired any apparent splicing-
specific insertion, relies upon its canonical features for its splicing activity and has undergone 
adaptations within the CP1 domain, the connecting β-strands and extensions and the 
conserved „WIG‟ peptide to accommodate RNA splicing, while maintaining functional levels 
of aminoacylation. 
Finally, I have worked on LeuRS-tRNA
Leu
 interactions via the LSD.  Evolutionarily, 
the LSD was inserted in some bacterial LeuRSs just prior to the catalytically critical 
„KMSKS‟ loop (Cusack, et al., 2000).  Deletion of the LSD abolishes aminoacylation (Vu 
and Martinis, 2007).  In this project I addressed the question as to what advantanges the LSD 
provides to those LeuRSs that acquired the domain as opposed to those which did not.  The 
H. pylori LeuRS was selected as a model since this bacterial enzyme completely lacks the 
LSD.  A chimeric H. pylori LeuRS was constructed that contained the LS domain from the E. 
coli enzyme.  Biochemical analysis showed that insertion of the LSD provided a significant 
advantage to the chimeric H. pylori LeuRS in aminoacylating the non-native E. coli tRNA
Leu
.  
Aminoacylation kinetic analysis and tRNA
Leu
 binding to the chimeric enzyme showed that 
enhanced aminoacylation was primarily due to an increased affinity of the E. coli tRNA
Leu
 to 
the enzyme.  I hypothesized that insertion of the LSD may directly have stabilizing 
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interactions with the 3´-end of the tRNA or may indirectly impact the mobility of the 
neighboring „KMKS‟ loop that is critical to ATP-binding and amino acid activation. 
In summary, my PhD thesis research focused on LeuRS-based translational fidelity, 
drug-resistance and a novel RNA splicing reaction.  In addition, critical enzyme-tRNA 
interactions during the aminoacylation reaction were also investigated in LeuRS.  I have 
dissected the editing activities of LeuRS, in terms of substrate-binding mechanism, shifting 
balance between diverse editing pathways, and assay development to study the intracellular 
impact of specific editing defects.  These studies provide valuable molecular level insights 
into the conservation, diversity and adaptations within the editing active site of LeuRS.  My 
studies on LeuRS-assisted RNA splicing significantly enhance our understanding of the 
overlaps and the diversities that LeuRS acquired to accommodate its dual roles of RNA 
splicing and aminoacylation.  
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Appendix.  Plasmid Constructs 
 
Alias Plasmid name Parent vector Description 
pJSyc1 pJSycD487G pHAPPY-1-1-0-1 Asp487 mutated to Gly 
pJSyc2 pJSycD487N pHAPPY-1-1-0-1 Asp487 mutated to Asn 
pJSyc3 pJSycD487A pHAPPY-1-1-0-1 Asp487 mutated to Ala 
pJSyc4 pJSycD487K pHAPPY-1-1-0-1 Asp487 mutated to Lys 
pJSyc5 pJSycD487R pHAPPY-1-1-0-1 Asp487 mutated to Arg 
pJSyc6 pJSycD487E pHAPPY-1-1-0-1 Asp487 mutated to Glu 
pJSyc7 pJSycD487G/T319A pJSycD487G Asp487 mutated to Gly; 
Thr319 mutated to Ala 
pJSyc8 pJSycD487N/T319A pJSycD487N Asp487 mutated to Asn; 
Thr319 mutated to Ala 
pJSyc9 pJSycD487A/T319A pJSycD487A Asp487 mutated to Ala; 
Thr319 mutated to Ala 
pJSyc10 pJSycD487K/R316D pJSycD487K Asp487 mutated to Lys; 
Arg316 mutated to Asp 
pJSyc11 pJSycD487K/R316E pJSycD487K Asp487 mutated to Lys; 
Arg316 mutated to Glu 
pJSyc12 pJSycD487R/R316D pJSycD487R Asp487 mutated to Arg; 
Arg316 mutated to Asp 
pJSyc13 pJSycD487R/R316E pJSycD487R Asp487 mutated to Arg; 
Arg316 mutated to Glu 
pJSyc14 pJS-pTrc-(EcoRI)-yctRNA
Leu
CAA-
(BamHI)   
pTrc Wild type yc tRNA
Leu
 CAA 
cloned in pTrc vector 
between EcoRI and BamH1 
pJSGFP15 pJS-Duet1-NZGFP(MCS1) pETDuet-1 (His)6-NZGFP cloned in 
MCS1 of pDuet1 vector 
between BamHI and EcoRI 
pJSGFP16 pJS-Duet1-NZGFPexact(MCS1) pETDuet-1 Specific amino acid deletions 
(Ref. Chapter V, Section 
V.2.A, p102) in NZGFP 
fragment within pDuet1 
vector to mimic the same 
fragment in pET11a vector 
(Regan Lab, Yale) 
pJSGFP17 pJS-Duet1-NZGFPexact(MCS1)-
modified 
pETDuet-1 BamHI site generated in 
MCS2 of pDuet1; XhoI site 
within the NZGFP sequence 
removed by conservative 
mutations (Ref. Chapter V, 
Section V.2.A, p103) 
pJSGFP18 pJS-Duet1-NZGFPexact(MCS1)-
WTecLRS(MCS2) 
pETDuet-1 (His)6-NZGFP and wild type 
E. coli LeuRS cloned in 
MCS1 and MCS2 of pDuet1 
vector, respectively 
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Appendix.  Plasmid Constructs (continued) 
 
Alias Plasmid name Parent vector Description 
pJSGFP19 pJS-Duet1-NZGFPexact(MCS1)-
YDDecLRS(MCS2) 
pETDuet-1 (His)6-NZGFP and YDD 
editing defective  E. coli 
LeuRS cloned in MCS1 and 
MCS2 of pDuet1 vector, 
repectively 
pJSspl20 p14JSymCP1-βext pET14b Isolated ymCP1-βext protein 
fragment:  ym CP1 domain 
including the β-strands and 
extensions (Lys232 to 
Tyr452) 
pJSspl21 p14JSymW238C-CP1-βext pET14b Isolated ymCP1-βext protein 
fragment bearing the 
mutation W238C 
pJSspl22 pGEX2T-MAT2-bI4matfix pGEX2T-MAT2 bI4 maturase gene corrected 
for missing Asn253 
 
